EOS Med Chem Impurity Stock 20201029-36

   

EOS Med Chem is serving more than 100 Pharma companies, we have the original Drug Discovery Compounds, Like Impurity, small molecule and inhibitor.

Impurity we keep stock more than 80000, most in stock, we are World Sole Original Supplier, Each impurity we could supply: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA.

EOS Med Chem Quotation include: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, COA, MSDS.

Welcome to visit: our youtube:  https://youtu.be/r5cJdXKNXHk 

Contact:

EOS Med Chem, Medicinal Chemical is Big

執大象，天下往，往而無害，安平泰

Ms Nina

Youtube: https://youtu.be/r5cJdXKNXHk 

E: info@eosmedchem.com 

W: www.eosmedchem.com 

Tel: 0086-531-69905422

SALE OFFICE: 16F, China Overseas Plaza, Jinan City, China

Tauroursodeoxycholic Acid-d4, CAS: /, stock: 5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₁D₄NO₆S.

Ursocholic Acid, CAS: 2955-27-3, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₀O₅.

Tacalcitol Monohydrate, CAS: 93129-94-3, stock: 9.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₃•H₂O.

Tachysterol3  (80%), CAS: 17592-07-3, stock: 9.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O.

Ursodeoxycholic Acid 2-Butyl Ester, CAS: /, stock: 9.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₈O₄.

Tributyrin, CAS: 60-01-5, stock: 5.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₆O₆.

Tributyrin-d5, CAS: /, stock: 5.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁D₅O₆.

Ursodeoxycholic Acid Acyl-β-D-glucuronide, >85%, CAS: 208038-28-2, stock: 9.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₈O₁₀.

Ursodeoxycholic Acid-d4, CAS: 347841-46-7, stock: 7.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₆D₄O₄.

Vitamin D3 β-D-Glucuronide Potassium Salt, CAS: /, stock: 9.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₁KO₇.

Vitamin D3 β-D-Glucuronide, >90%, CAS: 57918-08-8, stock: 6.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₂O₇.

Ursodeoxycholic Acid-d4 (Major), CAS: 347841-46-7, stock: 5.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₆D₄O₄.

Vitamin D3 β-D-Glucuronide-d7, CAS: /, stock: 6.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₅D₇O₇.

Vitamin D3 Sulfate Sodium Salt, CAS: 78392-27-5, stock: 2.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄NaO₄S.

Vitamin D3 Sulfate-D7 Sodium Salt, CAS: /, stock: 7.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₆D₇NaO₄S.

(-)-O-Methyldauricine, CAS: 2202-17-7, stock: 9.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₄₆N₂O₆.

(R)-(-)-Hydroxy Chloroquine Diphosphate, CAS: 158749-75-8, stock: 4.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂ClN₃O₉P₂.

(R)-(-)-Hydroxy Chloroquine-d4 Diphosphate, CAS: /, stock: 3.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈D₄ClN₃O₉P₂.

(R)-(-)-Hydroxy Chloroquine-d5 Diphosphate, CAS: /, stock: 7.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇D₅ClN₃O₉P₂.

(R)-Desethylchloroquine, CAS: 106848-88-8, stock: 8.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂ClN₃.

(S)-(+)-Hydroxy Chloroquine Diphosphate, CAS: 158749-76-9, stock: 3.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂ClN₃O₉P₂.

(S)-(+)-Hydroxy Chloroquine-d4 Diphosphate, CAS: /, stock: 7.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈D₄ClN₃O₉P₂.

(S)-(+)-Hydroxy Chloroquine-d5 Diphosphate, CAS: /, stock: 3.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇D₅ClN₃O₉P₂.

10-DEBC Hydrochloride, CAS: 925681-41-0, stock: 8.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅N₂OCl • HCl.

2-(4-((7-Chloroquinolin-4-yl)amino)pentyl)isoindoline-1,3-dione, CAS: /, stock: 7.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀ClN₃O₂.

2-Methyl-1,3-dioxolane-2-propanoic Acid Methyl Ester-d2, CAS: 1216512-70-7, stock: 7.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂D₂O₄.

2-Methyl-1,3-dioxolane-2-propanol-d4, CAS: 1215630-77-5, stock: 5.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀D₄O₃.

2-[[(4R)-4-[(7-chloro-4-quinolinyl)amino]pentyl]ethylamino]-ethanol, CAS: 137433-23-9, stock: 7.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆ClN₃O.

2-[[(4S)-4-[(7-chloro-4-quinolinyl)amino]pentyl]ethylamino]-ethanol, CAS: 137433-24-0, stock: 8.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆ClN₃O.

3-Acetopropanol, CAS: 1071-73-4, stock: 1.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₂.

4-Amino-1-pentanol-d4, CAS: 1216666-53-3, stock: 7.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉D₄NO.

4-Amino-1-pentanol-d4 Benzyl Ether, CAS: /, stock: 7.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃D₄NO₂.

4-[(7-Chloro-4-quinolinyl)amino]-1-pentanol-d4, CAS: 1215752-28-5, stock: 4.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃D₄ClN₂O.

5,6-Dimethoxy-8-nitroquinoline, CAS: 08/02/5333, stock: 6.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀N₂O₄.

5-(N-Ethyl-N-2-hydroxyethylamino)-2-penthlamine, CAS: 69559-11-1, stock: 2.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₂N₂O.

5-(N-Ethyl-N-2-hydroxyethylamino)-2-penthlamine-d4, CAS: /, stock: 4.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈D₄N₂O.

5-Fluoroorotic Acid Monohydrate (Ultra Pure), CAS: 220141-70-8, stock: 9.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅FN₂O₅.

5-Fluoroorotic Acid Monohydrate-13C15N2, CAS: /, stock: 7.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄¹³CH₅F¹⁵N₂O₅.

6-Chloro-1,2,3,4-tetrahydro-N-[2-(4-methyl-1-piperazinyl)ethyl]-9-acridinamine, CAS: /, stock: 1.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₇ClN₄.

7-Chloro-4-(2-methyl-1-pyrrolidinyl)-quinoline, CAS: 6281-58-9, stock: 8.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅ClN₂.

Amopyroquine, CAS: 550-81-2, stock: 7.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀ClN₃O.

bis-(4-Methyl-1-homopiperazinylthiocarbonyl)disulfide, CAS: 26087-98-9, stock: 3.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₆N₄S₄.

Chloroquine, CAS: 54-05-7, stock: 2.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆ClN₃.

Chloroquine Diphosphate Salt, CAS: 50-63-5, stock: 9.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂ClN₃O₈P₂.

Chloroquine Sulfate, CAS: 132-73-0, stock: 9.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁ClN₂O₆S.

Chloroquine-d4 Phosphate Salt, CAS: /, stock: 3.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂D₄ClN₃ •xH₃PO₄.

Cletoquine, CAS: 4298-15-1, stock: 5.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂ClN₃O.

Cletoquine Oxalate, CAS: 14142-64-4, stock: 5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄ClN₃O₅.

Cletoquine-d4, CAS: /, stock: 1.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈D₄ClN₃O.

Cletoquine-d4 Oxalate, CAS: 1216461-57-2, stock: 4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀D₄ClN₃O₅.

Clioquinol, CAS: 130-26-7, stock: 7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅ClINO.

Desethyl Chloroquine, CAS: 1476-52-4, stock: 9.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂ClN₃.

Desethyl Chloroquine-d4, CAS: 1189971-72-9, stock: 3.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈D₄ClN₃.

Didesethyl Chloroquine, CAS: 4298-14-0, stock: 8.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈ClN₃.

Didesethyl Chloroquine Hydroxyacetamide, CAS: 1159977-30-6, stock: 5.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀ClN₃O₂.

Didesethyl Chloroquine Hydroxyacetamide-d4, CAS: 1216956-86-3, stock: 9.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆D₄ClN₃O₂.

Didesethyl Chloroquine-d4, CAS: 1215797-41-3, stock: 3.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄D₄ClN₃.

Ferroquine, CAS: 185055-67-8, stock: 7.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄ClFeN₃.

Hydroxychloroquine Dimer, CAS: /, stock: 9.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₀Cl₂N₆O.

Hydroxychloroquine N-Oxide, CAS: 1449223-88-4, stock: 3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆ClN₃O₂.

Hydroxychloroquine O-Sulfate Sodium Salt, CAS: /, stock: 6.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅ClN₃NaO₄S.

Hydroxychloroquine Sulfate, CAS: 747-36-4, stock: 6.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈ClN₃O₅S.

Hydroxychloroquine-d4 O-Sulfate, CAS: /, stock: 2.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂D₄ClN₃O₄S.

Hydroxychloroquine-d4 Sulfate, CAS: 1216432-56-2, stock: 9.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄D₄ClN₃O₅S.

N-(Glycoloyloxy)-succinimide, CAS: 19374-87-9, stock: 3.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇NO₅.

N-Acetyl Desethyl Chloroquine-d4, CAS: 1216619-20-3, stock: 8.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀D₄ClN₃O.

N-Desethyl Chloroquine Hydrochloride, CAS: 07/11/4298, stock: 5.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃Cl₂N₃.

N-Didestethyl Chloroquine-d4 Phthalimide, CAS: /, stock: 3.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₆D₄ClN₃O₂.

N-[4-[(7-Chloro-4-quinolinyl)amino]pentyl]-N-ethyl-carbamic Acid 2,2,2-Trichloroethyl Ester, CAS: 1026601-42-2, stock: 5.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃Cl₄N₃O₂.

N1,N2-Bis(7-chloroquinolin-4-yl)ethane-1,2-diamine, CAS: 140926-75-6, stock: 7.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆Cl₂N₄.

N1,N4-Bis-(7-chloroquinolin-4-yl)-N1-ethylpentane-1,4-diamine, CAS: /, stock: 2.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₆Cl₂N₄.

Quensyl-1-acetate, CAS: 47493-14-1, stock: 5.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈ClN₃O₂.

Quensyl-1-acetate-d3, CAS: /, stock: 6.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅D₃ClN₃O₂.

((O,O’)-tert-Butyldimethylsilyl) Ezetimibe, CAS: /, stock: 2.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₉F₂NO₃Si₂.

((O,O’)-tert-Butyldimethylsilyl) Seco-ezetimibe, CAS: /, stock: 3.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₃F₂NO₃Si₂.

(1,1-Dimethylethyl)[[(3β,25R)-ergosta-5,24(28)-dien-3-yl]oxy]dimethyl Silane, CAS: /, stock: 7.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₆₀OSi.

(1-(Methoxy(methyl)amino)-1-oxopropan-2-yl)(methyl)carbamic Acid tert-Butyl Ester, CAS: /, stock: 7.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂O₄.

(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester (2Z)-2-Methyl-2-butenoic Acid, CAS: 1048973-04-1, stock: 6.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄O₅.

(20R)-17α,20-Dihydroxycholesterol, CAS: 17913-42-7, stock: 6.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₃.

(20R)-17α,20-Dihydroxycholesterol-d7, CAS: /, stock: 7.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₉D₇O₃.

(22S)-22-Hydroxycholest-5-en-3β-yl Acetate, CAS: 54604-57-8, stock: 3.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₈O₃.

(24S)-24,25-Epoxycholesterol, CAS: 77058-74-3, stock: 1.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₂.

(24S)-Campestanol, CAS: 09/02/6538, stock: 6.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₅₀O.

(25R)-26-​Hydroxycholesterol, CAS: 20380-11-4, stock: 6.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₂.

(2R,​3R,​6S)​-6-​(4-​Fluorophenyl)​tetrahydro-​2-​(4-​hydroxyphenyl)​-2H-pyran-3-carboxylic Acid, CAS: 1618657-31-0, stock: 9.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇FO₄.

(2S,3R)-2-((1aR,3aR,5aS,10R,10aR)-10-Methoxy-3a,5a-dimethylhexadecahydrocyclopenta[a]cyclopropa[2,3]cyclopenta[1,2-f]naphthalen-6-yl)-6-methylheptan-3-yl 4-nitrobenzoate, CAS: /, stock: 9.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₅₁NO₅.

(2S,3R)-2-((3S,10R,13S)-3-Hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-6-methylheptan-3-yl 4-Nitrobenzoate, CAS: /, stock: 7.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₉NO₅.

(3-Bromopropoxy)-tert-butyldimethylsilane, CAS: 89031-84-5, stock: 5.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₁BrOSi.

(3’R)-Ezetimibe, CAS: 163380-16-3, stock: 3.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁F₂NO₃.

(3’S)-ent-Ezetimibe, CAS: 1593543-00-0, stock: 7.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁F₂NO₃.

(3’S,3R,4R)-Ezetimibe, CAS: 1478664-02-6, stock: 4.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁F₂NO₃.

(3’S,3R,4S)-Desfluoro Ezetimibe, CAS: 190595-66-5, stock: 8.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂FNO₃.

(3α,5α,6α)-3,6-Dihydroxy-pregnan-20-one, CAS: 16134-81-9, stock: 8.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₄O₃.

(3α,5β,6α)-3,6-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-7-oxo-cholan-24-oic Acid, CAS: 125112-90-5, stock: 1.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₆O₅Si₂.

(3α,5β,6α)-3,6-Bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-7-oxo-cholan-24-oic Acid Methyl Ester, CAS: 125112-75-6, stock: 7.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₆₈O₅Si₂.

(3α,5β,6α)-3,6-Dihydroxy-7-oxo-cholan-24-oic Acid, CAS: 88725-42-2, stock: 6.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₈O₅.

(3α,5β,7α,12α)-3,7,12-Trihydroxy-cholest-24-en-26-oic Acid Ethyl Ester, CAS: 157401-01-9, stock: 8.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₈O₅.

(3α,5β,7α,12α)-3,7,12-Tris(ethoxymethoxy)-cholan-24-al, CAS: /, stock: 4.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₈O₇.

(3α,5β,7α,12α)-3,7,12-Tris(ethoxymethoxy)-cholan-24-oic Acid Methyl Ester, CAS: /, stock: 6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₆₀O₈.

(3α,5β,7α,12α)-3,7,12-Tris(ethoxymethoxy)-cholan-24-ol, CAS: /, stock: 2.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₆₀O₇.

(3α,5β,7α,12α)-3,7,12-Tris(ethoxymethoxy)-cholest-24-en-26-oic Acid Ethyl Ester, CAS: /, stock: 1.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₆₆O₈.

(3α,5β,7α,12α,24E)-3,7,12-Trihydroxy-cholest-24-en-26-oic Acid, CAS: 85552-38-1, stock: 4.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₅.

(3β)-24-Bromo-3-[(tert-butyl)dimethylsilyloxy]-chol-5-ene, CAS: 1384736-07-5, stock: 9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₃BrOSi.

(3β)-24-Bromochol-5-en-3-ol, CAS: 74041-57-9, stock: 8.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₉BrO.

(3β)-26,27-Dinorcholest-5-en-24-yne-3,20-diol, CAS: 1397692-46-4, stock: 6.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₈O₂.

(3β)-26,27-Dinorcholest-5-en-24-yne-3,20-diol-d4, CAS: /, stock: 3.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₄D₄O₂.

(3β)-3,25-Dihydroxycholest-5-en-7-one, CAS: 64907-23-9, stock: 4.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₃.

(3β)-3-(Acetyloxy)-chol-5-ene-24-carboxylic Acid Ethyl Ester, CAS: 75861-02-8, stock: 6.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₆O₄.

(3β)-3-O-tert-Butyldimethylsilyl-cholest-5-ene-3,24-diol, CAS: 84529-86-2, stock: 3.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₄O₂Si.

(3β)-3-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-26,27-dinorcholest-5-ene-25-nitrile, CAS: 1384736-11-1, stock: 7.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₅₃NOSi.

(3β)-3-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-cholest-5-en-24-ol, CAS: 296758-98-0, stock: 4.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₆₀O₂Si.

(3β)-3-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-cholest-5-en-24-ol-d3, CAS: /, stock: 1.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₇D₃O₂Si.

(3β)-3-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-cholest-5-en-24-one, CAS: 130474-20-3, stock: 8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₈O₂Si.

(3β)-3-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-cholest-5-en-24-one-d3, CAS: /, stock: 6.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₅D₃O₂Si.

(3β)-7-Dehydro Cholesterol, CAS: 434-16-2, stock: 7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O.

(3β)-7-Dehydro Cholesterol-d7, CAS: 388622-58-0, stock: 8.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇D₇O.

(3β)-7-Dehydro Cholesterol-d7 (Major), CAS: 388622-58-0, stock: 1.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇D₇O.

(3β)-Cholest-5-ene-3,24-diol 24-Methylbenzenesulfonate 3-O-Tetrahydropyranyl Ether, CAS: 70141-04-7, stock: 5.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₄O₅S.

(3β)-Cholesta-4,6-dien-3-ol, CAS: 14214-69-8, stock: 7.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O.

(3β)​-Ergosta-​5,​24(28)​-​dien-​3-​ol-​28-​13C, CAS: 1239278-54-6, stock: 5.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇¹³CH₄₆O.

(3β,12α)-3,12-Bis[(trimethylsilyl)oxy]-chol-5-en-26-oic Acid Methyl Ester, CAS: /, stock: 8.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₇₄O₅Si₂.

(3β,20S)-21-Iodo-20-methyl-pregn-3-en-3-ol Acetate, CAS: 129779-43-7, stock: 1.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₇IO₂.

(3β,20S)-5,6-Dibromo-20-formyl-3-hydroxy-5-pregnene 3-O-Acetate, CAS: /, stock: 8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₆Br₂O₃.

(3β,22R)-Dihydroxy Cholesterol, CAS: 596-94-1, stock: 6.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₃.

(3β,22S)-Dihydroxy Cholesterol, CAS: 26649-05-8, stock: 7.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₃.

(3β,24S)-Cholest-5-ene-3,24-diol, CAS: 474-73-7, stock: 8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₂.

(3β,25S)-Cholest-5-ene-3,26-diol, CAS: 56845-83-1, stock: 3.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₂.

(3β,5α,6β)-3,6-Dihydroxy-pregnan-20-one, CAS: 14357-63-2, stock: 7.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₄O₃.

(3β,5β,12α)-3,12-Bis(acetyloxy)-7-oxo-cholestan-26-oic Acid Methyl Ester, CAS: /, stock: 7.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₀O₇.

(3β,5β,12α)-3,12-Dihydroxy-7-oxo-cholestan-26-oic Acid Methyl Ester, CAS: /, stock: 9.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₆O₅.

(3β,5β,7α,12α)-3,7,12-Trihydroxy-cholest-24-en-26-oic Acid Ethyl Ester, CAS: /, stock: 5.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₈O₅.

(3β,5β,7α,12α)-3,7,12-Trihydroxy-cholestan-26-oic Acid, CAS: 78608-74-9, stock: 6.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₅.

(3β,5β,7α,12α)-3,7,12-Tris[(tetrahydro-2H-pyran-2-yl)oxy]-cholan-24-al, CAS: /, stock: 6.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₄O₇.

(3β,5β,7α,12α)-3,7,12-tris[(tetrahydro-2H-pyran-2-yl)oxy]-cholan-24-oic Acid Methyl Ester, CAS: /, stock: 9.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₆₆O₈.

(3β,5β,7α,12α)-3,7,12-Tris[(tetrahydro-2H-pyran-2-yl)oxy]-cholan-24-ol, CAS: /, stock: 7.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₆O₇.

(3β,5β,7α,12α)-3,7,12-Tris[[(1,1-dimethylethyl)dimethylsilyl]oxy]-cholan-24-oic Acid Methyl Ester, CAS: /, stock: 7.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₈₄O₅Si₃.

(3β,5β,7α,12α,24E)-3,7,12-Trihydroxy-cholest-24-en-26-oic Acid, CAS: /, stock: 4.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₅.

(3β,7α)-3-O-Benzoyl-7-O-tert-butyldimethylsilyl-cholest-5-ene-3,7-diol, CAS: /, stock: 2.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₆₄O₃Si.

(3β,7α)-Cholest-5-ene-3,7-diol 3-Benzoate, CAS: 40824-59-7, stock: 9.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₀O₃.

(3β,α,25R)-Cholest-5-ene-3,7,26-triol, CAS: 144300-24-3, stock: 3.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₃.

(3R)-2-(4-Fluorophenyl)-3-[4-(phenylmethoxy)phenyl]-2-azaspiro[3.5]nonane-1,7-dione, CAS: 194367-70-9, stock: 1.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₄FNO₃.

(3R,4R)-4-[4-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]phenyl]-1-(4-fluorophenyl)-3-[2-[2-(4-fluorophenyl)-5,5-dimethyl-1,3-dioxan-2-yl]ethyl]-2-azetidinone, CAS: 1478663-98-7, stock: 2.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₃F₂NO₄Si.

(3R,4R)-4-[4-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]phenyl]-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]-2-azetidinone, CAS: /, stock: 3.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₃F₂NO₃Si.

(3R,4R,3’R)-Ezetimibe, CAS: 1593542-96-1, stock: 4.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁F₂NO₃.

(3R,4S)-1-(4-Fluorophenyl)-3-[(3S)-3-(4-fluorophenyl)-3-[(trimethylsilyl)oxy]propyl]-4-[4-[(trimethylsilyl)oxy]phenyl]-2-azetidinone-d4, CAS: /, stock: 1.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₃D₄F₂NO₃Si₂.

(3R,6E,10E,14E,18E)-2,6,10,15,19,23-Hexamethyl-6,10,14,18,22-tetracosapentaene-2,3-diol, CAS: 63976-65-8, stock: 3.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₂O₂.

(3R,S)-Oxidosqualene (>90%), CAS: 7200-26-2, stock: 4.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₀O.

(3S,4S)-1-(4-Fluorophenyl)-3-[3-(4-fluorophenyl)-3-oxopropyl]-4-(4-hydroxyphenyl)-2-azetidinone, CAS: 1478664-17-3, stock: 2.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₉F₂NO₃.

(3S,4S)-4-(4-(Benzyloxy)phenyl)-3-((S)-1,2-dihydroxyethyl)-1-(4-fluorophenyl)azetidin-2-one, CAS: 221349-56-0, stock: 5.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂FNO₄.

(3S,4S,3’R)-Ezetimibe, CAS: 1478664-18-4, stock: 6.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁F₂NO₃.

(3S,4S,3’S)-Ezetimibe, CAS: 1593543-07-7, stock: 1.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁F₂NO₃.

(3Z,6Z,9Z,12Z,15Z)-21,21-Diethoxyhenicosa-3,6,9,12,15-pentaene, CAS: /, stock: 3.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₂O₂.

(4-Chlorophenyl)diphenylmethanol, CAS: 6922-89-0, stock: 6.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₅ClO.

(4α)-7-Dehydro-4,25-dihydroxycholesterol, CAS: /, stock: 9.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₃.

(4β)-7-Dehydro-4,25-dihydroxycholesterol, CAS: /, stock: 6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₃.

(4R)-3-[(2R,5S)-5-(2-Fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino][4-[(trimethylsilyl)oxy]phenyl]methyl]-1-oxo-5-[(trimethylsilyl)oxy]pentyl]-4-phenyl-2-oxazolidinone, CAS: /, stock: 3.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₄₆F₂N₂O₅Si₂.

(4R)-3-[(2S)-2-[(R)-[4-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]phenyl][(4-fluorophenyl)amino]methyl]-4-[2-(4-fluorophenyl)-5,5-dimethyl-1,3-dioxan-2-yl]-1-oxobutyl]-4-phenyl-2-oxazolidinone, CAS: 1593542-67-6, stock: 8.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₅₂F₂N₂O₆Si.

(4R)-3-[(2S)-2-[(S)-[4-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]phenyl][(4-fluorophenyl)amino]methyl]-4-[2-(4-fluorophenyl)-5,5-dimethyl-1,3-dioxan-2-yl]-1-oxobutyl]-4-phenyl-2-oxazolidinone, CAS: 1478664-10-6, stock: 3.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₅₂F₂N₂O₆Si.

(4R)-3-[4-[2-(4-Fluorophenyl)-5,5-dimethyl-1,3-dioxan-2-yl]-1-oxobutyl]-4-phenyl-2-oxazolidinone, CAS: 1478664-06-0, stock: 5.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈FNO₅.

(4R,6R)-6-[2-[(2S)-1,2-Dihydro-6-hydroxy-2-methyl-1-naphthalenyl]ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one, CAS: /, stock: 6.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂O₄.

(4S)-3-[(2R)-2-[(R)-[4-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]phenyl][(4-fluorophenyl)amino]methyl]-4-[2-(4-fluorophenyl)-5,5-dimethyl-1,3-dioxan-2-yl]-1-oxobutyl]-4-phenyl-2-oxazolidinone, CAS: 1478663-96-5, stock: 5.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₅₂F₂N₂O₆Si.

(4S)-3-[(2R)-2-[(S)-[4-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]phenyl][(4-fluorophenyl)amino]methyl]-4-[2-(4-fluorophenyl)-5,5-dimethyl-1,3-dioxan-2-yl]-1-oxobutyl]-4-phenyl-2-oxazolidinone, CAS: 1478663-95-4, stock: 2.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₅₂F₂N₂O₆Si.

(4S)-3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(R)-[(4-fluorophenyl)amino](4-hydroxyphenyl)methyl]-5-hydroxy-1-oxopentyl]-4-phenyl-2-oxazolidinone, CAS: 1621715-63-6, stock: 4.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₀F₂N₂O₅.

(4S)-3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino](4-hydroxyphenyl)methyl]-5-hydroxy-1-oxopentyl]-4-phenyl-2-oxazolidinone, CAS: 1185883-40-2, stock: 4.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₀F₂N₂O₅.

(4S)-3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino][4-[(trimethylsilyl)oxy]phenyl]methyl]-1-oxo-5-[(trimethylsilyl)oxy]pentyl]-4-phenyl-2-oxazolidinone-d4, CAS: /, stock: 9.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₄₂D₄F₂N₂O₅Si₂.

(4S)-3-[(4E)-5-(4-Fluorophenyl)-1-oxo-4-penten-1-yl]-4-phenyl-2-oxazolidinone, CAS: 190595-62-1, stock: 3.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈FNO₃.

(4S)-3-[4-[2-(4-Fluorophenyl)-5,5-dimethyl-1,3-dioxan-2-yl]-1-oxobutyl]-4-phenyl-2-oxazolidinone, CAS: 953805-20-4, stock: 8.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈FNO₅.

2,4,5-Trichloro-1,3-benzenedicarbonitrile, CAS: 23039-03-4, stock: 1.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈HCl₃N₂.

(4S,5R)-3-(4-Fluorophenyl)-5-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)-1,3-oxazinan-2-one, CAS: /, stock: 2.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₃F₂NO₄.

(4S,5R)-4-(4-(Benzyloxy)phenyl)-3-(4-fluorophenyl)-5-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-1,3-oxazinan-2-one, CAS: /, stock: 3.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₉F₂NO₄.

5-Iodo-2,4,6-trichloroisophthalonitrile, CAS: 1246814-99-2, stock: 2.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈Cl₃IN₂.

Chlorothalonil, CAS: 1897-45-6, stock: 7.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈Cl₄N₂.

(4S,5R)-5-((S)-3-((tert-Butyldimethylsilyl)oxy)-3-(4-fluorophenyl)propyl)-4-(4-((tert-butyldimethylsilyl)oxy)phenyl)-3-(4-fluorophenyl)-1,3-oxazinan-2-one, CAS: /, stock: 2.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₁F₂NO₄Si₂.

(4S3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino][4-[(trimethylsilyl)oxy]phenyl]methyl]-1-oxo-5-[(trimethylsilyl)oxy]pentyl]-4-phenyl-2-oxazolidinone, CAS: 272778-12-8, stock: 1.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₄₆F₂N₂O₅Si₂.

Hydroxy Chlorothalonil, CAS: 28343-61-5, stock: 6.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈HCl₃N₂O.

N-(Dimethylsulfamoyl)aniline-d5, CAS: 1246819-81-7, stock: 8.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇D₅N₂O₂S.

(5β,7α,12α)-7,12-Bis(formyloxy)-3-oxo-cholestan-26-oic Acid Methyl Ester, CAS: /, stock: 3.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₆O₇.

(5β,7α,12α)-7,12-Bis(formyloxy)-3-oxo-cholestan-4-en-26-oic Acid Methyl Ester, CAS: /, stock: 2.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₄O₇.

(5β,7α,12α)-7,12-Dihydroxy-3-oxo-cholestan-26-oic Acid Methyl Ester, CAS: 110107-08-9, stock: 8.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₆O₅.

(5R,6S)-1-(4-Fluorophenyl)-5-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-3-((S)-2-hydroxy-1-phenylethyl)-6-(4-hydroxyphenyl)dihydropyrimidine-2,4(1H,3H)-dione, CAS: /, stock: 5.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₀F₂N₂O₅.

(5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-Eicosapentaen-1-ol-1-(4-methylbenzenesulfonate), CAS: 1802728-83-1, stock: 1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₈O₃S.

(7α)-7-tert-Butyldimethylsilyloxy-cholest-5-en-3-one, CAS: /, stock: 9.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₈O₂Si.

(all-Z)-5,8,11,14,17-Eicosapentaen Chloride, CAS: /, stock: 4.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₁Cl.

(all-Z)-5,8,11,14,17-Eicosapentaen-1-al, CAS: /, stock: 7.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₂O.

(all-Z)-5,8,11,14,17-Eicosapentaen-1-carbonitrile, CAS: /, stock: 9.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁N.

(all-Z)-5,8,11,14,17-Eicosapentaen-1-ol, CAS: 164221-12-9, stock: 9.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂O.

(all-Z)-6,9,12,15,18-Heneicosapentaenoic Acid Ethyl Ester, CAS: 131775-86-5, stock: 9.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₆O₂.

(all-Z)-6,9,12,15,18-Heneicosapentaenoic Acid Ethyl Ester-d5, CAS: /, stock: 8.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁D₅O₂.

(E)-N-Benzylidene-4-fluoroaniline, CAS: 83306-62-1, stock: 5.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀FN.

(R)-3-((S)-5-(4-Fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one, CAS: 404874-94-8, stock: 6.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀FNO₄.

(R)-4-Hydroxy-6-(4-methoxyphenoxy)-4-methylhexanenitrile, CAS: /, stock: 4.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₃.

(S)-2-Methyl-CBS-oxazaborolidine (1 M in Toluene), CAS: 112022-81-8, stock: 1.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀BNO.

(S)-3-((R)-5-(4-Fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one, CAS: 528565-93-7, stock: 7.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀FNO₄.

(S)-3-((S)-5-Hydroxy-5-(p-tolyl)pentanoyl)-4-phenyloxazolidin-2-one, CAS: /, stock: 9.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO₄.

(S)-3-(1,5-Dioxo-5-(4-methyl)phenylpentyl)-4-phenyl-2-oxazolidinone, CAS: /, stock: 2.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁NO₄.

(S)-4-(4-Methoxyphenoxy)-2-methylbutane-1,2-diol, CAS: 209118-78-5, stock: 9.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈O₄.

(S)-4-Phenyl-2-oxazolidinone, CAS: 99395-88-7, stock: 2.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₂.

(S)-Ethyl 2-(2-Benzyl-3-((methylsulfonyl)oxy)propanamido)acetate, CAS: /, stock: 4.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO₆S.

(S)-N,5-Bis(4-fluorophenyl)-5-hydroxypentanamide, CAS: /, stock: 9.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇F₂NO₂.

(S)-N-(4-Fluorophenyl)-1-[hydroxy[4-(phenylmethoxy)phenyl]methyl]-4-oxo-cyclohexanecarboxamide, CAS: 182227-24-3, stock: 2.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₆FNO₄.

1,9-Bis(4-fluorophenyl)nonane-1,5,9-trione O,O,O-Trimethyl Trioxime, CAS: /, stock: 9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉F₂N₃O₃.

1,9-Bis(4-fluorophenyl)nonane-1,5,9-trione-d8 O,O,O-Trimethyl Trioxime, CAS: /, stock: 7.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁D₈F₂N₃O₃.

1-Methoxy-4-[(3-methyl-3-buten-1-yl)oxy]benzene, CAS: 169310-73-0, stock: 1.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₂.

1-[(3β,7α)-3-(Acetyloxy)cholesta-5,8-dien-7-yl]-1,2-hydrazinedicarboxylic Acid 1,2-Diisoprpyl Ester, CAS: /, stock: 5.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₆₀N₂O₆.

12-Hydroxy-3-oxo-cholest-4-en-26-oic Acid, CAS: /, stock: 5.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀O₄.

12-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-3,15-dihydroxy-cholest-5-en-26-oic Acid, CAS: /, stock: 5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₈O₅Si.

17α-Progesterone, CAS: 2000-66-0, stock: 6.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₀O₂.

19-Carboxy Cholesterol, CAS: 26319-96-0, stock: 3.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₃.

19-Hydroxy Cholesterol, CAS: 561-63-7, stock: 7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₂.

19-Hydroxy Cholesteryl 3-Acetate, CAS: 750-59-4, stock: 5.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₈O₃.

2,2,2-Trifluoroethyl perfluorobutanesulphonate, CAS: 79963-95-4, stock: 9.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂F₁₂O₃S.

2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47-Hexadecaoxanonatetracontan-49-ol, CAS: 133604-58-7, stock: 3.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₆₈O₁₇.

2-(3-Butynyloxy)tetrahydro-2H-pyran, CAS: 40365-61-5, stock: 5.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄O₂.

2-(4-Bromophenyl)naphthalene, CAS: 22082-99-1, stock: 3.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁Br.

2-(Acetyloxy)-1-[3,5-dimethoxy-4-(benzoyloxy)phenyl]ethanone, CAS: /, stock: 8.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈O₇.

2-(tert-Butoxycarbonyloxyimino)phenylacetonitrile, CAS: 58632-95-4, stock: 7.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄N₂O₃.

2-Bromoethylcyclopropane, CAS: 36982-56-6, stock: 8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉Br.

2-Cyclopropylethanol, CAS: 2566-44-1, stock: 7.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O.

2-Hexadecanone, CAS: 18787-63-8, stock: 4.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₂O.

2-Methylpyrrolidine, CAS: 765-38-8, stock: 10g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁N.

2-Pentynol, CAS: 6261-22-9, stock: 3.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈O.

2-[(3β)-Cholesta-5,24-dien-3-yloxy]tetrahydro-2H-pyran, CAS: 51231-31-3, stock: 7.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₂O₂.

2-[(E)-[(4-Fluorophenyl)imino]methyl]phenol, CAS: 252573-77-6, stock: 7.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀FNO.

2-[2-(4-Fluorophenyl)-2-oxo-1-phenyl-d5-ethyl]-4-methyl-3-oxo-pentanoic Acid, (2-Benzyloxy-phenyl)-amide, CAS: 1020719-43-0, stock: 5.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₅D₅FNO₄.

2-[2-(4-Fluorophenyl)-2-oxo-1-phenyl-d5-ethyl]-4-methyl-3-oxo-pentanoic Acid, (4-Benzyloxy-phenyl)-amide, CAS: 1020719-44-1, stock: 6.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₅D₅FNO₄.

2-[2-(4-Fluorophenyl)-2-oxo-1-phenyl-ethyl]-4-methyl-3-oxo-pentanoic Acid, (2-Benzyloxy-phenyl)-amide, CAS: 887355-33-1, stock: 2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₀FNO₄.

2-[2-(4-Fluorophenyl)-2-oxo-1-phenyl-ethyl]-4-methyl-3-oxo-pentanoic Acid, (4-Benzyloxy-phenyl)-amide, CAS: 163217-67-2, stock: 3.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₀FNO₄.

2-[[(3β)-24-Chlorochol-5-en-3-yl]oxy]tetrahydro-2H-pyran, CAS: /, stock: 7.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₇ClO₂.

20-Dehydro Cholesterol 3-Acetate, CAS: 54548-85-5, stock: 8.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₆O₂.

20-Dehydro Cholesterol-d7 3-Acetate, CAS: /, stock: 8.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₉D₇O₂.

20α-Hydroxy Cholesterol, CAS: 516-72-3, stock: 1.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₂.

20α-Hydroxy Cholesterol-d7, CAS: /, stock: 9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₉D₇O₂.

22(R)-Hydroxycholesterol-d7, CAS: 1246302-93-1, stock: 4.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₉D₇O₂.

22-Dehydro 25-Hydroxy Cholesterol, CAS: 85640-27-3, stock: 4.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₂.

22-Dehydro 25-Hydroxy Cholesterol 3-Acetate, CAS: 157171-88-5, stock: 1.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₆O₃.

22-Dehydro Cholesterol-d7 3-Acetate, CAS: /, stock: 9.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₉D₇O₂.

22-Hydroxy Cholesterol(Mixture of Diastereomers), CAS: 17711-16-9, stock: 1.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₂.

22-Hydroxy Cholesterol-d11(Mixture of Diastereomers), CAS: /, stock: 8.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₅D₁₁O₂.

22α-Hydroxy Cholesterol, CAS: 17954-98-2, stock: 9.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₂.

22β-Hydroxy Cholesterol, CAS: 22348-64-7, stock: 4.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₂.

24(R/S)-Hydroxycholesterol-d7, CAS: 144154-78-9, stock: 2.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₉D₇O₂.

24,25-Epoxycholesterol, CAS: 72542-49-5, stock: 3.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₂.

24-Epicerebrosterol, CAS: 27460-26-0, stock: 6.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₂.

24-Hydroxycholesterol, CAS: 30271-38-6, stock: 7.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₂.

24-Hydroxycholesterol-d4, CAS: /, stock: 6.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₂D₄O₂.

24-Ketocholesterol, CAS: 17752-16-8, stock: 8.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₂.

25-Hydroxy Cholesterol, CAS: 2140-46-7, stock: 6.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₂.

25-Hydroxy Cholesterol-d6, CAS: 88247-69-2, stock: 9.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀D₆O₂.

25-Hydroxy-cholesterol 3-Sulfate Ester Sodium Salt, CAS: 1174047-40-5, stock: 9.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₅NaO₅S.

25-Hydroxy-cholesterol 3-Sulfate Ester Sodium Salt-d6, CAS: /, stock: 6.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₉D₆NaO₅S.

25-Hydroxylumisterol, CAS: 61585-29-3, stock: 3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₂.

25-Hydroxyprovitamin D3, CAS: 22145-68-2, stock: 7.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₂.

25-Hydroxyprovitamin D3-d6, CAS: /, stock: 8.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₈D₆O₂.

25-Hydroxytachysterol, CAS: 39932-44-0, stock: 1.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

25R-3α,7α,12α-Trihydroxy-5β-cholestanoic Acid, CAS: 23740-14-9, stock: 3.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₅.

27-Alkyne Cholesterol, CAS: 1527467-07-7, stock: 3.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O.

27-Carboxy-7-keto Cholesterol, CAS: 148988-30-1, stock: 5.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₂O₄.

27-Carboxy-7-keto Cholesterol-d4, CAS: /, stock: 2.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₈D₄O₄.

27-Hydroxy-7-keto Cholesterol, CAS: 148988-28-7, stock: 5.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₃.

27-Hydroxy-7-keto Cholesterol-d4, CAS: /, stock: 1.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀D₄O₃.

27-Hydroxycholesterol-d6, CAS: 1246302-95-3, stock: 4.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀D₆O₂.

27-Nor-25-ketocholesterol, CAS: 7494-34-0, stock: 3.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₂O₂.

3(S)-Oxidosqualene, CAS: 54910-48-4, stock: 9.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₀O.

3,3’,5-Triiodo-D-thyronine, CAS: 09/08/5714, stock: 6.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂I₃NO₄.

3,3’,5-Triiodo-β-hydroxy-D/L-thyronine, CAS: /, stock: 6.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂I₃NO₅.

3,6-Bis(tosyloxy)-α-hyodeoxycholic Acid Methyl Ester, CAS: 1184-20-9, stock: 5.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₅₄O₈S₂.

3-(9-Adeninyl)propionoic Acid Ethyl Ester, CAS: 7083-40-1, stock: 5.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₅O₂.

3-Azido Neomycin B, CAS: 1448168-05-5, stock: 9.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₄N₈O₁₃.

3-Dehydroxy Ezetimibe, CAS: 204589-58-2, stock: 7.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁F₂NO₂.

3-Dodecanoyl-NBD Cholesterol, CAS: 1246303-05-8, stock: 2.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₇₀N₄O₅.

3-Fluoro-5-trifluoromethylbenzonitrile, CAS: 149793-69-1, stock: 3.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₃F₄N.

2,6,8-Trichloropurine, CAS: 2562-52-9, stock: 9.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅HCl₃N₄.

3-hexanoyl-NBD Cholesterol, CAS: 201731-19-3, stock: 4.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₅₈N₄O₅.

4-epi-Chlortetracycline Hydrochloride (>90% by HPLC), CAS: 101342-45-4, stock: 8.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄Cl₂N₂O₈.

4-epi-Demeclocycline (~90%), CAS: 14206-59-8, stock: 8.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁ClN₂O₈.

3-Hydroxy-2,2-dimethylpropanal, CAS: 597-31-9, stock: 4.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₂.

3-Hydroxy-3-methylglutaric Anhydride, CAS: 34695-32-4, stock: 2.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈O₄.

4-Epianhydrochlortetracycline Hydrochloride, CAS: 158018-53-2, stock: 7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂Cl₂N₂O₇.

Anhydro Chlortetracycline Hydrochloride, CAS: 65490-24-6, stock: 8.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂Cl₂N₂O₇.

3-Hydroxy-3-methylglutaric-d3 Anhydride, CAS: 115135-38-1, stock: 3.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅D₃O₄.

3-Hydroxy-4’,5-benzoyloxy-3’,5’,7-trimethoxyflavylium Chloride, CAS: /, stock: 3.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₅ClO₉.

Chlortetracycline Hydrochloride, CAS: 64-72-2, stock: 3.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄Cl₂N₂O₈.

Chlortetracycline-d6 Hydrochloride, CAS: /, stock: 2.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈D₆Cl₂N₂O₈.

3-β-[N-(N’,N’-Dimethylaminoethane)-carbamoyl]cholesterol, CAS: 137056-72-5, stock: 1.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₆N₂O₂.

3-Keto Cholesterol, CAS: 601-54-7, stock: 2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O.

Clomocycline, CAS: 1181-54-0, stock: 4.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅ClN₂O₉.

Demeclocycline, CAS: 127-33-3, stock: 6.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁ClN₂O₈.

3-Keto Cholesterol-d7, CAS: /, stock: 6.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇D₇O.

3-Methyl Isonicotinic Acid, CAS: 09/12/4021, stock: 2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₂.

Demethyltetracycline (>90%), CAS: 987-02-0, stock: 6.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂N₂O₈.

3-Methyl Isonicotinic Acid-d6, CAS: 1346599-31-2, stock: 8.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇HD₆NO₂.

3-O-Acetyl Ezetimibe 2,3,4-Tri-O-acetyl-β-D-glucuronide Methyl Ester, CAS: 190448-56-7, stock: 7.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₃₉F₂NO₁₃.

3-O-Acetyl Ezetimibe-d4 2,3,4-Tri-O-acetyl-β-D-glucuronide Methyl Ester, CAS: /, stock: 4.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₃₅D₄F₂NO₁₃.

3-O-Acetyl-26-hydroxy Cholesterol, CAS: 50681-37-3, stock: 9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₈O₃.

3-O-Benzoyl 16,26-Dihydroxy Cholesterol, CAS: /, stock: 5.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₀O₄.

3-O-Benzoyl-16-O-mesyl-26-O-trityl 16,26-Dihydroxy Cholesterol, CAS: /, stock: 8.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₆₆O₆S.

3-O-Benzoyl-26-O-trityl 16,26-Dihydroxy Cholesterol, CAS: /, stock: 3.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₆₄O₄.

3-O-tert-Butyldimethylsilyl 7β-Hydroxy Cholesterol-d7, CAS: /, stock: 4.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₃D₇O₂Si.

3-O-tert-Butyldimethylsilyl Cholesterol, CAS: 57711-50-9, stock: 6.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₆₀OSi.

3-O-tert-Butyldimethylsilyl Cholesterol-d7, CAS: /, stock: 9.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₃D₇OSi.

3-Phenyl-1H-indole-2-carboxylic Acid, CAS: 6915-67-9, stock: 1.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁NO₂.

3-(4-Chloro-3-nitrophenyl)-3-hydroxyphthalimidine, CAS: /, stock: 6.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉ClN₂O₄.

3-(4-Chlorophenyl)-1-isoindolinone, CAS: 2224-77-3, stock: 4.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀ClNO.

3-tert-Butyldimethylsilyl-20-dehydro Cholesterol, CAS: /, stock: 6.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₈OSi.

3-tert-Butyldimethylsilyl-20-dehydro Cholesterol-d7, CAS: /, stock: 3.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₁D₇OSi.

3-(4-Chlorophenyl)-1-isoindolinone-d4, CAS: /, stock: 6.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₆D₄ClNO.

3-(p-Chlorophenyl)-3-hydroxyphthalimidine, CAS: 956-92-3, stock: 8.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀ClNO₂.

3-[(5S)-(2-Fluorophenyl)-5-hydroxypentanoyl]-(4S)-phenyl-1,3-oxazolidin-2-one, CAS: /, stock: 8.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀FNO₄.

3-[(5S)-(4-Fluorophenyl)-5-hydroxypentanoyl]-(4S)-phenyl-1,3-oxazolidin-2-one, CAS: 189028-95-3, stock: 5.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀FNO₄.

3-Dehydroxy Chlorthalidone, CAS: 82875-49-8, stock: 4.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁ClN₂O₃S.

3-Dehydroxy Chlorthalidone-d4, CAS: /, stock: 7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₇D₄ClN₂O₃S.

3-[(E)-[(4-Fluorophenyl)imino]methyl]phenol, CAS: 1653959-48-8, stock: 8.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀FNO.

3-Hydroxy-3-[4-chloro-3-nitrophenyl]phthalimidine, CAS: /, stock: 2.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉ClN₂O₄.

Chlorthalidone, CAS: 77-36-1, stock: 5.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁ClN₂O₄S.

3’-(2-Fluorophenyl) Ezetimibe, CAS: 1798008-25-9, stock: 7.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁F₂NO₃.

3’-Anhydro Ezetimibe, CAS: 204589-68-4, stock: 1.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₉F₂NO₂.

Chlorthalidone Dimer, CAS: 1796929-84-4, stock: 2.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₁₉Cl₂N₃O₈S₂.

3’-Anhydro Ezetimibe Alcohol Impurity, CAS: 1374250-07-3, stock: 2.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃F₂NO₂.

3’-Anhydro Ezetimibe Lactam Ring-opened Sodium Salt Impurity, CAS: /, stock: 3.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₀F₂NNaO₃.

Chlorthalidone Impurity G, CAS: 16289-13-7, stock: 8.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉Cl₂NO₂.

Chlorthalidone Impurity G-d4, CAS: /, stock: 9.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₅D₄Cl₂NO₂.

3’-Anhydro-Z-Ezetimibe, CAS: /, stock: 9.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₉F₂NO₂.

3’-Dehydroxy-1,2-seco Ezetimibe Sodium Salt, CAS: /, stock: 6.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂F₂NNaO₃.

Chlorthalidone-13C6, CAS: /, stock: 4.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₆H₁₁ClN₂O₄S.

Chlorthalidone-d4, CAS: 1794941-44-8, stock: 1.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₇D₄ClN₂O₄S.

3α,11β-Dihydroxy-5α-pregnan-20-one, CAS: 23930-29-2, stock: 9.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₄O₃.

O-Ethyl Chlorthalidone, CAS: 1369588-00-0, stock: 5.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇ClN₂O₅S.

O-Isopropyl Chlorthalidone, CAS: /, stock: 4.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇ClN₂O₄S.

3α,7α,12α-Trihydroxy-5α-cholestan-26-oic Acid Methyl Ester Triacetate, CAS: 591219-56-6, stock: 7.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₄O₈.

3β,12α-Dihydroxy-7-oxo-5β-cholestanoic Acid, CAS: /, stock: 9.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₅.

O-Methyl Chlorthalidone, CAS: 96512-76-4, stock: 1.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃ClN₂O₄S.

O-Methyl Chlorthalidone-d4, CAS: /, stock: 1.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₉D₄ClN₂O₄S.

3β,5α,6β-Trihydroxycholestane, CAS: 1253-84-5, stock: 8.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₈O₃.

3β,5α,6β-Trihydroxycholestane-d7, CAS: 127684-07-5, stock: 3.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₁D₇O₃.

3β,7α,12α-Trihydroxy-5β-cholanic Acid Methyl Ester, CAS: 28050-54-6, stock: 4.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₂O₅.

3β,7α,25-Trihydroxycholest-5-ene, CAS: 64907-22-8, stock: 3.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₃.

3β-Acetoxy-Δ5-cholenyl Chloride, CAS: 51658-29-8, stock: 1.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₉ClO₃.

3β-Acetoxychol-5-enoic Acid, CAS: 19462-13-6, stock: 2.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₀O₄.

3β-Hydroxy-5-cholestenoic Acid, CAS: 6561-58-6, stock: 1.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₃.

4-((2R,3S,6S)-6-(4-Fluorophenyl)-3-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)phenol(Ezetimibe Impurity), CAS: /, stock: 6.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉FO₃.

4-(4-Methoxyphenoxy)-2-methyl-1-(4-methylbenzenesulfonate) 1,2-Butanediol, CAS: 303765-54-0, stock: 9.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄O₆S.

4-(Hydroxymethyl)-2-iodophenol, CAS: 197230-74-3, stock: 7.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇IO₂.

4-Benzyloxy-2-nitrophenol, CAS: 96315-18-3, stock: 4.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁NO₄.

4-Bromo-2,5-dimethylthiazole, CAS: 90672-80-3, stock: 1.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆BrNS.

4-Dehydroxy-4-amino Ezetimibe, CAS: 1354716-98-5, stock: 5.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂F₂N₂O₂.

4-Dehydroxy-4-amino Ezetimibe-d4, CAS: /, stock: 8.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₈D₄F₂N₂O₂.

4-Fluoro-2-(hydroxymethyl)phenylboronic Acid, CAS: 1061223-45-7, stock: 7.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈BFO₃.

4-O-Methylphenyl Ezetimibe-d4 Ketone, CAS: /, stock: 6.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₁D₄F₂NO₃.

4-Pyridineacetonitrile Hydrochloride, CAS: 92333-25-0, stock: 1.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇ClN₂.

4’-(Trifluoromethyl)acetanilide, CAS: 349-97-3, stock: 4.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈F₃NO.

4’-O-Benzyloxy Ezetimibe Diol Impurity, CAS: 1374250-06-2, stock: 4.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₁F₂NO₃.

4”DeFluoro-4”methyl-Ezetimibe, CAS: 1700622-07-6, stock: 3.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄FNO₃.

4”DeFluoro-4”methyl-ezetimibe-d4, CAS: /, stock: 6.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₀D₄FNO₃.

4”DeFluoro-4”methyl-ezetimibe-d7, CAS: /, stock: 7.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₇D₇FNO₃.

4α,25-Dihydroxy Cholesterol, CAS: /, stock: 5.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₃.

4α,25-Dihydroxy Cholesterol Diacetate, CAS: /, stock: 9.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₅₀O₅.

4α,25-Dihydroxy Cholesterol Triacetate, CAS: /, stock: 6.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₂O₆.

4α-​Methyl-5α-​cholesta-​8,​24-​dien-​3-​one, CAS: 7377-73-3, stock: 2.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O.

4α-Carboxy-4β-methyl-5α-cholestan-3β-ol, CAS: 47694-30-4, stock: 2.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₀O₃.

4α-Carboxy-4β-methyl-cholest-8,24-dien-3β-ol, CAS: 32468-21-6, stock: 6.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₆O₃.

4α-Carboxy-5α-cholestan-3β-ol, CAS: 913254-06-5, stock: 5.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₈O₃.

4α-Hydroxy Cholesterol, CAS: 34310-86-6, stock: 8.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₂.

4α-Methyl-cholest-5-en-3β-ol, CAS: 15073-00-4, stock: 9.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₈O.

4α-Methylzymosterol, CAS: 05/03/7448, stock: 6.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₆O.

4β-Hydroxy Cholesterol, CAS: 17320-10-4, stock: 3.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₂.

4β-Hydroxy Cholesterol 4-Acetate, CAS: 2515-18-6, stock: 6.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₈O₃.

4β-Hydroxy Cholesterol-d7, CAS: 1246302-80-6, stock: 9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₉D₇O₂.

4β-Hydroxy Cholesterol-d7 4-Acetate, CAS: 1363529-54-7, stock: 7.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₁D₇O₃.

5,5-bis(2-Fluorophenyl)-5-hydroxyvaleric Acid, CAS: /, stock: 9.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆F₂O₃.

5-Bromo-5α-cholestane-3,6-diol 3-Acetate, CAS: 1258-35-1, stock: 1.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₉BrO₃.

5-Iodo-1-oxaspiro[2.5]octa-4,7-dien-6-one, CAS: 197230-75-4, stock: 8.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅IO₂.

5alpha-hydroxy-6-keto Cholesterol, CAS: 13027-33-3, stock: 7.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₃.

5α-Cholestan-3β-ol, CAS: 80-97-7, stock: 5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₈O.

5α-Cholestan-3β-ol-d7, CAS: 84061-69-8, stock: 2.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₁D₇O.

5β-Cholanic Acid-3α,6β-diol, CAS: 668-49-5, stock: 2.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₀O₄.

5β-Cholestan-3-one, CAS: 601-53-6, stock: 8.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O.

5β-Cholestane, CAS: 481-20-9, stock: 8.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₈.

6(R)-[2-(8(S)-Hydroxy]-2(S),6(R)-dimethyl-1,2,6,7,8,8a(R)-hexahydro-1(S)-naphthyl]ethyl-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one, CAS: 79952-42-4, stock: 3.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈O₄.

6,6’-Binicotinic Acid, CAS: 1802-30-8, stock: 3.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈N₂O₄.

6-Amino-9H-purine-9-propanoic Acid, CAS: 4244-47-7, stock: 8.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N₅O₂.

6-Keto Cholestanol, CAS: 1175-06-0, stock: 6.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₂.

6’-Hydroxymethyl Lovastatin Sodium Salt, CAS: /, stock: 9.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₇NaO₇.

6β-Methoxy-3α,5-cyclo-5α-cholestan-(22S)-ol, CAS: /, stock: 6.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₈O₂.

7,8-Didehydrocholesterol Acetate, CAS: 1059-86-5, stock: 8.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₆O₂.

7-Dehydro Desmosterol, CAS: 1715-86-2, stock: 9.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₂O.

7-Dehydro Desmosterol-d6, CAS: /, stock: 2.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₆D₆O.

7-Keto Cholesterol (~98%), CAS: 566-28-9, stock: 8.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₂.

7-Keto Cholesterol-d7, CAS: 127684-08-6, stock: 8.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇D₇O₂.

7-Oxo Cholesterol 3-Acetate, CAS: 809-51-8, stock: 9.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₆O₃.

7-Oxo Cholesterol-d7 3-Acetate, CAS: /, stock: 3.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₉D₇O₃.

7-p-Toluenesulfonylhydrazide Cholesterol 3-Acetate, CAS: 54201-67-1, stock: 7.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₄N₂O₄S.

7-p-Toluenesulfonylhydrazide Cholesterol-d7 3-Acetate, CAS: /, stock: 3.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₇D₇N₂O₄S.

7ß-Hydroxycholesterol-d7, CAS: 349553-97-5, stock: 4.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₉D₇O₂.

7α,12α-Dihydroxycholest-4-en-3-one, CAS: 1254-03-1, stock: 9.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₃.

7α,12α-Dihydroxycholest-4-en-3-one-d7, CAS: /, stock: 8.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇D₇O₃.

7α-Hydroxy Cholesterol, CAS: 566-26-7, stock: 3.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₂.

7α-Hydroxy Cholesterol-d7 (major), CAS: /, stock: 6.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₉D₇O₂.

7α-Hydroxy-4-cholesten-3-one, CAS: 3862-25-7, stock: 7.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₂.

7α-Hydroxy-4-cholesten-3-one-d7, CAS: /, stock: 5.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇D₇O₂.

7α-Hydroxy-4-cholesten-3-one-d7 (contains 2% d0), CAS: /, stock: 3.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇D₇O₂.

7α-Hydroxycholesterol-d7, CAS: 349553-94-2, stock: 4.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₉O₂D₇.

7α-Hydroxycholesteryl 3β-Acetate, CAS: /, stock: 4.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₁D₇O₃.

7α-tert-Butyldimethylsilyloxycholest-5-en-3β-ol, CAS: /, stock: 9.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₆₀O₂Si.

7β-Hydroxy Cholesterol, CAS: 566-27-8, stock: 4.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₂.

7β-Hydroxy Cholesterol 3β-Acetate, CAS: 17974-77-5, stock: 4.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₈O₃.

7β-Hydroxy Cholesterol 3β-Acetate-d7, CAS: /, stock: 8.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₁D₇O₃.

7β-Hydroxy Cholesterol-d7, CAS: /, stock: 6.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₉D₇O₂.

7β-Hydroxy-4-cholesten-3-one, CAS: 25876-54-4, stock: 6.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₂.

7β-Hydroxy-4-cholesten-3-one-d7, CAS: 1262046-74-1, stock: 8.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇D₇O₂.

8-Dehydrocholesterol, CAS: 70741-38-7, stock: 1.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O.

8-[(S)-Hydroxy[4-benzyloxyphenyl]methyl]-1,4-dioxaspiro[4.5]decane-8-carboxylic Acid Ethyl Ester, CAS: 182227-19-6, stock: 4.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₀O₆.

9H-Fluorene-9-carboxylic Acid, CAS: 1989-33-9, stock: 5.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀O₂.

Alisol A, CAS: 19885-10-0, stock: 6.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₀O₅.

Androsta-4,8(14)-diene-3,17-dione, CAS: 17305-49-6, stock: 9.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄O₂.

Apocholic Acid, CAS: 641-81-6, stock: 9.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₈O₄.

Aramchol, CAS: 246529-22-6, stock: 2.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₇₉NO₅.

Arzoxifene, CAS: 182133-25-1, stock: 1.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₉NO₄S.

Avasimibe, CAS: 166518-60-1, stock: 9.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₃NO₄S.

Avasimibe-13C6, CAS: 324016-61-7, stock: 4.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃¹³C₆H₄₃NO₄S.

AY 9944, CAS: 366-93-8, stock: 3.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₀Cl₄N₂.

Bempedoic Acid, CAS: 738606-46-7, stock: 5.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₆O₅.

Bovine DHCR7 (7-dehydrocholesterol reductase) ELISA Kit (96T), CAS: /, stock: 5.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine NCEH1 (Neutral cholesterol ester hydrolase 1) ELISA Kit (96T), CAS: /, stock: 1.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Brassicasterol, CAS: 474-67-9, stock: 2.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₆O.

Brassicasterol-(2,2’,3,4,4’,6-D6), CAS: /, stock: 3.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₀D₆O.

Campestanol O-(4-Methylbenzoate), CAS: /, stock: 1.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₆O₂.

Chlorotrityl Chloride, CAS: 27023-37-6, stock: 2.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₄Cl₂.

Cholesta-4,6-dien-3-one, CAS: 566-93-8, stock: 1.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₂O.

Cholesta-4,6-dien-3-one-d7, CAS: /, stock: 6.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₅D₇O.

Cholesta-​1,​4,​6-​trien-​3-​one, CAS: 3464-60-6, stock: 5.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀O.

Cholesterol, CAS: 57-88-5, stock: 8.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O.

Cholesterol 3-Acetate, CAS: 604-35-3, stock: 8.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₈O₂.

Cholesterol 3-Acetate-d7, CAS: 1345629-08-4, stock: 8.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₁D₇O₂.

Cholesterol 3-Sulfate Sodium Salt, CAS: 2864-50-8, stock: 4.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₅NaO₄S.

Cholesterol 5beta,6beta-Epoxide, CAS: 4025-59-6, stock: 2.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₂.

Cholesterol 5α,6α-Εpoxide, CAS: 1250-95-9, stock: 5.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₂.

Cholesterol Benzoate, CAS: 604-32-0, stock: 9.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₀O₂.

Cholesterol Laurate, CAS: 08/11/1908, stock: 3.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₈O₂.

Cholesterol Phenylacetate, CAS: 33998-26-4, stock: 1.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₅₂O₂.

Cholesterol Sulfo-NHS Succinate Sodium Salt, CAS: /, stock: 2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₅₂NNaO₉S.

Cholesterol-13C5, CAS: 150044-24-9, stock: 8.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂¹³C₅H₄₆O.

Cholesterol-3-18O, CAS: 59613-51-3, stock: 4.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆¹⁸O.

Cholesterol-3-octanoate (octanoate-1-13c, 99%), CAS: 110888-06-7, stock: 9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄¹³CH₆₀O₂.

Cholesterol-d4, CAS: 956029-28-0, stock: 9.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₂D₄O.

Cholesterol-d6, CAS: 92543-08-3, stock: 3.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀D₆O.

Cholesterol-d6, CAS: 60816-17-3, stock: 9.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀D₆O.

Cholesterol-d7, CAS: 83199-47-7, stock: 1.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₉D₇O.

Cholesterol-d7 Tetrahydropyranyl Ether, CAS: /, stock: 2.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₇D₇O₂.

Cholesteryl Acetate Dibromide(Mixture of Diastereomers), CAS: 514-50-1, stock: 9.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₈Br₂O₂.

Cholesteryl Decanoate, CAS: 1183-04-6, stock: 6.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₆₄O₂.

Cholesteryl Decanoate-d3, CAS: /, stock: 4.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₆₁D₃O₂.

Cholesteryl Hemisuccinate, CAS: 1510-21-0, stock: 4.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₅₀O₄.

Cholesteryl Linolenate, CAS: 2545-22-4, stock: 2.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₇₄O₂.

Cholesteryl N-(trimethylammonioethyl)carbamate chloride, CAS: 188022-80-2, stock: 9.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₉ClN₂O₂.

Cholesteryl oleate, CAS: 303-43-5, stock: 4.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₇₈O₂.

Cholesteryl Palmitate, CAS: 601-34-3, stock: 6.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₇₆O₂.

CI-976, CAS: 114289-47-3, stock: 3.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₉NO₄.

Ciprofibrate-d6-O-β-Glucuronide, CAS: /, stock: 4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆D₆Cl₂O₉.

Ciprofibrate-O-β-Glucuronide, CAS: 102623-15-4, stock: 7.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂Cl₂O₉.

cis-4,7,10,13,16,19-Docosahexaenoic Acid Methyl Ester, CAS: 2566-90-7, stock: 2.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₄O₂.

cis-4,7,10,13,16,19-Docosahexaenoic Acid Methyl Ester-D5, CAS: /, stock: 8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉D₅O₂.

cis-4,7,10,13,16,19-Docosahexaenoic Acid Methyl-d3 Ester, CAS: /, stock: 6.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁D₃O₂.

Colesevelam Hydrochloride (Technical Grade), CAS: 182815-44-7, stock: 5.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  (C₁₂H₂₇ClN₂ •C₁₃H₂₇N •C ₃H₇N •C ₃H₅ClO)ₓ •(H.

Colestilan, CAS: 95522-45-5, stock: 6.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  (C₄H₆N₂ . C ₃H₅ClO)x.

Coprostan-3-ol, CAS: 360-68-9, stock: 2.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₈O.

Cytochalasin C, CAS: 22144-76-9, stock: 6.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₇NO₆.

Cytochalasin D, CAS: 22144-77-0, stock: 2.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₇NO₆.

D,L-Mevalonic Acid Dicyclohexylammonium Salt, CAS: 1215802-31-5, stock: 6.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₅NO₄.

D,L-Mevalonic Acid-d3, CAS: 52061-66-2, stock: 9.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉D₃O₄.

D,L-Mevalonic Acid-d3 Dicyclohexylamine Salt, CAS: 1329796-98-6, stock: 6.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂D₃NO₄.

D-myo-Inositol 1-Phosphate Disodium Salt, CAS: 956031-56-4, stock: 1.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁Na₂O₉P.

D-myo-Inositol 1-Phosphate Disodium Salt-d6, CAS: /, stock: 8.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅D₆Na₂O₉P.

DC-Cholesterol, CAS: 166023-21-8, stock: 5.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₆N₂O₂ • HCl.

Decarestrictin J, CAS: 144161-44-4, stock: 4.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆O₄.

Dehydroergosterol, CAS: 516-85-8, stock: 6.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₂O.

Desfluoro Ezetimibe, CAS: 302781-98-2, stock: 5.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂FNO₃.

Desmosterol, CAS: 313-04-2, stock: 5.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O.

Desmosterol-d6, CAS: 1246298-67-8, stock: 8.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₈D₆O.

Di-desfluoro Ezetimibe, CAS: 1251741-03-3, stock: 2.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃NO₃.

Di-O-methyl-β-cyclodextrin, CAS: 51166-71-3, stock: 7.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₆H₉₈O₃₅.

Diethyl Hexylphosphonate, CAS: 16165-66-5, stock: 2.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₃O₃P.

Diformylphloroglucinol, CAS: 4396-13-8, stock: 3.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆O₅.

Digitonin, CAS: 11024-24-1, stock: 6.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₆H₉₂O₂₉.

Diosgenin, CAS: 512-04-9, stock: 2.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₂O₃.

E-Ospemifene, CAS: 238089-02-6, stock: 9.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃ClO₂.

Elaidic Acid, CAS: 112-79-8, stock: 4.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₄O₂.

Elaidic Acid Ethyl Ester, CAS: 6114-18-7, stock: 2.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₈O₂.

Elaidic Acid Ethyl-d5 Ester, CAS: 1217226-00-0, stock: 8.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₃D₅O₂.

Ergosterol, CAS: 57-87-4, stock: 9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₄O.

Ergosterol-d5, CAS: /, stock: 8.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₉D₅O.

Eritadenine Acetonide, CAS: 29031-25-2, stock: 2.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅N₅O₄.

Ethylcarbamic Acid 4-Nitrophenyl Ester, CAS: 17576-41-9, stock: 9.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O₄.

Evacetrapib, CAS: 1186486-62-3, stock: 9.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₆F₆N₆O₂.

Ezetimibe, CAS: 163222-33-1, stock: 6.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁F₂NO₃.

Ezetimibe Diol Impurity, CAS: 1374250-08-4, stock: 2.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅F₂NO₃.

(R)-(-)-Chlorpheniramine Maleate, CAS: 23095-76-3, stock: 2.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉ClN₂ •  C₄H₄O₄.

Ezetimibe Phenoxy β-D-Glucuronide, CAS: 190448-57-8, stock: 8.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₉F₂NO₉.

Ezetimibe-13C6, CAS: 438624-68-1, stock: 7.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³C₆H₂₁F₂NO₃.

(R)-Chlorpheniramine-d6 Maleate Salt, CAS: /, stock: 6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇D₆ClN₂O₄.

(S)-Chlorpheniramine Maleate Salt, CAS: 2438-32-6, stock: 4.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃ClN₂O₄.

Ezetimibe-d4, CAS: 1093659-90-5, stock: 7.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₇D₄F₂NO₃.

Ezetimibe-d4, CAS: 1093659-89-2, stock: 2.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₇D₄F₂NO₃.

(S)-Chlorpheniramine-d6 Maleate Salt, CAS: /, stock: 6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇D₆ClN₂O₄.

2,2’-Dipyridylamine, CAS: 1202-34-2, stock: 5.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉N₃.

Ezetimibe-d4 Diol Impurity, CAS: /, stock: 7.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁D₄F₂NO₃.

Ezetimibe-d4 β-D-Glucuronide, >85%, CAS: /, stock: 1.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₅D₄F₂NO₉.

4-Chloro-α-[2-(dimethylamino)ethyl]benzeneacetonitrile, CAS: 73775-50-5, stock: 9.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅ClN₂.

5-Hydroxyindole-3-acetic Acid, CAS: 54-16-0, stock: 4.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉NO₃.

Filipin III, CAS: 480-49-9, stock: 8.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₅₈O₁₁.

5-Hydroxyindole-3-acetic Acid-13C3, CAS: /, stock: 1.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³C₃H₆NO₃.

5-Hydroxyindole-3-acetic Acid-D2, CAS: 56209-31-5, stock: 6.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇D₂NO₃.

Galactinol Hydrate, CAS: 1217474-91-3, stock: 6.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂O₁₁•2(H₂O).

5-Hydroxyindole-3-acetic Acid-D5, CAS: 81587-11-3, stock: 2.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₄D₅NO₃.

Chlorpheniramine Maleate Salt, CAS: 113-92-8, stock: 7.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃ClN₂O₄.

Glycitein, CAS: 40957-83-3, stock: 7.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂O₅.

Guar Gum, CAS: 9000-30-0, stock: 2.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  (C₁₈H₃₀O₁₆)n.

Chlorpheniramine N-Oxide Dihydrochloride, CAS: 120244-82-8, stock: 4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁Cl₃N₂O.

Chlorpheniramine Nitrile, CAS: 65676-21-3, stock: 5.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈ClN₃.

GW 501516, CAS: 317318-70-0, stock: 6.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₈F₃NO₃S₂.

GW3965, CAS: 405911-09-3, stock: 5.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₁ClF₃NO₃.

Chlorpheniramine Nitrile-d6, CAS: 1329488-38-1, stock: 4.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂D₆ClN₃.

Chlorpheniramine-d4 Maleate Salt, CAS: /, stock: 2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉D₄ClN₂O₄.

Heptakis(2,3-dimethyl)-β-cyclodextrin, CAS: 123155-05-5, stock: 10g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₆H₉₈O₃₅.

Hexacarboxybenzyl Neomycin C, CAS: 1216950-86-5, stock: 7.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇₁H₈₂N₆O₂₅.

Chlorpheniramine-d6 Maleate Salt, CAS: 1219806-45-7, stock: 5.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇D₆ClN₂O₄.

Chlorpheniramine-d6 N-Oxide Dihydrochloride, CAS: /, stock: 3.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃D₆ClN₂O.2HCl.

Hexacarboxybenzyl Neomycin C Hepta-acetate, CAS: /, stock: 5.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈₅H₉₆N₆O₃₂.

Hexylphosphonic Dichloride, CAS: 928-64-3, stock: 1.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃Cl₂OP.

Desmethyl Chlorpheniramine Maleate Salt, CAS: 22630-25-7, stock: 4.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁ClN₂O₄.

Dexchlorpheniramine n-Oxide Dihydrochloride, CAS: /, stock: 5.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉ClN₂O • 2(HCl).

Hirsutidin Chloride, CAS: 4092-66-4, stock: 9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇ClO₇.

Hirsutidin Chloride-d3, CAS: /, stock: 4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄D₃ClO₇.

Didesmethyl Chlorpheniramine Maleate Salt, CAS: 23052-94-0, stock: 3.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉ClN₂O₄.

Methyl 5-Hydroxy-3-indoleacetate, CAS: 15478-18-9, stock: 6.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₃.

Human 27 OHC(27-Hydroxycholesterol) ELISA Kit (96T), CAS: /, stock: 9.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human CH25H (Cholesterol 25-hydroxylase) ELISA Kit (96T), CAS: /, stock: 4.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Methyl 5-Hydroxy-3-indoleacetate-d3, CAS: /, stock: 4.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈D₃NO₃.

Monodesmethylchlorpheniramine, CAS: 20619-12-9, stock: 8.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇ClN₂.

Human CYP11A1(Cholesterol side-chain cleavage enzyme, mitochondrial) ELISA Kit (96T), CAS: /, stock: 5.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human CYP7A1(Cholesterol 7-alpha-monooxygenase) ELISA Kit (96T), CAS: /, stock: 5.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human CYP7B1 (25-hydroxycholesterol 7-alpha-hydroxylase) ELISA Kit (96T), CAS: /, stock: 1.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human DHCR7 (7-dehydrocholesterol reductase) ELISA Kit (96T), CAS: /, stock: 7.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human HDLC(HDL-cholesterol) ELISA Kit (96T), CAS: /, stock: 7.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human NCEH1 (Neutral cholesterol ester hydrolase 1) ELISA Kit (96T), CAS: /, stock: 2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

ω-Muricholic Acid, CAS: 01/03/6830, stock: 4.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₀O₅.

ω-Muricholic Acid O-TBS, CAS: /, stock: 7.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₈O₅Si₂.

ω-Muricholic Acid-d5, CAS: /, stock: 8.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₅D₅O₅.

Δ4-Cholesten-3-one, CAS: 601-57-0, stock: 2.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O.

α-Cholesterol-d6, CAS: 92543-07-2, stock: 2.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀D₆O.

α-Hyodeoxycholic Acid Methyl Ester, CAS: 2868-48-6, stock: 6.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₂O₄.

β-Hydroxy-3,5-diiodo-tyrosine, CAS: 90347-71-0, stock: 6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉I₂NO₄.

β-Hydroxy-O-(phenylmethyl)tyrosine, CAS: 99208-38-5, stock: 3.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇NO₄.

β-Hydroxytyrosine, CAS: 6809-69-4, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₄.

β-Naphthalenesulfonyl-D-valine, CAS: 182227-17-4, stock: 4.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇N₄S.

β-Sitosterol (Synthetic), CAS: 83-46-5, stock: 1.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₀O.

γ-Linolenic Acid Ethyl Ester, CAS: 31450-14-3, stock: 3.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄O₂.

γ-Linolenic Acid Ethyl Ester-d5, CAS: /, stock: 3.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₉D₅O₂.

γ-Oryzanol, CAS: 11042-64-1, stock: 5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₈O₄.

Keto-Ezetimibe β-D-Glucuronide, CAS: 861404-71-9, stock: 9.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₇F₂NO₉.

Keto-Ezetimibe-d4 β-D-Glucuronide, CAS: /, stock: 9.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₃D₄F₂NO₉.

L-Mevalonic Acid Lithium Salt (>90%), CAS: /, stock: 3.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁LiO₄.

Lanosterol, CAS: 79-63-0, stock: 5.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₀O.

Lanosterol (Technical Grade), CAS: 79-63-0, stock: 7.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₀O.

Lanosterol-D3, CAS: 134869-65-1, stock: 4.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₇D₃O.

Lanosterol-D6, CAS: /, stock: 3.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₄D₆O.

Lapaquistat Acetate, CAS: 189060-13-7, stock: 5.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₁ClN₂O₉.

Lapaquistat-d9 Acetate, CAS: 1292841-28-1, stock: 3.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₂D₉ClN₂O₉.

Lathosterol, CAS: 80-99-9, stock: 6.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O.

Lathosterol-d7, CAS: /, stock: 1.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₉D₇O25.

Lovastatin-d9(Mixture of Diastereomers), CAS: /, stock: 1.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇D₉O₅.

Methyl (3α,5β)-3-(Acetyloxy)-7-oxo-cholan-24-oic Acid Ester, CAS: 10452-65-0, stock: 9.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₂O₅.

Methyl (3α,5β,6α)-3-(Acetyloxy)-6-bromo-7-oxo-cholan-24-oic Acid Ester, CAS: 10452-64-9, stock: 5.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₁BrO₅.

Methyl (3β,5β,7α,12α)-7,12-Dihydroxy-3-[(1-oxoeicosyl)amino]-cholan-24-oic Acid Ester, CAS: 246529-32-8, stock: 7.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₈₁NO₅.

Methyl 3,6-dihydroxy-7-oxo-cholan-24-oic Acid Ester, CAS: 28071-17-2, stock: 9.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₀O₅.

Methyl 3-p-Toluenesulfonate-cholic Acid Ester, CAS: 28192-77-0, stock: 9.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₈O₇S.

Methyl 3α,7α,12α-Trihydroxy-5β-cholestanoate, CAS: 23740-22-9, stock: 9.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₈O₅.

Methyl 3β-Amino-7α,12α-dihydroxy-5β-cholan-24-oate, CAS: 135053-62-2, stock: 7.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₃NO₄.

Methyl 3β-azido-3,7-dideoxycholate, CAS: 135053-61-1, stock: 8.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₁N₃O₄.

Methyl 5-Bromo-2-thiophenecarboxylate, CAS: 62224-19-5, stock: 6.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅BrO₂S.

Methyl 5-Chloro-2-pyridinecarboxylate, CAS: 132308-19-1, stock: 5.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆ClNO₂.

Methyl-d3-magnesium Iodide, ~ 1.0 M in diethyl ether, CAS: 41251-37-0, stock: 9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  CD₃IMg.

Mevastatin Hydroxy Acid Sodium Salt, CAS: 99782-89-5, stock: 3.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₅NaO₆.

Mevastatin Hydroxy Acid t-Butylamine Salt, CAS: 262285-80-3, stock: 4.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₇NO₆.

MK 0773, CAS: 606101-58-0, stock: 8.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₄FN₅O₂.

Mouse Ch25h (Cholesterol 25-hydroxylase) ELISA Kit (96T), CAS: /, stock: 8.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Cyp7b1 (25-hydroxycholesterol 7-alpha-hydroxylase) ELISA Kit (96T), CAS: /, stock: 4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Dhcr7 (7-dehydrocholesterol reductase) ELISA Kit (96T), CAS: /, stock: 9.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

myo-Inositol, CAS: 87-89-8, stock: 5.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₆.

myo-Inositol-2-d, CAS: /, stock: 5.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁DO₆.

myo-Inositol-d6, CAS: 68922-44-1, stock: 3.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆D₆O₆.

N,N’-Dibenzylethylenediamine Diacetate Salt, CAS: 122-75-8, stock: 4.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈N₂O₄.

N-2-Benzyloxyphenyl α-Benzilidene Isobutyrylacetamide, CAS: 163217-77-4, stock: 1.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₅NO₃.

N-2-Benzyloxyphenyl α-Benzilidene-d5 Isobutyrylacetamide, CAS: 1020719-18-9, stock: 4.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₀D₅NO₃.

N-3-(Sulfopropyl)-3-methoxy-5-methylaniline, CAS: 766502-50-5, stock: 9.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇NO₄S.

N-4-Benzyloxyphenyl α-Benzilidene Isobutyrylacetamide, CAS: 163217-66-1, stock: 5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₅NO₃.

N-4-Benzyloxyphenyl α-Benzilidene-d5 Isobutyrylacetamide, CAS: 1020719-20-3, stock: 9.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₀D₅NO₃.

N-Acetyl N-Penta-cbz Neomycin B, CAS: /, stock: 1.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₅H₇₈N₆O₂₄.

N-Acetyl N-Penta-cbz Neomycin B O-Pentaacetate, CAS: /, stock: 2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇₅H₈₈N₆O₂₉.

N-Benzyl-4-fluoroaniline Hydrochloride, CAS: 856627-88-8, stock: 4.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃ClFN.

N-Des(4-Fluorophenyl)-N-(3-chlorophenyl)-ezetimibe, CAS: 1700622-08-7, stock: 5.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁ClFNO₃.

N-Des(4-Fluorophenyl)-N-(3-chlorophenyl)-ezetimibe-d4, CAS: /, stock: 6.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₇D₄ClFNO₃.

N-Des(4-Fluorophenyl)-N-(3-fluorophenyl) Ezetimibe, CAS: 1700622-06-5, stock: 3.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁F₂NO₃.

N-Des(4-Fluorophenyl)-N-(3-Fluorophenyl)-Ezetimibe-d4, CAS: /, stock: 3.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₇D₄F₂NO₃.

N-Penta-cbz 3-Azido Neomycin B, CAS: /, stock: 1.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₃H₇₄N₈O₂₃.

N-Penta-cbz Neomycin B, CAS: /, stock: 6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₃H₇₆N₆O₂₃.

N-[[4-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]phenyl]methylene]-4-fluorobenzenamine, CAS: 179411-51-9, stock: 1.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄FNOSi.

Neomycin B, CAS: 119-04-0, stock: 3.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₆N₆O₁₃.

Neomycin B Hexaacetate, CAS: /, stock: 4.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₆N₆O₁₃ •6(CH₃COOH).

Neomycin B-LP Acetate Salt Hydrate, CAS: /, stock: 1.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₈N₆O₁₄  • x(C ₂H₄O₂) y( H₂O).

Neomycin B-LP Trifluoroacetic Acid Salt, CAS: /, stock: 5.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₈N₆O₁₄  • x(C ₂HF₃O₂).

Neomycin C Hexaacetate, CAS: /, stock: 5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₆N₆O₁₃ • 6( CH₃COOH).

Neomycin Trisulfate Hydrate, CAS: 1405-10-3, stock: 2.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₆N₆O₁₃.

Neomycin Trisulfate Hydrate Deuterated, CAS: 1173840-30-6, stock: 4.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₆N₆O₁₃ .3(H₂SO₄)  .xH₂O(for undeuterated).

Ostreasterol, CAS: 474-63-5, stock: 1.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₆O.

para-Clotrimazole Isomer, CAS: 23593-71-7, stock: 8.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₇ClN₂.

PCI-34051, CAS: 950762-95-5, stock: 4.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆N₂O₃.

Pravastatin 6’-Ketone Sodium Salt, CAS: /, stock: 1.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₃NaO₇.

rac-syn-Ezetimibe, CAS: /, stock: 4.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁F₂NO₃.

Rat Ch25h (Cholesterol 25-hydroxylase) ELISA Kit (96T), CAS: /, stock: 8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Cyp7a1(Cholesterol 7-alpha-monooxygenase) ELISA Kit (96T), CAS: /, stock: 2.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Cyp7b1 (25-hydroxycholesterol 7-alpha-hydroxylase) ELISA Kit (96T), CAS: /, stock: 2.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Dhcr7 (7-dehydrocholesterol reductase) ELISA Kit (96T), CAS: /, stock: 7.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat LCAT(Lecithin-Cholesterol Acyltransferase) ELISA Kit (96T), CAS: /, stock: 8.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Nceh1 (Neutral cholesterol ester hydrolase 1) ELISA Kit (96T), CAS: /, stock: 1.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Resveratrol-4’-O-(6”-galloyl)glucoside, CAS: 64898-03-9, stock: 4.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₆O₁₂.

Ro 48-8071 Fumarate, CAS: 189197-69-1, stock: 4.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₁BrFNO₆.

Rosuvastatin Ethyl Ester, CAS: 851443-04-4, stock: 4.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₂FN₃O₆S.

S-​Methyl-​L-​cysteine Sulfoxide-d3, CAS: /, stock: 4.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆D₃NO₃S.

S-Methyl-L-cysteine sulfoxide, CAS: 6853-87-8, stock: 6.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉NO₃S.

SBC-115,076, CAS: 489415-96-5, stock: 3.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₃N₃O₅.

Sch 58053, CAS: 194423-53-5, stock: 5.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₃ClFNO₃.

Sch 58053-d4, CAS: /, stock: 2.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₉D₄ClFNO₃.

Sesamin, CAS: 607-80-7, stock: 2.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈O₆.

Squalene, CAS: 111-02-4, stock: 7.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₀.

Squalene 2,3:22,23-Dioxide, CAS: 31063-19-1, stock: 4.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₀O₂.

Squalene-2,3-glycol, CAS: 14031-37-9, stock: 8.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₂O₂.

1-Phenyl-4,5-dichloro-6-pyridazone-d5, CAS: /, stock: 9.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀HD₅Cl₂N₂O.

Squalene-d6, CAS: /, stock: 1.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₄D₆.

Stigmastanol, CAS: 83-45-4, stock: 5.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₂O.

Chloridazon, CAS: 1698-60-8, stock: 7.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈ClN₃O.

Chloridazon-d5, CAS: 1246818-99-4, stock: 4.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₃D₅ClN₃O.

Chloridazon-d5 (Major), CAS: 1246818-99-4, stock: 2.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₃D₅ClN₃O.

Desphenyl Chloridazon, CAS: 6339-19-1, stock: 1.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄ClN₃O.

Terpendole C, CAS: 156967-65-6, stock: 3.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₁NO₅.

Terpendole E, CAS: 167427-23-8, stock: 2.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₉NO₃.

Desphenyl Chloridazon-15N2, CAS: 1189649-21-5, stock: 5.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄ClN¹⁵N₂O.

Methyldesphenylchloridazon, CAS: 17254-80-7, stock: 5.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆ClN₃O.

Methyldesphenylchloridazon-d3, CAS: /, stock: 6.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃D₃ClN₃O.

Thiocholesterol, CAS: 1249-81-6, stock: 3.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆S.

Thromboxane A2 Potassium Salt, CAS: 98509-73-0, stock: 9.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₁KO₅.

TopFluor 3-O-Acetyl Cholesterol, CAS: /, stock: 7.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₃BF₂N₂O₂.

TopFluor Cholesterol, CAS: 878557-19-8, stock: 3.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₁BF₂N₂O.

Trifluoroacetic Anhydride, CAS: 407-25-0, stock: 10g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄F₆O₃.

Trifluoroacetic Anhydride-13C4, CAS: 1346603-60-8, stock: 9.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₄F₆O₃.

Trihydroxycoprostane, CAS: 547-96-6, stock: 2.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₈O₃.

Trihydroxycoprostane-d7, CAS: /, stock: 4.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₁D₇O₃.

Trihydroxycoprostane-d7 24-Phenylsulfonyl 3,7,12-Triethoxymethyl Ether, CAS: /, stock: 2.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₆₃D₇O₈S.

Trihydroxycoprostane-d7 3,7,12-Triethoxymethyl Ether, CAS: /, stock: 7.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₉D₇O₆.

Ursodeoxycholic Acid Methyl Ester, CAS: 10538-55-3, stock: 6.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₂O₄.

Ursodeoxycholic Acid-d5 Methyl Ester, CAS: 93701-19-0, stock: 2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₇D₅O₄.

Verticilide, CAS: 693778-57-3, stock: 2.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₇₆N₄O₁₂.

VULM 1457, CAS: 228544-65-8, stock: 1.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇N₃O₃S.

YM 750, CAS: 138046-43-2, stock: 9.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₆N₂O.

ZLN 024 Hydrochloride, CAS: 1883548-91-1, stock: 9.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄BrClN₂OS.

Zymostenol, CAS: 566-97-2, stock: 7.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O.

Zymosterol, CAS: 128-33-6, stock: 1.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O.

Zymosterol-d6, CAS: /, stock: 4.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₈D₆O.

[(3β)-Cholesta-5,24-dien-3-yloxy](1,1-dimethylethyl)dimethylsilane, CAS: 220150-72-1, stock: 9.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₈OSi.

[[(3β,24E)-Cholesta-5,24-dien-3-yl-26-13C]oxy](1,1-dimethylethyl)dimethylsilane-d6, CAS: /, stock: 5.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₂D₆OSi.

(3α,5β,7β)-3,7-Dihydroxy-24-norcholane-23-nitrile, CAS: 118316-12-4, stock: 6.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₇NO₂.

(3α,5β,7β)-Cholane-3,7,24-triol, CAS: 130593-75-8, stock: 9.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₂O₃.

(3α,5β,7β)-Cholane-3,7,24-triol-d5, CAS: /, stock: 2.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₇D₅O₃.

12-Hydroxy Taurolithocholic Acid O-3-Glucuronide Dipotassium Salt, CAS: 75672-37-6, stock: 2.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₁NO₁₂S.2K.

12-Hydroxy Taurolithocholic Acid-2,2,3,4,4-d5 O-3-Glucuronide Dipotassium Salt, CAS: /, stock: 9.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₆D₅NO₁₂S.2K.

12-Hydroxy Taurolithocholic Acid-2,2,3,4,4-d5 Sulfate Disodium Salt, CAS: /, stock: 6.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₈D₅NNa₂O₉S₂.

24-Phenylsulfonyl-5β-Cholane-3α,7α,12α-triol 3,7,12-Triethoxymethyl Ether, CAS: /, stock: 1.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₆₄O₈S.

3,12-Dihydroxy-nor-cholanyldiphenylcarbinol, CAS: 83116-96-5, stock: 7.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₅₀O₃.

3-Sulfo-glycodeoxycholic Acid Disodium Salt, CAS: 66874-10-0, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₁NNa₂O₈S.

3-Sulfo-glycoursodeoxycholic Acid Disodium Salt, CAS: 71781-63-0, stock: 8.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₁NNa₂O₉S.

(5R,6S)-2-[(4-Chlorophenyl)amino]-5-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-5,6-dihydro-4H-1,3-oxazin-4-one, CAS: /, stock: 6.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅ClN₂O₆.

3-Sulfo-taurocholic Acid Disodium Salt, CAS: 71781-33-4, stock: 4.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₃NNa₂O₁₀S₂.

(5R,6S)-2-[(4-Chlorophenyl)amino]-5-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]-5,6-dihydro-4H-1,3-oxazin-4-one-d4, CAS: /, stock: 6.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁D₄ClN₂O₆.

1,1’-[Iminobis(carbonimidoyliminohexane-6,1-dil)]bis[5-(4-chlorophenyl)biguadine], CAS: /, stock: 6.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₇Cl₂N₁₅.

3α,12-α-Dihydroxy-7-diazirdinecholanic Acid, CAS: 86933-63-3, stock: 4.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₀N₂O₄.

1,1’-[Iminobis(carbonimidoyliminohexane-6,1-dil)]bis[5-(4-chlorophenyl)biguadine]-d4, CAS: /, stock: 7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₃D₄Cl₂N₁₅.

1,6-Bis(cyano-guanidino)hexane N-Analine, CAS: /, stock: 7.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₅N₉.

1-(4-Chlorophenyl)-5-[6-[[4-[(4-chlorophenyl)amino]-6-[(1S,2R,3R,4R)-1,2,3,4,5-pentahydroxypentyl]-1,3,5-triazin-2-yl]amino]hexyl]biguanide D-Gluconic Acid Salt, CAS: /, stock: 3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₈Cl₂N₁₀O₅  • C ₆H₁₂O₇.

1-(4-Chlorophenyl)-5-[6-[[4-[(4-chlorophenyl)amino]-6-[(1S,2R,3R,4R)-1,2,3,4,5-pentahydroxypentyl]-1,3,5-triazin-2-yl]amino]hexyl]biguanide Penta-acetate D-Gluconic Acid Salt, CAS: /, stock: 7.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₈Cl₂N₁₀O₁₀ • C ₁₆H₂₂O₁₂.

1-(4-Chlorophenyl)-5-[6-[[4-[(4-chlorophenyl)amino]-6-[(1S,2R,3R,4R)-1,2,3,4,5-pentahydroxypentyl]-1,3,5-triazin-2-yl]amino]hexyl]biguanide-d8, CAS: /, stock: 4.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₀D₈Cl₂N₁₀O₅.

2-Chlorhexidine-4-deschloro Digluconate Impurity N N-Nitrile, CAS: /, stock: 8.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄ClN₉.

5β-Androstan-3β,17β-diol, CAS: 6038-31-9, stock: 1.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₂O₂.

2-Chloroaniline Hydrochloride, CAS: 137-04-2, stock: 2.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆ClN • HCl.

3,12-Diimino-2,4,11,13-tetraazatetradecanediamide, CAS: 1797132-41-2, stock: 5.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₂N₈O₂.

4-​Chloroaniline(4-Chlorophenylamine), CAS: 106-47-8, stock: 5.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆ClN.

4-​Chloroaniline-d4, CAS: 191656-33-4, stock: 7.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂D₄ClN.

5β-Cholane, CAS: 80373-86-0, stock: 9.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₂.

Chlorhexidine, CAS: 55-56-1, stock: 6.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₀C₂N₁₀.

Chlorhexidine Diacetate, CAS: 56-95-1, stock: 7.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₀Cl₂N₁₀•2[CH₃COOH].

5β-Petromyzonol 3,7,12-Triethoxymethyl Ether, CAS: /, stock: 6.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₆₀O₇.

6α-Ethyl-23(S)-methylcholic Acid, CAS: 1199796-29-6, stock: 3.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₆O₅.

Chlorhexidine Diacetate Impurity A, CAS: 152504-08-0, stock: 8.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄ClN₉.

Chlorhexidine Diacetate Impurity C, CAS: 62247-48-7, stock: 6.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈Cl₂N₈O₂.

7,7-Azo-3-α,12-α-dihydroxycholanic Acid, CAS: 86992-52-1, stock: 3.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₈N₂O₄.

Chlorhexidine Digluconate (In 20% solution), CAS: 18472-51-0, stock: 6.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₄Cl₂N₁₀O₁₄.

Chlorhexidine Digluconate Impurity K Dihydrochloride (>75%), CAS: /, stock: 9.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₁Cl₄N₉O.

Chlorhexidine Digluconate Impurity N Hydrochloride, CAS: /, stock: 5.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₅ClN₈• x( HCl).

Chlorhexidine Digluconate Impurity N-d4 Hydrochloride, CAS: /, stock: 3.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁D₄ClN₈ •xHCl.

Chlorhexidine Dihydrochloride, CAS: 3697-42-5, stock: 5.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₂Cl₄N₁₀.

Chlorhexidine Dihydrochloride Impurity B, CAS: 1308292-89-8, stock: 9.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₈Cl₃N₉O.

Cholic Acid, CAS: 81-25-4, stock: 4.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₀O₅.

Chlorhexidine Impurity E, CAS: /, stock: 3.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈Cl₂N₁₀.

Chlorhexidine-d8 Dihydrochloride, CAS: 1246816-96-5, stock: 5.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄D₈Cl₄N₁₀.

Cholic Acid 3-O-β-Glucuronide Disodium Salt, CAS: 59274-69-0, stock: 6.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₆NNa₂O₁₁.

Cholic Acid-d5, CAS: 53007-09-3, stock: 9.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₅D₅O₅.

N,N’-[(6-Aminohexyl)carbonimidoyl]bis-carbamic Acid C,C’-Bis(1,1-dimethylethyl) Ester, CAS: 160677-41-8, stock: 9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₄N₄O₄.

N-​(6-​Aminohexyl)​-​N’-​(4-​chlorophenyl)​imidodicarbonimidic Diamide Dihydrochloride, CAS: 165678-61-5, stock: 5.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅Cl₃N₆.

Cholic Acid-d6, CAS: /, stock: 3.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₄D₆O₅.

N-[6-[(Aminoiminomethyl)amino]hexyl]-N’-(4-chlorophenyl)imidodicarbonimidic-d4 N7,N8-Diboc Diamide, CAS: /, stock: 3.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₇D₄ClN₈O₄.

N1,N2-Diboc N-[6-[(Aminoiminomethyl)amino]hexyl]-N’-(4-chlorophenyl)-imidodicarbonimidic Diamide, CAS: /, stock: 6.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₁ClN₈O₄.

Glycocholic Acid 3-O-β-Glucuronide Disodium Salt, CAS: 75672-42-3, stock: 9.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₁NNa₂O₁₂.

Glycodeoxycholic Acid, CAS: 360-65-6, stock: 1.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₃NO₅.

N1-(4-chlorophenyl)-3,12-diimino-N14-2-chlorophenyl-2,4,11,13-Tetraazatetradecanediimidamide, CAS: /, stock: 1.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₀Cl₂N₁₀.

N1-(4-chlorophenyl)-3,12-diimino-N14-2-chlorophenyl-2,4,11,13-Tetraazatetradecanediimidamide-d4, CAS: /, stock: 5.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆D₄Cl₂N₁₀.

Glycodeoxycholic Acid Sodium Salt, CAS: 16409-34-0, stock: 8.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₂NNaO₅.

Glycodeoxycholic Acid-3-O-β-glucuronide Disodium Salt, CAS: 75672-36-5, stock: 7.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₉NNa₂O₁₁.

N1-(4-chlorophenyl)-3,12-diimino-N14-2-chlorophenyl-2,4,11,13-Tetraazatetradecanediimidamide-d4 Hydrochloride, CAS: /, stock: 2.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆D₄Cl₂N₁₀ • x(HCl).

N1-(4-chlorophenyl)-3,12-diimino-N14-phenyl-2,4,11,13-Tetraazatetradecanediimidamide, CAS: 152504-12-6, stock: 2.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₁ClN₁₀.

Glycodeoxycholic Acid-D5, CAS: /, stock: 7.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₈D₅NO₅.

Glycoursodeoxycholic Acid-3-O-β-glucuronide Disodium Salt, CAS: 75672-31-0, stock: 1.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₉NNa₂O₁₁.

N1-(4-Chlorophenyl)-3,12-diimino-N14-phenyl-2,4,11,13-Tetraazatetradecanediimidamide Dihydrochloride, CAS: /, stock: 8.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₁ClN₁₀ • 2(HCl).

N1-(4-chlorophenyl)-3,12-diimino-N14-phenyl-2,4,11,13-Tetraazatetradecanediimidamide-d5, CAS: /, stock: 7.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆D₅ClN₁₀.

Petromyzonol, CAS: 28979-29-5, stock: 2.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₂O₄.

N1-(6-Aminohexyl)-3-(4-chlorophenyl) Biuret, CAS: /, stock: 3.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈D₄ClN₅O₃.

p-Chloro-N,N-diethylaniline-d10, CAS: /, stock: 7.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₄D₁₀ClN.

Petromyzonol 24-Sulfate Sodium Salt, CAS: 1271318-61-6, stock: 4.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₁NaO₇S.

Petromyzonol 3,7,12,24-Tetrasulfate Tetrapotassium Salt, CAS: 384342-62-5, stock: 6.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₈K₄O₁₆S₄.

p-Chloroaniline-d4 Deuterium Chloride, CAS: /, stock: 8.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂D₄ClN • DCl.

Penta-O-acetyl-D-gluconic Acid, CAS: 17430-71-6, stock: 8.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂O₁₂.

Sodium Tauroglycocholate, CAS: 11006-55-6, stock: 5.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₇N₂O₈SNa.

Penta-O-acetylgluconyl Chloride, CAS: 53555-69-4, stock: 3.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁ClO₁₁.

tert-Butyl (6-(3-(N-(4-Chlorophenyl)carbamimidoyl)guanidino)hexyl)carbamate, CAS: /, stock: 7.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₁ClN₆O₂.

Taurocholic Acid-3-O-β-glucuronide Dipotassium Salt, CAS: 75672-43-4, stock: 1.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₉K₂NO₁₃S.

Taurolithocholic Acid 3-O-Glucuronide Sulfate Disodium Salt, CAS: 75672-16-1, stock: 2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₁NNa₂O₁₁S.

tert-Butyl (6-(3-Cyanoguanidino)hexyl)carbamate, CAS: /, stock: 5.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₅N₅O₂.

[(N-Cyanoformimidamide-6-aminohexyl)carbonimidoyl]bis-carbamic Acid Bis(1,1-dimethylethyl) Ester, CAS: /, stock: 5.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₅N₇O₄.

Taurolithocholic Acid-2,2,3,4,4-d5 3-O-Glucuronide Sulfate Disodium Salt, CAS: /, stock: 4.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₆D₅NNa₂O₁₁S.

Tauroursodeoxycholic Acid, Sodium Salt, CAS: /, stock: 8.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₅NO₆S.

Tauroursodeoxycholic Acid-3-O-β-glucuronide Dipotassium Salt, CAS: 75672-32-1, stock: 9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₁K₂NO₁₂S.

Ursodeoxycholic Acid, CAS: 128-13-2, stock: 8.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₀O₄.

Ursodeoxycholic Acid-3-O-β-D-glucuronide Disodium Salt, CAS: 75672-30-9, stock: 1.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₆Na₂O₁₀.

Ursodeoxycholic Acid-d5 (Contains d0), CAS: 93701-18-9, stock: 7.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₅D₅O₄.

17-Acetoxy-6-chloro-3-ethoxypregna-3,5-dien-20-one, CAS: 4809-88-5, stock: 5.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₅ClO₄.

1α-(Chloromethyl) Chlormadinone Acetate, CAS: 17183-98-1, stock: 6.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀Cl₂O₄.

1α-(Methoxymethyl) Chlormadinone Acetate, CAS: /, stock: 2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₃ClO₅.

6-Chloro-2-methyl-3,20-dioxopregn-4-en-17-yl Acetate, CAS: /, stock: 1.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₃ClO₄.

Chlormadinol Acetate, CAS: 3114-44-1, stock: 7.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁ClO₄.

Chlormadinol Acetate-d3 (Major), CAS: /, stock: 5.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈D₃ClO₄.

Chlormadinol Acetate-d7, CAS: /, stock: 5.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄D₇ClO₄.

Chlormadinone, CAS: 1961-77-9, stock: 9.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇ClO₃.

Chlormadinone Acetate, CAS: 302-22-7, stock: 2.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉ClO₄.

Chlormadinone-d6, CAS: /, stock: 8.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁D₆ClO₃.

Chlormadinone-d6 Acetate, CAS: /, stock: 3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₃D₆ClO₄.

Delmadinone, CAS: 15262-77-8, stock: 2.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅ClO₃.

Delmadinone Acetate, CAS: 13698-49-2, stock: 9.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇ClO₄.

Delmadinone-d5, CAS: /, stock: 1.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀D₅ClO₃.

(E)-4-[4-[Bis(2-chloroethyl)amino]phenyl]-3-butenoic Acid, CAS: 73027-06-2, stock: 8.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇Cl₂NO₂.

Phenylacetic Mustard, CAS: 10477-72-2, stock: 5.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅Cl₂NO₂.

Phenylacetic Mustard-d8, CAS: /, stock: 6.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇D₈Cl₂NO₂.

Triphenylphosphine, CAS: 603-35-0, stock: 4.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅P.

Triphenylphosphine-d15, CAS: 24762-44-5, stock: 5.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈D₁₅P.

1-O-Methyl Chlorogenic Acid, CAS: 374728-77-5, stock: 4.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀O₉.

3-​(Benzyloxy)​-hippuric Acid Benzyl Ester, CAS: /, stock: 9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁¹³C₂H₂₁¹⁵NO₄.

3β,6β-Chlorogenin, CAS: 41743-71-9, stock: 1.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₄.

Glycine-13C2,15N p-Toluenesulfonate, CAS: /, stock: 5.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₂H₅¹⁵NO₂ •  C₇H₈O₃S.

m-Hydroxyhippuric Acid, CAS: 1637-75-8, stock: 3.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₄.

m-Hydroxyhippuric Acid-13C2, 15N, CAS: /, stock: 7.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇¹³C₂H₉¹⁵NO₄.

N-(3-Hydroxybenzoyl)glycine Ethyl Ester, CAS: 1093641-59-8, stock: 2.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₄.

(+)-Donepezil, CAS: 142698-19-9, stock: 6.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉NO₃.

(+)-Muscarine Iodide, CAS: 24570-49-8, stock: 3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀INO₂.

(+)-Muscarine-d9 Iodide, CAS: /, stock: 2.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁D₉INO₂.

(+)-Tubocurarine Chloride Hydrochloride Pentahydrate, CAS: 6989-98-6, stock: 3.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₅₂Cl₂N₂O₁₁.

(+/-)-Muscarine Chloride, CAS: 2936-25-6, stock: 7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀ClNO₂.

(+/-)-Muscarine-D9 Chloride, CAS: /, stock: 2.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁D₉ClNO₂.

(+/-)-Nicotine-d3 Salicylate Salt, CAS: /, stock: 8.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇D₃N₂O₃.

(+/-)-Vesamicolmiddot Hydrochloride (AH-5183), CAS: 120447-62-3, stock: 7.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅NO  • HCl.

(-)-3-Epimuscarine Chloride, CAS: 35119-40-5, stock: 8.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀ClNO₂.

(-)-3-Epimuscarine-D9 Chloride, CAS: /, stock: 6.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁D₉ClNO₂.

(-)-Anatoxin A, CAS: 92142-32-0, stock: 3.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅NO.

(-)-Donepezil, CAS: 142057-80-5, stock: 1.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉NO₃.

(-)-Esermethole, CAS: 65166-97-4, stock: 1.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O.

(-)-Eseroline Fumarate Salt, CAS: 70310-73-5, stock: 5.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O • ( C₄H₄O₄).

(-)-Muscarine Chloride, CAS: 35119-35-8, stock: 4.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀ClNO₂.

(-)-Muscarine-D9 Chloride, CAS: /, stock: 2.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁D₉ClNO₂.

(-)-N-Methylphysostigmine, CAS: 103877-07-2, stock: 8.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃N₃O₂.

(-)-Nicotine Hemisulfate Salt, CAS: 65-30-5, stock: 7.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  2(C₁₀H₁₄N₂) • (  H₂O₄S).

(-)-Scopolamine Hydrochloride, CAS: 55-16-3, stock: 9.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO₄ •HCl.

(11E)-11-Eicosenoic Acid, CAS: 62322-84-3, stock: 3.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₈O₂.

(1R,5S)-4-[(2-Bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)ethoxy]ethyl]morpholinium Bromide (1:1), CAS: 1235355-01-7, stock: 7.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₉Br₂NO₄.

(2-Bromoethyl)trimethylammonium Bromide, CAS: 07/06/2758, stock: 9.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₃Br₂N.

(2E)-2-[(3-Methoxyphenyl)methylene]hydrazinecarbothioamide, CAS: 1334180-01-6, stock: 2.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₃OS.

(2E)-Dehydrodonepezil(Donepezil Impurity), CAS: 145546-80-1, stock: 7.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇NO₃.

(2R)-Eriodictyol, CAS: 116301-03-2, stock: 2.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂O₆.

(2R,3’R)-Glycopyrrolate Bromide, CAS: 475468-09-8, stock: 7.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈BrNO₃.

(2R,6R)-rel-tert-Butyl 4-(hydroxymethyl)-2,6-dimethyl-d6-piperidine-1-carboxylate, CAS: /, stock: 7.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉D₆NO₃.

(2R,6R)-rel-tert-Butyl 4-(hydroxymethyl)-2,6-dimethylpiperidine-1-carboxylate, CAS: 658076-63-2, stock: 2.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₅NO₃.

(3α)-3-Deoxy-3-chlorogalanthamine, CAS: 146274-40-0, stock: 6.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀ClNO₂.

(3R)-α,α-Diphenyl-3-pyrrolidineacetamide, CAS: 134002-27-0, stock: 7.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀N₂O.

(3S)-1-Azabicyclo[2.2.2]octan-3-ol, CAS: 34583-34-1, stock: 1.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO.

(3S)-1-Tosyl-α,α-diphenyl-3-pyrrolidineacetonitrile, CAS: 133099-09-9, stock: 8.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄N₂O₂S.

(Carbethoxymethylene)triphenylphosphorane, CAS: 1099-45-2, stock: 5.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁O₂P.

(Carbethoxymethylene)triphenylphosphorane-13C2, CAS: 90830-64-1, stock: 5.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀¹³C₂H₂₁O₂P.

(αS)-N,N,α-Trimethyl-3-(4-nitrophenoxy)benzenemethanamine, CAS: 1346242-32-7, stock: 4.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₂O₃.

(βS)-β-[(1,1-tert-Butyloxycarbonyl)amino]-4-hydroxy-benzenepropanoic Acid Methyl Ester, CAS: 474295-85-7, stock: 10g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO₅.

(R)-(-)-3-Quinuclidinol, CAS: 25333-42-0, stock: 1.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO.

(R)-(-)-3-Quinuclidinol-d7, CAS: /, stock: 7.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇D₆NO.

(R)-1-Benzyl-3-piperidinol, CAS: 91599-81-4, stock: 5.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO.

(R)-1-N-Boc-3-pyrrolidinol, CAS: 109431-87-0, stock: 3.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₃.

(R)-2,2-Diphenyl-2-(pyrrolidin-3-yl)acetonitrile Hydrobromide, CAS: 1229355-35-4, stock: 2.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈N₂•HBr.

(R)-3-((R)-2-(4-Chlorophenyl)-2-cyclopentyl-2-hydroxyacetoxy)-1,1-dimethylpyrrolidin-1-ium Bromide, CAS: /, stock: 7.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₇BrClNO₃.

(R)-3-((S)-2-(4-Chlorophenyl)-2-cyclopentyl-2-hydroxyacetoxy)-1,1-dimethylpyrrolidin-1-ium Bromide, CAS: /, stock: 7.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₇BrClNO₃.

(R)-3-Quinuclidinyl Benzilate, CAS: 62869-69-6, stock: 2.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO₃.

(R)-3-Quinuclidinyl Benzilate-d5, CAS: /, stock: 4.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₈D₅NO₃.

(R)-N-Boc-pyrrolidine-3-methanol, CAS: 138108-72-2, stock: 2.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉NO₃.

(R)-Rivastigmine, CAS: 415973-05-6, stock: 9.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₂O₂.

(R)-Rivastigmine Tartrate Salt, CAS: /, stock: 4.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈N₂O₈.

(RS, SR) 3-[[2-(4-Chlorophenyl)-2-cyclopentyl-2-hydroxyacetyl]oxy]-1,1-dimethylpyrrolidinium Bromide, CAS: /, stock: 8.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₇BrClNO₃.

(S)-(-)-Nicotine, CAS: 54-11-5, stock: 9.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂.

(S)-(-)-Nicotine (1.0 mg/mL in Methanol), CAS: 54-11-5, stock: 4.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂.

(S)-(-)-Nicotine Mono Tartrate, CAS: 6550-19-2, stock: 5.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O₆.

(S)-(-)-Nicotine-15N, CAS: 72496-00-5, stock: 8.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N¹⁵N.

(S)-(-)-Nicotine-d3, CAS: /, stock: 3.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁D₃N₂.

(S)-(-)-Nicotine-d4, CAS: 284685-07-0, stock: 6.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀D₄N₂.

(S)-1-(3-Methoxyphenyl)-N,N-dimethylethanamine, CAS: 889443-69-0, stock: 3.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇NO.

(S)-1-Tosyl-3-pyrrolidinol, CAS: 943587-25-5, stock: 8.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₃S.

(S)-3-((R)-2-(4-Chlorophenyl)-2-cyclopentyl-2-hydroxyacetoxy)-1,1-dimethylpyrrolidin-1-ium Bromide, CAS: /, stock: 4.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₇BrClNO₃.

(S)-3-((S)-2-(4-Chlorophenyl)-2-cyclopentyl-2-hydroxyacetoxy)-1,1-dimethylpyrrolidin-1-ium Bromide, CAS: /, stock: 7.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₇BrClNO₃.

(S)-3-(2-Azetidinylmethoxy)-pyridine Dihydrochloride, CAS: 174740-86-4, stock: 7.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄Cl₂N₂O.

(S)-3-Butyn-2-amine, CAS: 54164-69-1, stock: 1.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇N.

(S)-6-Aminonicotine Hydrochloride, CAS: 81990-64-9, stock: 2.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆ClN₃.

(S)-6-Methylnicotine, CAS: 13270-56-9, stock: 1.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂.

(S)-α-Glycerophosphocholine, CAS: 4217-84-9, stock: 5.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₂₀NO₆P.

(S)-Rivastigmine, CAS: 123441-03-2, stock: 3.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₂O₂.

(S)​-​1-​(2-​Fluorophenyl)​ethanol, CAS: 171032-87-4, stock: 7.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉FO.

(Z)-Triprolidine Hydrochloride, CAS: 51657-91-1, stock: 1.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃ClN₂.

1,1-Dimethyl-4-phenylpiperazinium Iodide, CAS: 54-77-3, stock: 8.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉IN₂.

1,13-Tridecanediol, CAS: 13362-52-2, stock: 5.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₈O₂.

1,2-bis(Heptanoylthio)glycerophosphocholine, CAS: 89019-63-6, stock: 7.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₄NO₆PS₂.

1,2-Dimethoxyethane, CAS: 110-71-4, stock: 1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀O₂.

1,2-Dimyristoyl-sn-glycero-3-phosphocholine, CAS: 18194-24-6, stock: 7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₇₂NO₈P.

1,2-Dimyristoyl-sn-glycero-3-phosphocholine-d9, CAS: /, stock: 1.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₆₃D₉NO₈P.

1,2-Dioleoyl-sn-glycero-3-phosphocholine, CAS: 4235-95-4, stock: 7.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₈₄NO₈P.

1,2-Dioleoyl-sn-glycero-3-phosphocholine-d9, CAS: /, stock: 1.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₇₅D₉NO₈P.

1,2-Dipalmitoyl-rac-glycero-3-phosphocholine, CAS: 2644-64-6, stock: 8.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₈₀NO₈P.

1,2-Distearoyl-sn-glycero-3-phosphocholine, CAS: 816-94-4, stock: 2.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₈₈NO₈P.

1,2-Distearoyl-sn-glycero-3-phosphocholine-d9, CAS: /, stock: 6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₇₉D₉NO₈P.

1,2-Ethylene Glycol, CAS: 107-21-1, stock: 2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₆O₂.

1,3-Diaminopropane, CAS: 109-76-2, stock: 2.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₁₀N₂.

1,3-Diaminopropane-d6, CAS: 90375-98-7, stock: 9.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₄D₆N₂.

1,4-Dibromobutane, CAS: 110-52-1, stock: 4.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈Br₂.

1,5-Bis(4-Allyldimethylammoniumphenyl)pentan-3-one, Dibromide, CAS: 402-40-4, stock: 1.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₈Br₂N₂O.

1,8-Dibromooctane, CAS: 4549-32-0, stock: 1.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆Br₂.

1,​2-​Dipalmitoyl-​sn-​glycero-​3-​phosphocholine (Colfosceril Palmitate), CAS: 63-89-8, stock: 4.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₈₀NO₈P.

1,2-Dichloroethanol Acetate, CAS: 10140-87-1, stock: 9.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆Cl₂O₂.

1-(1,4-Benzodioxan-2-ylcarbonyl)piperazine, CAS: 70918-00-2, stock: 7.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₂O₃.

3-Methyl-2-benzothiazolinone Hydrazone Hydrochloride Hydrate, CAS: 149022-15-1, stock: 4.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀ClN₃S•xH₂O.

Ammonium Bromide, CAS: 12124-97-9, stock: 7.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  BrH₄N.

1-(3-(4-(4-Chlorophenyl)piperazin-1-yl)propyl)-3-ethyl-4-(2-phenoxyethyl)-1H-1,2,4-triazol-5(4H)-one Hydrochloride, CAS: /, stock: 7.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₃Cl₂N₅O₂•HCl.

1-(3-Chlorophenyl)-4-(3-chloropropyl)piperazine Hydrochloride, CAS: 57059-62-8, stock: 3.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈Cl₂N₂•x(HCl).

Azocarmine G, CAS: 25641-18-3, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₁₈N₃O₆S₂Na.

1-(4-Methylbenzyl)piperazine, CAS: 23173-57-1, stock: 8.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂.

1-(6,7,9,10-Tetrahydro-6,10-methano-8H-pyrazino[2,3-h][3]benzazepin-8-yl)ethanone, CAS: 1213781-59-9, stock: 2.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅N₃O.

Chloramine B, CAS: 127-52-6, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅NO₂NaSCl.

1-(Benzyl-d5)-4-[(5-benzyloxy-6-methoxy-1-indanone)-2-ylidenyl]methylpiperidine, CAS: 1217253-68-3, stock: 8.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₆D₅NO₃.

1-(Benzyl-d5)-4-[(6-benzyloxy-5-methoxy-1-indanone)-2-ylidenyl]methylpiperidine, CAS: 1185246-73-4, stock: 1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₆D₅NO₃.

Chloramine B, CAS: 304655-80-9, stock: 6.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅ClNNaO₂S • xH  ₂O.

Chloramine-T Hydrate, CAS: 149358-73-6, stock: 8.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₂SClNa •  H₂O.

1-(Phenylmethyl)-4-piperidinamine, CAS: 50541-93-0, stock: 9.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂.

1-(Phenylmethyl)-4-[(trimethylsilyl)oxy]-4-piperidinecarbonitrile, CAS: 156215-49-5, stock: 5.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄N₂OSi.

Chloramine-T Trihydrate, CAS: 7080-50-4, stock: 8.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇ClNNaO₂S  •3H₂O.

Chlorantine Fast Red 5B, CAS: 09/11/2610, stock: 4.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₁₉N₅Na₂O₈S₂.

1-Acetyl-4-methylpiperazine, CAS: 60787-05-5, stock: 1.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄N₂O.

1-Arachidoyl-sn-glycero-3-phosphocholine, CAS: 108341-80-6, stock: 3.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₅₈NO₇P.

Chlorazol Fast Pink, CAS: 2829-43-8, stock: 6.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₆N₈O₁₅S₄ • 4Na.

Chlorozol Black E (Technical Grade), CAS: 1937-37-7, stock: 4.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₂₅N₉Na₂O₇S₂.

1-Arachidoyl-sn-glycero-3-phosphocholine-d9, CAS: /, stock: 7.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₉D₉NO₇P.

1-Arachydyl-2-stearidonoyl Glycerol 3-Phosphocholine, CAS: /, stock: 8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₈₄NO₈P.

Dichloramine B, CAS: 473-29-0, stock: 6.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅Cl₂NO₂S.

Direct Black 17, CAS: 2945-96-2, stock: 7.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂N₆O₅SNa.

1-Benzyl-4-butylpiperidine Hydrochloride, CAS: /, stock: 5.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₆ClN.

1-Benzyl-4-[(5-benzyloxy-6-methoxy-1-indanone)-2-ylidenyl]methylpiperidine, CAS: 120013-75-4, stock: 8.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₁NO₃.

Direct Brown 95, Techincal Grade, CAS: 16071-86-6, stock: 1.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₁₈CuN₆Na₂O₉S.

1-Benzyl-4-[(6-benzyloxy-5-methoxy-1-indanone)-2-ylidenyl]methylpiperidine, CAS: 1076198-90-7, stock: 7.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₁NO₃.

1-Bromo-2-chloromethyl-4,5-dimethoxybenzene, CAS: /, stock: 5.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀BrClO₂.

1-Bromopinacolone, CAS: 5469-26-1, stock: 6.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁BrO.

1-Cbz-piperazine, CAS: 31166-44-6, stock: 5.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O₂.

Direct Orange 26, CAS: 3626-36-6, stock: 8.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₂N₆Na₂O₉S₂.

1-Decylamine, CAS: 2016-57-1, stock: 7.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₃N.

1-Decylamine Hydrobromide, CAS: 32509-44-7, stock: 2.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₄BrN.

Direct violet 51, CAS: 5489-77-0, stock: 9.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₉N₅O₈S₂ • 2Na.

1-Docosahexaenoin-2-oleoyl 3-Phosphocholine, CAS: 99265-02-8, stock: 1.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₈₂NO₈P.

1-Docosahexaenoin-2-oleoyl 3-Phosphocholine-d9, CAS: /, stock: 9.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₇₃D₉NO₈P.

Direct Yellow 8, CAS: 10130-29-7, stock: 7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₉N₄NaO₅S₂.

Meclizine Dihydrochloride, CAS: 1104-22-9, stock: 9.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇ClN₂•2HCl.

1-Docosahexaenoyl-2-stearoyl-sn-glycero-3-phosphocholine, CAS: 99264-99-0, stock: 3.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₈₄NO₈P.

1-Docosahexaenoyl-2-stearoyl-sn-glycero-3-phosphocholine-d9, CAS: /, stock: 9.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₇₅D₉NO₈P.

N-Chloromethanamine, CAS: 6154-14-9, stock: 1.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  CH₄ClN.

o-Chloramine T, CAS: 110076-44-3, stock: 4.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₂NaSCl.

1-Docosahexaenoyl-sn-glycero-3-phosphocholine, CAS: 162440-05-3, stock: 2.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₀NO₇P.

1-Docosahexaenoyl-sn-glycero-3-phosphocholine (90% Purity), CAS: 162440-05-3, stock: 9.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₀NO₇P.

Thiazine Red R, CAS: 2150-33-6, stock: 6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₅N₃Na₂O₇S₃.

Thioflavine S (Tehnical Grade), CAS: 1326-12-1, stock: 6.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  N/A.

1-Docosahexaenoyl-sn-glycero-3-phosphocholine-d9, CAS: /, stock: 6.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₁D₉NO₇P.

1-Eicosa-8,11,14,17-tetraenoyl Glycerol 3-Phosphocholine, CAS: /, stock: 2.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₅₀NO₇P.

1-Eicosapentaenoyl-sn-glycerol-3-phosphocholine, CAS: 162440-04-2, stock: 2.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₈NO₇P.

1-Eicosapentaenoyl-sn-glycerol-3-phosphocholine-d9, CAS: /, stock: 1.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₉D₉NO₇P.

1-Ethyl-3-hydroxypiperidine, CAS: 13444-24-1, stock: 8.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO.

1-Methyl-pyridinium Chloride, CAS: 7680-73-1, stock: 4.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈ClN.

1-Miristoyl-2-linoleoyl Glycerol 3-Phosphocholine, CAS: 92345-33-0, stock: 1.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₇₆NO₈P.

1-Myristoyl-sn-glycero-3-phosphocholine, CAS: 20559-16-4, stock: 9.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₆NO₇P.

1-Myristoyl-sn-glycero-3-phosphocholine-d9, CAS: /, stock: 2.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₇D₉NO₇P.

1-O-Dodecyl-sn-glycerol, CAS: 99651-65-7, stock: 3.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₃₂O₃.

1-O-Octadecyl-2-O-benzyl-rac-glycerol, CAS: 86008-21-1, stock: 2.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₅₀O₃.

1-O-Octadecyl-2-O-benzyl-rac-glycerol-d5, CAS: /, stock: 2.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₅D₅O₃.

1-O-Propylglycerol, CAS: 61940-71-4, stock: 3.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄O₃.

1-O-Propylglycerol-d5, CAS: /, stock: 1.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉D₅O₃.

1-O-Trityl-2-stearoyl-sn-glycero-3-phosphocholine, CAS: /, stock: 3.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₆₈NO₇P.

1-O-Trityl-sn-glycero-3-phosphocholine, CAS: 103675-56-5, stock: 9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₅NO₆P.

1-Oleoyl-sn-glycero-3-phosphocholine, CAS: 19420-56-5, stock: 5.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₅₂NO₇P.

1-Oleoyl-sn-glycero-3-phosphocholine-d9, CAS: /, stock: 5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₃D₉NO₇P.

1-Oxyl-2,2,5,5,-tetramethyl-3-vinyl-∆3-pyrroline, CAS: 105843-07-0, stock: 2.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆NO.

1-Palmitoyl-2-arachidoyllecithin, CAS: 35418-58-7, stock: 9.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₈₀NO₈P.

1-Palmitoyl-2-arachidoyllecithin-d9, CAS: /, stock: 7.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₇₁D₉NO₈P.

1-Palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine, CAS: 26853-31-6, stock: 9.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₈₂NO₈P.

1-Palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine-13C16 (Contained up to 2% unlabeled), CAS: /, stock: 8.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆¹³C₁₆H₈₂NO₈P.

1-Palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine-13C18, CAS: /, stock: 3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄¹³C₁₈H₈₂NO₈P.

1-Palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine-d31, CAS: 179093-76-6, stock: 7.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₅₁D₃₁NO₈P.

1-Palmitoyl-2-pyrenedecanoylphosphatidylcholine, CAS: 95864-17-8, stock: 2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₇₆NO₈P.

1-Palmitoyl-2-pyrenedecanoylphosphatidylcholine-d9, CAS: /, stock: 6.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₀H₆₇D₉NO₈P.

1-Palmitoyl-2-stearoyl-sn-glycero-3-phosphocholine, CAS: 59403-51-9, stock: 1.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₈₄NO₈P.

1-Palmitoyl-2-[3-(diphenylhexatriene)propanoyl]-sn-phosphatidylcholine, CAS: 98014-38-1, stock: 6.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₆₈NO₈P.

1-Palmitoyl-2-[3-(diphenylhexatriene)propanoyl]-sn-phosphatidylcholine-d9, CAS: /, stock: 7.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₅₉D₉NO₈P.

1-Palmitoyl-rac-glycerol-d5, CAS: /, stock: 1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₃D₅O₄.

1-Palmitoyl-sn-glycero-3-phosphocholine, CAS: 17364-16-8, stock: 7.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₅₀NO₇P.

1-Palmitoyl-sn-glycero-3-phosphocholine-d9, CAS: 182257-09-6, stock: 5.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₁D₉NO₇P.

1-Palmitoyl-sn-glycerol, CAS: 32899-41-5, stock: 5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₈O₄.

1-[[2-[(2-Aminophenyl)amino]-5-methyl-3-thienyl]carbonyl]-4-methyl-piperazine, CAS: 138564-61-1, stock: 5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂N₄OS.

1-[[2-[(2-Aminophenyl)amino]-5-methyl-3-thienyl]carbonyl]-4-methyl-piperazine-D3, CAS: /, stock: 4.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉D₃N₄OS.

1H-Indazole-5-carboxylic Acid, CAS: 61700-61-6, stock: 3.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆N₂O₂ • (HCl).

1H-Indazole-6-carboxylic Acid, CAS: 704-91-6, stock: 3.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆N₂O₂.

2,2’-((Disulfanediylbis(ethane-2,1-diyl))bis(4-hydroxy-3,1-phenylene))diacetic Acid, CAS: /, stock: 8.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂O₆S₂.

2,3,4,5-Tetrahydro-1H-1,5-methano-3-benzazepine Hydrochloride, CAS: 230615-52-8, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄ClN.

2,3,4,5-Tetrahydro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine, CAS: 230615-51-7, stock: 3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂F₃NO.

2,3-Dihydro-5,6-dimethoxy-2-[(1-oxido-4-pyridinyl)methylene]-1H-inden-1-one, CAS: 896134-06-8, stock: 4.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅NO₄.

2,4-Dinitrobenzoyl Chloride, CAS: 20195-22-6, stock: 8.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃ClN₂O₅.

2,4-Pyridinediamine, CAS: 461-88-1, stock: 3.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇N₃.

2-((1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one, CAS: 608511-44-0, stock: 9.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇NO₃.

2-((1-Benzylpiperidin-4-yl)methyl)-5,6-dimethoxy-1H-inden-1-one, CAS: /, stock: 9.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇NO₃.

2-((Methyl-d3)amino)ethanol, CAS: 1216441-01-8, stock: 5.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₆D₃NO.

2-(2-(Methoxymethoxy)propanoyl)-N-(2-phenoxyethyl)hydrazinecarboxamide, CAS: 98159-87-6, stock: 4.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁N₃O₅.

2-(3-Aminopropylamino)ethanol, CAS: 4461-39-6, stock: 9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₄N₂O.

2-(4-Chlorophenyl)ethylamine, CAS: 156-41-2, stock: 8.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀ClN.

2-(Dimethylamino)-ethanesulfonyl Chloride Hydrochloride, CAS: 118646-39-2, stock: 9.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀ClNO₂S •HCl.

2-(Dimethylamino)ethanethiol Hydrochloride, CAS: 13242-44-9, stock: 1.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₂ClNS.

2-(N-Hexadecanoylamino)-4-aminophenylphosphocholine, CAS: /, stock: 7.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₅₁N₃O₅P.

2-(N-Hexadecanoylamino)-4-nitrophenylphosphocholine Hydroxide, CAS: 60438-73-5, stock: 5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₅₀N₃O₈P.

2-Amino-1,1,3-propenetricarbonitrile, CAS: 868-54-2, stock: 9.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₄.

2-Amino-1-cyclopentene-1-carbonitrile, CAS: 2941-23-3, stock: 6.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₂.

2-Amino-1-cyclopentene-1-carbonitrile-d2, CAS: /, stock: 4.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆D₂N₂.

2-Amino-5-iodo-3-nitropyridine, CAS: 25391-57-5, stock: 8.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄IN₃O₂.

2-Arachidonoyl-d11-sn-glycero-3-phosphocholine, CAS: /, stock: 3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₉D₁₁NO₇P.

2-Arachidonoyl-sn-glycero-3-phosphocholine (>90%), CAS: 67341-29-1, stock: 4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₅₀NO₇P.

2-​Oleoyl-​1-​stearoyl-​sn-​glycero-​3-​phosphocholine, CAS: 56421-10-4, stock: 4.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₈₆NO₈P.

2-​[[Hydroxy[(2R)​-​2-​oxiranylmethoxy]​phosphinyl]​oxy]​-​N,​N,​N-​trimethyl-​ethanaminium Inner Salt, CAS: /, stock: 6.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉D₉NO₅P.

2-​[[Hydroxy[(2R)​-​2-​[(1-​oxohexadecyl)​oxy]​-​3-​(triphenylmethoxy)​propoxy]​phosphinyl]​oxy]​-​N,​N,​N-​trimethyl-​ethanaminium Inner Salt, CAS: 123231-97-0, stock: 3.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₆₄NO₇P.

2-Bromoethyl Methyl Ether, CAS: 6482-24-2, stock: 7.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₇BrO.

2-Carboxyethyl Methanethiosulfonate, Choline Ester Chloride Salt, CAS: 1219378-82-1, stock: 6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀ClNO₄S₂.

2-Carboxyethyl-bromo-choline Ester, Chloride Salt, CAS: 1219417-69-2, stock: 5.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇BrClNO₂.

2-Chloro-1,3,2-dioxaphospholane-2-oxide, CAS: 6609-64-9, stock: 8.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₄ClO₃P.

2-Chloro-1,3,2-dioxaphospholane-2-oxide (Technical Grade), CAS: 6609-64-9, stock: 3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₄ClO₃P.

2-Chloro-N,N-diethylacetamide, CAS: 2315-36-8, stock: 2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂ClNO.

2-Dimethylaminoethanol, CAS: 108-01-0, stock: 3.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₁NO.

2-Docosahexaenoin-1-oleoyl 3-Phosphocholine, CAS: 99296-82-9, stock: 3.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₈₂NO₈P.

2-Docosahexaenoin-1-oleoyl 3-Phosphocholine-d9, CAS: /, stock: 4.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₇₃D₉NO₈P.

2-Docosahexaenoyl-d5-sn-glycero-3-phosphocholine, CAS: /, stock: 6.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₅D₅NO₇P.

2-Docosahexaenoyl-sn-glycero-3-phosphocholine, CAS: 159407-32-6, stock: 6.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₀NO₇P.

2-Eicosapentaenoyl-sn-glycerol-3-phosphocholine, CAS: 112667-21-7, stock: 6.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₈NO₇P.

2-Eicosapentaenoyl-sn-glycerol-3-phosphocholine-d5, CAS: /, stock: 2.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₃D₅NO₇P.

2-Ethoxybenzo[b]thiophen-4-ol, CAS: /, stock: 1.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₂S.

2-Ethyl-2-methyl-1,3-dioxolane, CAS: 126-39-6, stock: 1.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₂.

2-Fluoro-3-picoline, CAS: 2369-18-8, stock: 2.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆FN.

2-Fluoro-6-formylpyridine, CAS: 208110-81-0, stock: 7.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄FNO.

2-Fluoro-A 85380 Tartrate Salt, CAS: 186588-98-7, stock: 7.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇FN₂O₇.

2-Fluorotoluene-α-d1, CAS: 17359-78-3, stock: 7.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆DF.

2-Hydroxy-N,N,N-trimethylethanaminium Iodide, CAS: 17773-10-3, stock: 4.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₄INO.

2-Hydroxyethyl Methyl Sulfone, CAS: 15205-66-0, stock: 8.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₈O₃S.

2-Iodophenyl Methylcarbamate, CAS: 13538-28-8, stock: 3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈INO₂.

2-Methacryloyloxyethyl Phosphatidylcholine, CAS: 67881-98-5, stock: 7.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂NO₆P.

2-Methoxymethyl Methansulfonate, CAS: 16427-44-4, stock: 1.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀O₄S.

2-Methyl-2-propen-1-ol, CAS: 513-42-8, stock: 2.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈O.

2-Methyl-3-[(2S)-2-pyrrolidinylmethoxy]-pyridine Dihydrochloride, CAS: 161416-61-1, stock: 9.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O•2HCl.

2-Naphthyl Chloroformate, CAS: 7693-50-7, stock: 5.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇O₂Cl.

2-Nitroamino-2-imidazoline, CAS: 5465-96-3, stock: 6.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₆N₄O₂.

2-Nitroamino-2-imidazoline-d4, CAS: /, stock: 5.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₂D₄N₄O₂.

2-Oleoyl-sn-glycero-3-phosphocholine, CAS: 22248-65-3, stock: 4.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₅₂NO₇P.

2-Oleoyl-sn-glycero-3-phosphocholine-d17, CAS: /, stock: 9.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₅D₁₇NO₇P.

2-Oxazolecarboxylic Acid, CAS: 672948-03-7, stock: 2.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃NO₃.

2-p-Tolylaminoethanol, CAS: 2933-74-6, stock: 2.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃NO.

2-Palmitoyl-sn-glycero-3-phosphocholine, CAS: 66757-27-5, stock: 2.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₅₀NO₇P.

2-Palmitoyl-sn-glycero-3-phosphocholine-d31, CAS: /, stock: 1.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₉D₃₁NO₇P.

2-Stearoyl-d35-sn-glycero-3-phosphocholine, CAS: /, stock: 9.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₉D₃₅NO₇P.

2-Stearoyl-sn-glycero-3-phosphocholine, CAS: 4421-58-3, stock: 7.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₅₄NO₇P.

2-Tetradecyl-1-octadecanol, CAS: 32582-32-4, stock: 1.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₆₆O.

2-[[1-[1-[(4-Fluorophenyl)methyl]-1H-benzimidazol-2-yl]-4-piperidinyl]methylamino]-6-methyl-4(3H)-Pyrimidinone, CAS: 108612-60-8, stock: 9.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇FN₆O.

2-[[[(11-Aminoundecyl)oxy]hydroxyphosphinyl]oxy]-N,N,N-trimethyl-Ethanaminium Inner Salt, CAS: 1354620-97-5, stock: 1.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₇N₂O₄P.

3,4-Dihydro-9-[(benzyl)amino]-1(2H)-acridinone, CAS: 104675-27-6, stock: 8.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈N₂O.

3,7-Diazabicyclo[3.3.1]nonane Dihydrochloride, CAS: 1402430-53-8, stock: 2.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄N₂•(HCl)₂.

3-(1-Azepanyl)-1-propanamine, CAS: 3437-33-0, stock: 2.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀N₂.

3-(1-Pyrrolidinyl)propiophenone, CAS: 94-39-3, stock: 7.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO.

3-(3-Pyridinylcarbonyl)-1-(trimethylsilyl)-2-pyrrolidinone, CAS: /, stock: 4.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄D₄N₂O₂Si.

3-(Chloromethyl)-1,2,3-benzotriazin-4(3H)-one, CAS: 24310-41-6, stock: 5.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆ClN₃O.

3-(Dimethylamino)-1-(1-naphthalenyl)-1-propanone Hydrochloride, CAS: 5409-58-5, stock: 2.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈ClNO.

3-Acetyl-2-bromopyridine, CAS: 84199-61-1, stock: 6.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆BrNO.

3-Amino-N-[(4-chlorophenyl)methyl]-4,6-dimethylthieno[2,3-b]pyridine-2-carboxamide, CAS: 633283-39-3, stock: 7.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆ClN₃OS.

3-Bromo-2-furoic Acid, CAS: 14903-90-3, stock: 1.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃BrO₃.

3-Bromocytisine, CAS: 207390-14-5, stock: 5.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃BrN₂O.

3-Butyn-2-ol, CAS: 2028-63-9, stock: 9.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆O.

3-Carene, CAS: 13466-78-9, stock: 9.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆.

3-Carene-D3, CAS: /, stock: 9.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃D₃.

3-Deoxygalanthamine, CAS: 312920-69-7, stock: 9.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO₂.

3-Deoxygalanthamine-d3, CAS: /, stock: 1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈D₃NO₂.

3-Epigalanthamine acetate, CAS: 27281-90-9, stock: 5.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃NO₄.

3-Fluoro-2-methylpyridine, CAS: 15931-15-4, stock: 1.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆FN.

3-Fluorobenzenesulfonic Acid 5,8,13,13a-Tetrahydro-3,10-dimethoxy-6H-dibenzo[a,g]quinolizin-9-yl Ester, CAS: 1233353-87-1, stock: 5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄FNO₅S.

3-Fluorotoluene-α-d1, CAS: /, stock: 9.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆DF.

3-Hydroxy Donepezil (Donepezil Impurity), CAS: 2097683-67-3, stock: 6.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉NO₄.

3-Hydroxy Donepezil-d5 (Donepezil Impurity), CAS: /, stock: 6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₄D₅NO₄.

3-Hydroxy-1-methyl-1-Azoniabicyclo[2.2.2]octane Bromide, CAS: /, stock: 5.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆BrNO.

3-Hydroxy-1-methyl-pyridinium Bromide, CAS: 31034-86-3, stock: 6.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈BrNO.

3-Hydroxyphenyltrimethylammonium Iodide, CAS: 2498-27-3, stock: 8.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄INO.

3-Hydroxyphenyltrimethylammonium-d3 Iodide, CAS: /, stock: 9.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁D₃INO.

3-Iodo-4-methylpyridine, CAS: 38749-96-1, stock: 6.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆IN.

3-Keto Donepezil, CAS: 1023500-88-0, stock: 9.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇NO₄.

3-Keto Donepezil-d6, CAS: /, stock: 2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁D₆NO₄.

3-Keto-2-ene Donepezil, CAS: /, stock: 7.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅NO₄.

3-Methoxyphenyl Methylcarbamate, CAS: 3938-28-1, stock: 3.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₃.

3-Methylbenzyl Alcohol, CAS: 587-03-1, stock: 8.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀O.

3-Nitrophenyl Ethyl(methyl)carbamate, CAS: 1346242-31-6, stock: 7.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O₄.

3-O-Hexadecyl-sn-glycerol, CAS: 10550-58-0, stock: 3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₄₀O₃.

3-O-Hexadecyl-sn-glycerol-d5, CAS: /, stock: 6.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₅D₅O₃.

3-O-tert-Butyldimethylsilyl-D-erythro-sphingosylphosphorylcholine, CAS: 168411-99-2, stock: 9.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₆₃N₂O₅PSi.

3-Quinuclidinol, CAS: 1619-34-7, stock: 6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃NO.

3-Quinuclidinol-d7, CAS: 1619-34-7, stock: 4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆D₇NO.

3-Quinuclidyl Benzilate, CAS: 02/06/6581, stock: 2.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO₃.

3-Sulfo-tauroursodeoxycholic Acid Disodium Salt, CAS: 71781-66-3, stock: 3.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₃NNa₂O₉S₂.

3-[[2-(4-Chlorophenyl)-2-cyclopentyl-2-hydroxyacetyl]oxy]-1,1-dimethylpyrrolidinium Bromide, CAS: 1404453-68-4, stock: 9.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₇BrClNO₃.

3’-Hydroxy-4’-methoxyflavanone, CAS: 1621-70-1, stock: 2.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄O₄.

4,6,7,8,9,10-Hexahydro-6,10-methano-1H-pyrazino[2,3-h][3]benzazepine-2,3-dione, CAS: 357424-07-8, stock: 4.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₃O₂.

4-((3,4-Dimethoxybenzamido)methyl)phenyl 3,4-dimethoxybenzoate, CAS: /, stock: 6.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₅NO₇.

4-(2-(2-((1R,5S)-6,6-Dimethylbicyclo[3.1.1]hept-2-en-2-yl)ethoxy)ethyl)morpholine, CAS: /, stock: 8.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₉NO₂.

4-(2-Bromo-4,5-dimethoxyphenyl)-4-(2-chloroethyl)-3-methylmorpholin-4-ium Bromide, CAS: /, stock: 3.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂Br₂ClNO₃.

4-(2-Pyridinyl)benzoyl Chloride, CAS: 190850-37-4, stock: 3.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈ClNO.

4-(4-n-Butylpiperidin-1-yl)butanenitrile, CAS: 244291-78-9, stock: 9.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₄N₂.

4-(Dimethylamino)butanal Hydrochloride (May contain hydrate), CAS: 2109021-35-2, stock: 4.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄ClNO.

4-(Ethylenediol-methoxy)-9H-carbazole, CAS: /, stock: 6.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅NO₂.

4-Acetyl-1,1-dimethylpiperazinium Iodide, CAS: 75667-84-4, stock: 4.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇IN₂O.

4-Amino-1H-indazole-5-carboxylic Acid, CAS: 81115-63-1, stock: 3.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇N₃O₂.

4-Amino-3-methylpyridine, CAS: 1990-90-5, stock: 4.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₂.

4-Amino-benzenethiol, CAS: 1193-02-8, stock: 6.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇NS.

4-Amino-cis-L-proline Dihydrochloride, CAS: 16257-84-4, stock: 2.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂Cl₂N₂O₂.

4-Amino-L-trans-proline, CAS: 16257-88-8, stock: 4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀N₂O₂.

4-Aminophenyl 1-Thio-β-D-glucopyranoside, CAS: 58737-22-7, stock: 9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₅S.

4-Aminophenylphosphorylcholine, CAS: 102185-28-4, stock: 5.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉N₂O₄P.

4-​Pyridinecarboxaldehy​de N-​Oxide, CAS: 7216-42-4, stock: 4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅NO₂.

4-Bromo-3-methylpyrazole, CAS: 13808-64-5, stock: 1.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅BrN₂.

4-Bromophenyl Methylcarbamate, CAS: 13538-50-6, stock: 4.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈BrNO₂.

4-Butylpiperidine Hydrochloride, CAS: 372195-85-2, stock: 2.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀ClN.

4-Des(4-methyl-1-piperazinyl)-4-amino-10-(2-nitrophenyl) Olanzapine Hydrochloride, CAS: /, stock: 5.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅ClN₄O₂S.

4-Diphenylacetoxy-N-(2-chloroethyl)piperidine, CAS: 130817-71-9, stock: 6.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄ClNO₂.

4-Fluoroolanzapine, CAS: /, stock: 3.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉FN₄S.

4-Fluoroolanzapine-d3, CAS: /, stock: 2.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆D₃FN₄S.

4-Fluorotoluene-α-d1, CAS: 13108890-9, stock: 6.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆DF.

4-Hydroxy-3-(p-diazophenylphosphorylcholine) Phenylacetic Acid, CAS: 359435-74-8, stock: 7.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄N₃O₇P.

4-Iodo-3-methyl-1H-pyrazole, CAS: 15802-75-2, stock: 7.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅IN₂.

4-Methoxyoxazole-5-carboxylic Acid, CAS: 2510-32-9, stock: 2.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅NO₃.

4-Methyl-1,3-dioxolane, CAS: 1072-47-5, stock: 3.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈O₂.

4-Methylbenzoyl Cyanide, CAS: 14271-73-9, stock: 4.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇NO.

4-Methyloxazole, CAS: 693-93-6, stock: 1.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅NO.

4-Methylumbelliferyl Phosphocholine, CAS: 97055-84-0, stock: 2.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀NO₆P.

4-Nitrophenylphosphorylcholine, CAS: 21064-69-7, stock: 3.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇N₂O₆P.

4-Pyridinealdoxime, CAS: 696-54-8, stock: 3.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O.

4-[(2,3-Dihydro-5,6-dimethoxy-1-oxo-1H-inden-2-yl)methyl]-1,1-bis(phenylmethyl)piperidinium-d14 Bromide, CAS: /, stock: 6.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₂D₁₄BrNO₃.

4-[2-(Dimethylamino)ethoxy]benzonitrile, CAS: 24197-95-3, stock: 2.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O.

42-O-[2-[[Hydroxy[2-(trimethylammonio)ethoxy]phosphinyl]oxy]ethyl] Rapamycin Inner Salt >75%, CAS: 1062645-51-5, stock: 8.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₈H₉₅N₂O₁₇P.

4BP-TQS, CAS: 360791-49-7, stock: 7.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇BrN₂O₂S.

5,6-Di(meth-d3-oxy)indane-1,3-dione, CAS: /, stock: 1.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₄D₆O₄.

5,6-Dimethoxyindane-1,3-dione, CAS: 36517-91-6, stock: 8.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀O₄.

5-(1-Methyl-4-piperidinyl)-5H-dibenzo[a,d]cyclohepten-5-ol, CAS: 3967-32-6, stock: 2.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃NO.

5-Aminovaleric Acid, CAS: 660-88-8, stock: 4.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂.

5-Bromo-2-methoxypyridine, CAS: 13472-85-0, stock: 5.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆BrNO.

5-Chloro-2,4-difluoroaniline, CAS: 348-65-2, stock: 8.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄ClF₂N.

5-Chlorofuran-2-carboxylic Acid, CAS: 618-30-4, stock: 1.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃ClO₃.

5-Ethynyl Nicotine, CAS: 179120-92-4, stock: 7.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂.

5-Isoxazolecarbaldehyde, CAS: 16401-14-2, stock: 7.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃NO₂.

5-Isoxazolecarboxylic Acid, CAS: 21169-71-1, stock: 8.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃NO₃.

5-methoxy-2-naphthalenecarbonitrile, CAS: 2741-80-2, stock: 7.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₉NO.

5-O-Desmethyl Donepezil, CAS: 120013-57-2, stock: 5.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇NO₃.

5-O-Desmethyl Donepezil-d5, CAS: 1189929-21-2, stock: 7.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂D₅NO₃.

5-Oxo-2-azabicyclo[2.2.1]heptane-2-carboxylic Acid Phenylmethyl Ester, CAS: 140927-13-5, stock: 1.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅NO₃.

5-Triisopropylsilyl-ethynyl (S)-(-)-Nicotine, CAS: 916046-39-4, stock: 6.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₄N₂Si.

6,7,8,9-Tetrahydro-5,9-methano-5H-pyrido[3,4-d]azepine, CAS: 833458-84-7, stock: 6.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂.

6,7,8,9-Tetrahydro-5,9-methano-5H-pyrido[3,4-d]azepine Dihydrochloride, CAS: 833458-83-6, stock: 5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄Cl₂N₂.

6,7-Dehydrohyoscyamine, CAS: 61616-97-5, stock: 1.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO₃.

6-(Dimethylamino)-1-hexanol, CAS: 1862-07-3, stock: 8.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₉NO.

6-(O-Phosphorylcholine)hydroxyhexanoic Acid, CAS: 73839-24-4, stock: 8.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₄NO₆P.

6-Amino-2(1H)-pyridinone, CAS: 5154-00-7, stock: 1.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₂O.

6-Anilino-5,8-quinolinedione, CAS: 91300-60-6, stock: 2.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀N₂O₂.

6-Carboxyhexylphosphocholine p-Nitrophenyl Ester, CAS: 73785-43-0, stock: 1.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₇N₂O₈P.

6-Hexadecanoylamino-4-methylumbelliferyl Phosphorylcholine, CAS: 904315-61-3, stock: 2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₅₁N₂O₇P.

6-Hydroxy-L-DOPA, CAS: 27244-64-0, stock: 2.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₅.

6-O-Desmethyl Donepezil, CAS: 120013-56-1, stock: 9.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇NO₃.

6-O-Desmethyl Donepezil β-D-Glucuronide, CAS: 220170-73-0, stock: 4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₅NO₉.

6-O-Desmethyl Donepezil-d5, CAS: 1189443-74-0, stock: 1.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂D₅NO₃.

7,8,9,10-Tetrahydro-6,10-Methano-6H-pyrazino[2,3-h][3]benzazepine 1,4-Dioxide, CAS: 1337563-47-9, stock: 2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₃O₂.

7,8-Dihydro-5(6H)-quinolone, CAS: 53400-41-2, stock: 9.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO.

7-Acetoxy-1-methylquinolinium iodide, CAS: 7270-83-9, stock: 1.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂NO₂ • I.

7-Diethylamino-4-hydroxy-chromen-2-one, CAS: 64369-55-7, stock: 5.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅NO₃.

7-Ethoxy Resorufin, CAS: 5725-91-7, stock: 3.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁NO₃.

8-anti-Ipratropium Bromide, CAS: 58073-59-9, stock: 7.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀BrNO₃.

8-Isoprostaglandin E1, CAS: 21003-46-3, stock: 4.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄O₅.

A 867744, CAS: 1000279-69-5, stock: 1.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉ClN₂O₃S.

ABT-418 Hydrochloride, CAS: 147388-83-8, stock: 10g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂O •HCl.

Aceclidine Hydrochloride, CAS: 6109-70-2, stock: 9.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆ClNO₂.

Acetyl-β-methylcholine Bromide, CAS: 333-31-3, stock: 5.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈BrNO₂.

Acetylcholine Bromide, CAS: 66-23-9, stock: 3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆BrNO₂.

Acetylcholine Chloride, CAS: 60-31-1, stock: 5.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆ClNO₂.

Acetylcholine Iodide, CAS: 2260-50-6, stock: 10g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆INO₂.

Acetylcholine Perchlorate, CAS: 927-86-6, stock: 1.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆NO₂⁺ •ClO₄⁻.

Acetylcholine-1,1,2,2-d4 Bromide, CAS: 93449-31-1, stock: 7.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂D₄NO₂•Br.

Acetylcholine-d13 Bromide (N,N,N-trimethyl-d9; 1,1,2,2-d4), CAS: /, stock: 9.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₃D₁₃NO₂•Br.

Acetylcholine-d16 Bromide, CAS: 347841-43-4, stock: 5.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇D₁₆NO₂•Br.

Acetylcholine-d4 Chloride, CAS: 344298-94-8, stock: 8.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂D₄NO₂.Cl.

Acetylcholine-d9 Bromide, CAS: 93449-32-2, stock: 5.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇D₉BrNO₂.

Acetylcholine-d9 Chloride, CAS: 344298-95-9, stock: 6.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇D₉ClNO₂.

Acetylethylcholine Mustard Hydrochloride, CAS: 103994-00-9, stock: 5.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆ClNO₂ • (HCl).

Acetylthiocholine Chloride, CAS: 6050-81-3, stock: 3.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆ClNOS.

Acetylthiocholine Iodide, CAS: 1866-15-5, stock: 2.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆NOS  •I.

Ach(Acetylcholine) ELISA Kit (96T), CAS: /, stock: 9.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Alanycarb, CAS: 83130-01-2, stock: 3.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅N₃O₄S₂.

Ambenonium Dichloride, CAS: 115-79-7, stock: 8.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₂Cl₄N₄O₂.

Anabaseine, CAS: 04/05/3471, stock: 3.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂.

Anabaseine-d4, CAS: 1020719-05-4, stock: 5.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈D₄N₂.

Anabasine Hydrochloride, CAS: 15251-47-5, stock: 7.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂ • HCl.

Anisodine Hydrobromide, CAS: 76822-34-9, stock: 4.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂BrNO₅.

anti- Choline kinase alpha antibody, CAS: /, stock: 6.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

anti- Choline kinase alpha-Specific antibody, CAS: /, stock: 5.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Apo-ipratropium Iodide, CAS: /, stock: 5.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈INO₂.

(3R)-N-[(1S)-1-Phenylethyl]-1-azabicyclo[2.2.2]octan-3-amine Dihydrochloride, CAS: 120570-09-4, stock: 7.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂ •2HCl.

Apobuscopan, CAS: 92714-23-3, stock: 6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈BrNO₃.

Apobuscopan-d9, CAS: /, stock: 3.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉D₉BrNO₃.

3-Hydroxy-1-azabicyclo[2.2.2]octane-3-methanol, CAS: 61573-79-3, stock: 4.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₂.

3-Quinuclidinone Hydrochloride, CAS: 1193-65-3, stock: 4.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂ClNO.

Arecaidine Ethyl Ester Hydrochloride, CAS: 17210-50-3, stock: 3.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆ClNO₂.

Arecaidine Hydrobromide, CAS: 6013-57-6, stock: 8.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂BrNO₂.

CEV (R)-S-Oxide, CAS: 124751-37-7, stock: 9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₂S.

CEV Trityl-MCS, CAS: /, stock: 9.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉NOS.

Arecaidine-d5 Hydrobromide, CAS: /, stock: 2.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇D₅BrNO₂.

Arecoline Hydrobromide, CAS: 300-08-3, stock: 3.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄BrNO₂.

Cevimeline Hydrochloride Salt, CAS: 107220-28-0, stock: 3.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈ClNOS.

Cevimeline N,S-dioxide (Mixture of diastereomers), CAS: /, stock: 2.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₃S.

Arecoline-d5 Hydrobromide Salt, CAS: 131448-18-5, stock: 9.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉D₅BrNO₂.

ARL 14495, CAS: 123319-03-9, stock: 7.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₂.

Cevimeline N-Glucuronide(Mixture of Diastereomers), CAS: /, stock: 8.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₅NO₇S.

Cevimeline N-Oxide, CAS: 469890-14-0, stock: 6.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₂S.

Arsenobetaine Bromide, CAS: 71642-15-4, stock: 3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂AsBrO₂.

Arsenobetaine-d3 Bromide, CAS: /, stock: 5.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉D₃AsBrO₂.

Cevimeline Sulfoxide, CAS: 124751-36-6, stock: 1.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₂S.

Cevimeline-d4 Hydrochloride Salt (Major), CAS: /, stock: 5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄D₄ClNOS.

Arsenocholine Bromide, CAS: 71802-31-8, stock: 1.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₄AsBrO.

rac 3-Hydroxy-3-mercaptomethylquinuclidine, CAS: 107220-26-8, stock: 8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NOS.

Spiro[1-azabicyclo[2.2.2]octane-3,2’-oxirane] Hydrochloride, CAS: 64168-68-9, stock: 6.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄ClNO.

Azidophosphorylsphingosylcholine, CAS: /, stock: 7.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₇N₄O₅P.

Azinphos-methyl, CAS: 86-50-0, stock: 2.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₃O₃PS₂.

Azinphos-methyl-D6, CAS: /, stock: 4.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆D₆N₃O₃PS₂.

Bamipine, CAS: 4945-47-5, stock: 3.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄N₂.

Bamipine-d5, CAS: /, stock: 2.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉D₅N₂.

Benactyzine Hydrochloride, CAS: 57-37-4, stock: 7.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆ClNO₃.

Bensulide, CAS: 741-58-2, stock: 4.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₄NO₄PS₃.

Benzetimide Hydrochloride, CAS: 5633-14-7, stock: 2.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇ClN₂O₂.

Benzilic Acid, CAS: 76-93-7, stock: 3.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂O₃.

Benzilide, CAS: 467-32-3, stock: 9.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₀O₄.

Benzoylcholine Bromide, CAS: 24943-60-0, stock: 5.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈BrNO₂.

Benzoylcholine Chloride, CAS: 02/09/2964, stock: 3.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈ClNO₂.

Benzoylcholine Iodide, CAS: 17518-43-3, stock: 9.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈INO₂.

Benzoylthiocholine Iodide, CAS: 10561-14-5, stock: 1.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈INOS.

Benzyl Nicotinate, CAS: 94-44-0, stock: 6.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁NO₂.

Beperidium Iodide, CAS: 86434-57-3, stock: 1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₉IN₂O₂.

Betaine, CAS: 107-43-7, stock: 7.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁NO₂.

Betaine Aldehyde Chloride, CAS: 7758-31-8, stock: 3.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂ClNO.

Bethanechol Chloride, CAS: 590-63-6, stock: 1.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₇ClN₂O₂.

Bethanechol-d9, CAS: /, stock: 2.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈D₉ClN₂O₂.

Bevonium Methyl Sulfate, CAS: 5205-82-3, stock: 4.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁NO₇S.

Bis(4-carbamoyl-1-pyridiniomethyl) Ether Dichloride, CAS: 21260-10-6, stock: 7.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆Cl₂N₄O₃.

Bis[1-(carbo-β-diethylaminoethoxy)-1-phenylcyclopentane]ethanedisulfonate, CAS: 125-86-0, stock: 1.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  2(C₁₈H₂₇NO₂) • C  ₂H₆O₆S₂.

Boc-(2S,4S)-4-amino-1-Fmoc-pyrrolidine-2-carboxylic Acid, CAS: 221352-74-5, stock: 6.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈N₂O₆.

Bovine BCHE (Cholinesterase) ELISA Kit (96T), CAS: /, stock: 6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine CHPT1 (Cholinephosphotransferase 1) ELISA Kit (96T), CAS: /, stock: 1.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine PCTP (Phosphatidylcholine transfer protein) ELISA Kit (96T), CAS: /, stock: 5.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

BQCA, CAS: 338747-41-4, stock: 7.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅NO₄.

Bretylium Tosylate, CAS: 61-75-6, stock: 5.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄BrNO₃S.

Bromoacetylcholine Bromide, CAS: 22004-27-9, stock: 7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅Br₂NO₂.

Bromocyclopentane, CAS: 137-43-9, stock: 3.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉Br.

Bromocyclopentane-d9, CAS: 35468-44-1, stock: 3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅D₉Br.

Butocarboxim, CAS: 34681-10-2, stock: 4.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄N₂O₂S.

Butocarboxim-d3, CAS: 1795141-34-2, stock: 4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₁D₃N₂O₂S.

Butropium Bromide, CAS: 29025-14-7, stock: 6.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₈BrNO₄.

Butropium Bromide-d9, CAS: /, stock: 6.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₉D₉BrNO₄.

Butyltrimethylammonium Chloride, CAS: 14251-72-0, stock: 6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₈ClN.

Butyrylcholine Chloride, CAS: 2963-78-2, stock: 4.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀ClNO₂.

Butyrylcholine Iodide, CAS: 2494-56-6, stock: 9.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀INO₂.

Butyrylcholine Perchlorate, CAS: 20292-68-6, stock: 7.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀NO₂ • ClO ₄.

Butyrylthiocholine Iodide, CAS: 1866-16-6, stock: 3.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀INOS.

Captan, CAS: 133-06-2, stock: 6.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈Cl₃NO₂S.

Captan-d6, CAS: 1330190-00-5, stock: 3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂D₆Cl₃NO₂S.

Carbamylcholine Chloride, CAS: 51-83-2, stock: 6.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₅ClN₂O₂.

Carbaryl, CAS: 63-25-2, stock: 8.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO₂.

Carbaryl-13C10, CAS: /, stock: 3.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₁₀H₁₁NO₂.

Carbaryl-d7, CAS: 362049-56-7, stock: 8.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₄D₇NO₂.

Carbonodithioic Acid O-(Octahydro-4,7-methano-1H-inden-5-yl) Ester Potassium Salt, CAS: 83373-60-8, stock: 7.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆KOS₂.

Cerasidin, CAS: 64200-22-2, stock: 7.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀O₆.

Chicken CEPT1 (Choline/ethanolaminephosphotransferase 1) ELISA Kit (96T), CAS: /, stock: 6.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Chicken CHPT1 (Cholinephosphotransferase 1) ELISA Kit (96T), CAS: /, stock: 5.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Chlorocholine Chloride, CAS: 999-81-5, stock: 2.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₃Cl₂N.

Chlorocholine Chloride-d4, CAS: /, stock: 8.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉D₄Cl₂N.

Chlorocholine Chloride-d9, CAS: 1219257-11-0, stock: 2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄D₉Cl₂N.

Chlorpyriphos-methyl, CAS: 5598-13-0, stock: 7.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇Cl₃NO₃PS.

Chlorpyriphos-methyl-d6, CAS: /, stock: 1.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇HD₆Cl₃NO₃PS.

Choline Bitartrate, CAS: 87-67-2, stock: 5.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₉NO₇.

Choline Chloride, CAS: 67-48-1, stock: 6.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₄ClNO.

Choline Dihydrogen Citrate, CAS: 77-91-8, stock: 8.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁NO₈.

Choline Fenofibrate, CAS: 856676-23-8, stock: 7.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈ClNO₅.

Choline Fenofibrate-d6, CAS: /, stock: 2.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂D₆ClNO₅.

Choline Hydroxide in Methanol Solution, CAS: 123-41-1, stock: 1.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₅NO₂.

Choline p-Toluenesulfonate Salt, CAS: 55357-38-5, stock: 6.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₄NO • C  ₇H₇O₃S.

Choline-d4 Chloride, CAS: 285979-70-6, stock: 9.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀D₄NO⁺ •  Ci⁻.

Choline-d9 Chloride, CAS: 61037-86-3, stock: 3.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅D₉ClNO.

Choline-d9 Phosphate Barium Salt Chloride, CAS: /, stock: 2.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄D₉BaClNO₄P.

cis-2-Methyl-5-trimethylammoniummethyl-1,3-oxathiolane Iodide, CAS: 76541-57-6, stock: 3.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈INOS.

Citatepine, CAS: 65509-66-2, stock: 1.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈N₂S.

Citicoline Sodium Salt, CAS: 33818-15-4, stock: 3.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅N₄NaO₁₁P₂.

Citric Acid (3-Methanethiosulfonate Ethyl Amide), CAS: 1797099-42-3, stock: 6.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉NO₈S₂.

Clidinium Bromide, CAS: 3485-62-9, stock: 8.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆BrNO₃.

Clidinium-d7 Bromide, CAS: /, stock: 1.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉D₇BrNO₃.

Clofedanol Hydrochloride, CAS: 511-13-7, stock: 6.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁Cl₂NO.

Clofedanol-d5 Hydrochloride, CAS: 1346599-66-3, stock: 3.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆D₅Cl₂NO.

Clozapine-d4, CAS: 204395-52-8, stock: 2.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅D₄ClN₄.

Colchicinic Acid, CAS: 6877-18-5, stock: 4.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅NO₅.

Colfosceril-d9 Palmitate, CAS: /, stock: 3.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₇₁D₉NO₈P.

Condelphine, CAS: 7633-69-4, stock: 6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₉NO₆.

Cornuside I, CAS: 131189-57-6, stock: 8.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀O₁₄.

Corytuberine Methiodide, CAS: 4277-43-4, stock: 7.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄INO₄.

Crufomate, CAS: 299-86-5, stock: 3.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉ClNO₃P.

Crufomate-d6, CAS: 1794892-06-0, stock: 3.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃D₆ClNO₃P.

Cyanine 3 Monofunctional Hexanoic Acid Dye GABA Amide Potassium Salt, CAS: /, stock: 1.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₄KN₃O₉S₂.

Cyanophos, CAS: 2636-26-2, stock: 7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀NO₃PS.

Cyclopropyltropine Benzylate, CAS: 575463-96-6, stock: 9.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅NO₃.

Cyproheptadine Hydrochloride Sesquihydrate, CAS: 41354-29-4, stock: 5.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅ClNO.

Cyproheptadine Hydrochloride-d3, CAS: /, stock: 1.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉D₃ClN.

Cyproheptadine N-Oxide, CAS: 100295-63-4, stock: 8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁NO.

Cytidine 5’-Diphosphocholine, CAS: 987-78-0, stock: 2.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₆N₄O₁₁P₂.

Cytisine, CAS: 485-35-8, stock: 7.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O.

Cytisine-d4 (Major), CAS: /, stock: 9.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀D₄N₂O.

D,L-Trihexyphenidyl Hydrochloride, CAS: 52-49-3, stock: 4.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂ClNO.

D,L-Trihexyphenidyl Hydrochloride-D11, CAS: /, stock: 4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁D₁₁ClNO.

D-erythro-Sphingosylphosphorylcholine (Synthetic), CAS: 1670-26-4, stock: 8.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₉N₂O₅P.

D-Tetrahydropalmatine, CAS: 3520-14-7, stock: 4.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅NO₄.

Darifenacin N-Oxide, CAS: 1391080-40-2, stock: 3.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₀N₂O₃.

Decamethonium Bromide, CAS: 541-22-0, stock: 6.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₈Br₂N₂.

Dehydro Glycopyrrolate Iodide (Mixture of Diastereomers), CAS: /, stock: 5.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₆INO₃.

Dehydro Glycopyrrolate Iodide-D3(Mixture of Diastereomers), CAS: /, stock: 4.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃D₃INO₃.

Dehydrotrospium Chloride, CAS: 113922-55-7, stock: 2.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈NO₃•Cl.

Demecarium Bromide, CAS: 56-94-0, stock: 7.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₂Br₂N₄O₄.

Demethyltrichlorfon, CAS: 684-31-1, stock: 4.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₆Cl₃O₄P.

Depyrazine 6,8-Diaminophenyl Varenicline Hydrochloride, CAS: /, stock: 8.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N₃•HCl.

Des [3-(1-Dimethylamino)ethyl] 3-Acetyl Rivastigmine, CAS: 855300-09-3, stock: 9.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₃.

Desbenzyl Donepezil-13C3, CAS: /, stock: 6.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄¹³C₃H₂₃NO₃.

Desformylflustrabromine Hydrochloride, CAS: 951322-11-5, stock: 7.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁BrN₂ • (HCl).

Desmethyl Rivastigmine L-Tartrate, CAS: /, stock: 2.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₆N₂O₈.

Desmethyl Rivastigmine-d6 L-Tartrate, CAS: /, stock: 7.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀D₆N₂O₈.

Desoxypeganine Hydrochloride, CAS: 61939-05-7, stock: 5.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂ • (HCl).

Dianicline, CAS: 292634-27-6, stock: 7.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₂O.

Diazinon, CAS: 333-41-5, stock: 9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₁N₂O₃PS.

Diazinon-13C4, CAS: /, stock: 2.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₄H₂₁N₂O₃PS.

Diazinon-d10, CAS: 100155-47-3, stock: 8.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁D₁₀N₂O₃PS.

Diazoxon, CAS: 962-58-3, stock: 8.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₁N₂O₄P.

Diazoxon-d10, CAS: /, stock: 7.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁D₁₀N₂O₄P.

Dibenzosuberyl Chloride, CAS: 1210-33-9, stock: 3.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃Cl.

Dibromoethane, CAS: 106-93-4, stock: 1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₄Br₂.

Dichlorvos, CAS: 62-73-7, stock: 7.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇Cl₂O₄P.

Dichlorvos-d6, CAS: 203645-53-8, stock: 7.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄HD₆Cl₂O₄P.

Dicrotophos, CAS: 141-66-2, stock: 9.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆NO₅P.

Diethyl (Trichloromethyl)phosphonate, CAS: 866-23-9, stock: 5.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀Cl₃O₃P.

Diethyl 2,2’-(1,3-Dithietane-2,4-diylidene)bis(cyanoacetate), CAS: 22624-54-0, stock: 1.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀N₂O₄S₂.

Diethyl Carbonate, CAS: 105-58-8, stock: 6.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀O₃.

Diethyl Chlorophosphite, CAS: 589-57-1, stock: 8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀ClO₂P.

Diethyl Phosphoramidate, CAS: 1068-21-9, stock: 6.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₂NO₃P.

Diethyl Rivastigmine, CAS: 1230021-34-7, stock: 6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄N₂O₂.

Diethyl Rivastigmine-d10, CAS: 1346599-05-0, stock: 2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄D₁₀N₂O₂.

Diethyl-d10 Carbonate, CAS: 440671-47-6, stock: 3.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅D₁₀O₃.

Dihydro-β-erythroidine Hydrobromide, CAS: 29734-68-7, stock: 1.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₃ • HBr.

Dihydronarwedine, CAS: 21041-10-1, stock: 8.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO₃.

Dihydronarwedine-d3, CAS: /, stock: 9.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈D₃NO₃.

Diisopropyl Fluorophosphate, CAS: 55-91-4, stock: 4.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄FO₃P.

Dimethindene Maleate, CAS: 3614-69-5, stock: 5.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈N₂O₄.

Dimethindene-d6 Maleate, CAS: /, stock: 1.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂D₆N₂O₄.

Dimethoate, CAS: 60-51-5, stock: 3.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂NO₃PS₂.

Dimethoate-13C3, CAS: /, stock: 2.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₃H₁₂NO₃PS₂.

Dimethoate-d6, CAS: 1219794-81-6, stock: 7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆D₆NO₃PS₂.

Dimethyl-d-tubocurarine Iodide, CAS: 36653-49-3, stock: 1.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₄₅IN₂O₆.

Dimethyl-d-tubocurarine-d6 Iodide, CAS: /, stock: 2.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₉D₆IN₂O₆.

Diphemanil Methosulfate, CAS: 62-97-5, stock: 2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇NO₄S.

Diphenyl 2-(Dimethylamino)ethylphosphoric Acid Ester, CAS: 1549811-48-4, stock: 5.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀NO₄P.

Distigmine Bromide, CAS: 15876-67-2, stock: 4.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₂Br₂N₄O₄.

Distigmine Bromide-d6, CAS: /, stock: 9.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆D₆Br₂N₄O₄.

Disulfoton, CAS: 298-04-4, stock: 7.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₉O₂PS₃.

Disulfoton Sulfoxide, CAS: 06/07/2497, stock: 6.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₉O₃PS₃.

Disulfoton-D10, CAS: /, stock: 3.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉D₁₀O₂PS₃.

Dodecylphosphocholine (D38, 98%), CAS: 130890-78-7, stock: 5.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₈NO₄P.

Donepezil, CAS: 120014-06-4, stock: 5.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉NO₃.

Donepezil Hydrochloride, CAS: 120011-70-3, stock: 10g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀ClNO₃.

Donepezil O-Benzyl Enol Ether, CAS: /, stock: 6.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₅NO₃.

Donepezil O-Benzyl Enol Ether-d7, CAS: /, stock: 7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₈D₇NO₃.

Donepezil-13C3 Hydrochloride, CAS: 1246814-90-3, stock: 6.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁¹³C₃H₃₀ClNO₃.

Donepezil-4-hydroxy, CAS: 197010-22-3, stock: 9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉NO₄.

Donepezil-d7 Hydrochloride, CAS: 1261394-20-0, stock: 5.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃D₇ClNO₃.

Doxacurium Chloride (Mixture of Diastereomers), CAS: 106819-53-8, stock: 9.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₆H₇₈Cl₂N₂O₁₆.

Echothiophate Iodide, CAS: 513-10-0, stock: 4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₃INO₃PS.

Echothiophate-d3 Iodide, CAS: /, stock: 9.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀D₃INO₃PS.

Edrophonium Chloride, CAS: 116-38-1, stock: 1.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆ClNO.

Edrophonium-d5 Chloride, CAS: /, stock: 6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁D₅ClNO.

Eicosapentaenoic Sphingomyelin, CAS: /, stock: 6.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₇₇N₂O₆P.

Elemicin, CAS: 487-11-6, stock: 4.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₃.

Emepronium Bromide, CAS: 3614-30-0, stock: 2.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈BrN.

Emepronium-d5 Bromide, CAS: /, stock: 8.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃D₅BrN.

Encenicline Hydrochloride, CAS: 550999-74-1, stock: 6.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇ClN₂OS . HCl.

ent NAP 226-90, CAS: 851086-95-8, stock: 6.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅NO.

Epi Galanthamine, CAS: 1668-85-5, stock: 1.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO₃.

Epi Galanthamine 6-O-Nitrobenzoate, CAS: /, stock: 8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₄N₂O₆.

Epi-galanthamine-O-methyl-d3, CAS: 1217655-71-4, stock: 5.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈D₃NO₃.

Eriodictyol, CAS: 552-58-9, stock: 3.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂O₆.

Ethoprophos, CAS: 13194-48-4, stock: 7.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₉O₂PS₂.

Ethyl 2-Cyclopentyl-2-oxoacetate, CAS: 33537-18-7, stock: 3.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄O₃.

Ethyl 4-Quinuclidinecarboxylate, CAS: 22766-68-3, stock: 5.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₂.

Ethyl Dichlorophosphate, CAS: 1498-51-7, stock: 9.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₅Cl₂O₂P.

exo-2-Amino-7-Boc-azabicyclo[2.2.1]heptane, CAS: 500556-93-4, stock: 5.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀N₂O₂.

Fenamiphos 90%, CAS: 22224-92-6, stock: 6.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₂NO₃PS.

Fenpiverinium Bromide, CAS: 125-60-0, stock: 6.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉BrN₂O.

Fensulfothion Oxon, CAS: 6552-21-2, stock: 5.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇O₅PS.

Fensulfothion Oxon Sulfide, CAS: 3070-13-1, stock: 5.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇O₄PS.

Fensulfothion Oxon Sulfide-d10, CAS: /, stock: 8.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇D₁₀O₄PS.

Fensulfothion Oxon Sulfone, CAS: 6132-17-8, stock: 2.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇O₆PS.

Fensulfothion Oxon Sulfone-d10, CAS: /, stock: 2.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇D₁₀O₆PS.

Fensulfothion Oxon-d10, CAS: /, stock: 4.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇D₁₀O₅PS.

Fensulfothion Sulfide, CAS: 3070-15-3, stock: 8.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇O₃PS₂.

Fensulfothion Sulfide-d10, CAS: /, stock: 7.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇D₁₀O₃PS₂.

Fensulfothion Sulfone, CAS: 14255-72-2, stock: 7.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇O₅PS₂.

Fensulfothion Sulfone-d10, CAS: /, stock: 6.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇D₁₀O₅PS₂.

Fipronil Amide, CAS: 205650-69-7, stock: 6.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆Cl₂F₆N₄O₂S.

Fluoromethylcholine Chloride, CAS: 459424-38-5, stock: 2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₃ClFNO.

Fmoc-(2S,5R)-5-phenyl-pyrrolidine-2-carboxylic Acid, CAS: 215190-21-9, stock: 6.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₃NO₄.

Fmoc-bpa-oh, CAS: 117666-96-3, stock: 6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₅NO₅.

Galanthamine, CAS: 357-70-0, stock: 2.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO₃.

Galanthamine Hydrobromide, CAS: 04/04/1953, stock: 6.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂BrNO₃.

Galanthamine Impurity 2, CAS: /, stock: 3.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO₅.

Galanthamine Methiodide, CAS: 3891-74-5, stock: 7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄INO₃.

Galanthamine N-Oxide, CAS: 134332-50-6, stock: 8.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO₄.

Galanthamine-O-(methyl-d3)-N-(methyl-d3), CAS: 1128109-00-1, stock: 3.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅D₆NO₃.

Galanthamine-O-methyl-d3, CAS: 1279031-09-2, stock: 9.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈D₃NO₃.

Galanthamine-O-methyl-d3 Hydrobromide, CAS: /, stock: 6.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉D₃BrNO₃.

Galanthamine-O-methyl-d3 N-Oxide, CAS: 1217860-44-0, stock: 8.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈D₃NO₄.

Galanthaminone, CAS: 510-77-0, stock: 6.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉NO₃.

Gap 27, CAS: 198284-64-9, stock: 7.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₀H₁₀₁N₁₅O₁₇.

Garcinone C, CAS: 76996-27-5, stock: 4.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆O₇.

Gemcitabine Diphosphate Choline, CAS: 1643126-46-8, stock: 3.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₄F₂N₄O₁₀P₂.

Gitogenin, CAS: 511-96-6, stock: 6.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₄.

Glycerol 3-Phosphoethanolamine Sodium Salt (>90%), CAS: /, stock: 5.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₃NNaO₆P.

Glycopyrrolate Bromide, CAS: 596-51-0, stock: 3.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈BrNO₃.

Guthoxon, CAS: 961-22-8, stock: 1.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₃O₄PS.

Guthoxon-d6, CAS: /, stock: 4.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆D₆N₃O₄PS.

HA 155, CAS: 1229652-22-5, stock: 7.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₉BFNO₅S.

Harmalol, CAS: 525-57-5, stock: 2.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂N₂O.

Hexadecyl Diphenyl Phosphate, CAS: 56827-92-0, stock: 3.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₃O₄P.

Hexadecyl Diphenyl Phosphate-d10, CAS: /, stock: 6.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₃D₁₀O₄P.

Hexafluorenium Bromide, CAS: 317-52-2, stock: 3.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₂Br₂N₂.

Hexafluorenium-d12 Bromide, CAS: /, stock: 7.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₀D₁₂Br₂N₂.

Hexahydro-1H-pyrrolizin-7a-ylmethanol, CAS: 78449-72-6, stock: 5.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO.

Human ACHAP(Acetylcholinesterase Associated Protein) ELISA Kit (96T), CAS: /, stock: 6.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human ACHE(Acetylcholinesterase) ELISA Kit (96T), CAS: /, stock: 1.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human AchR-Ab(Acetylcholine Receptors-Ab) ELISA Kit (96T), CAS: /, stock: 9.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human Anti-AChR(Anti-Acetylcholine Receptor Antibody) ELISA Kit (96T), CAS: /, stock: 3.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human BCHE (Cholinesterase) ELISA Kit (96T), CAS: /, stock: 8.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human BCHE(Cholinesterase) ELISA Kit (96T), CAS: /, stock: 3.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human CHAT(Choline O-acetyltransferase) ELISA Kit (96T), CAS: /, stock: 4.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human CHKA (Choline kinase alpha) ELISA Kit (96T), CAS: /, stock: 2.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human CHKB (Choline/ethanolamine kinase) ELISA Kit (96T), CAS: /, stock: 2.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human Choline kinase alpha ELISA Kit (96T), CAS: /, stock: 4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human CHPT1 (Cholinephosphotransferase 1) ELISA Kit (96T), CAS: /, stock: 7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human CHRM1 (Muscarinic acetylcholine receptor M1) ELISA Kit (96T), CAS: /, stock: 7.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human CHRM2(Cholinergic Receptor, Muscarinic 2) ELISA Kit (96T), CAS: /, stock: 2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human CHRM3(Muscarinic acetylcholine receptor M3) ELISA Kit (96T), CAS: /, stock: 9.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human LCAT(Phosphatidylcholine-sterol acyltransferase) ELISA Kit (96T), CAS: /, stock: 2.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human LPCAT2(Lysophosphatidylcholine acyltransferase 2) ELISA Kit (96T), CAS: /, stock: 3.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human M-AChR(Muscarinic Acetylcholine Receptor) ELISA Kit (96T), CAS: /, stock: 3.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human SLC18A3 (Vesicular acetylcholine transporter) ELISA Kit (96T), CAS: /, stock: 1.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Hupehenine, CAS: 98243-57-3, stock: 8.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₅NO₂.

Imidaclothiz, CAS: 105843-36-5, stock: 6.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈ClN₅O₂S.

Imidaclothiz-d4, CAS: /, stock: 1.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄D₄ClN₅O₂S.

Iodocholine Iodide, CAS: 28508-22-7, stock: 7.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₃I₂NO.

Ipidacrine Hydrochloride Hydrate, CAS: 118499-70-0, stock: 5.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂ • HCl • H ₂O.

Ipratropium Bromide, CAS: 22254-24-6, stock: 3.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀BrNO₃.

Ipratropium Bromide Methoxy Impurity, CAS: /, stock: 9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₂BrNO₃.

Isodimethoate, CAS: 04/11/3344, stock: 6.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂NO₃PS₂.

Isopilocarpine Hydrochloride, CAS: 28958-85-2, stock: 5.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₂  •HCl.

Isoprocarb, CAS: 2631-40-5, stock: 6.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₂.

Isopropamide Iodide, CAS: 71-81-8, stock: 4.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₃IN₂O.

Isopropyl Methyl Phosphorodithioate, CAS: 92351-18-3, stock: 8.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₇O₂PS₂.

α-Ethyl-benzeneacetyl Chloride, CAS: 36854-57-6, stock: 5.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁ClO.

α-Lobeline Hydrochcloride, CAS: 134-63-4, stock: 1.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈ClNO₂.

β-Caryophyllene Epoxide, CAS: 1139-30-6, stock: 3.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₄O.

β-Methylcholine Chloride, CAS: 2382-43-6, stock: 4.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₆ClNO.

JNJ 10181457, CAS: 544707-19-9, stock: 7.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈N₂O.

K252b, CAS: 99570-78-2, stock: 1.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₁₉N₃O₅.

L-Dierucoyl Lecithin, CAS: 51779-95-4, stock: 1.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₁₀₀NO₈P.

L-Dierucoyl Lecithin-D9, CAS: /, stock: 6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₉D₉NO₈P.

L-α-Dilauroyl Phosphatidylcholine, CAS: 18194-25-7, stock: 10g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₆₄NO₈P.

L-α-Dilauroyl Phosphatidylcholine-d46, CAS: 136565-60-1, stock: 8.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₁₈D₄₆NO₈P.

L-α-Dipalmitoylphosphatidyl-N-monomethylethanolamine, CAS: 3930-13-0, stock: 8.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₇₆NO₈P.

Lauroylcholine Chloride, CAS: 25234-60-0, stock: 4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₆ClNO₂.

Levetiracetam Acid, CAS: 103833-72-3, stock: 4.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃NO₃.

Lupenone, CAS: 1617-70-5, stock: 9.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₈O.

Lupenone-d2, CAS: /, stock: 2.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₆D₂O.

LY 2087101, CAS: 913186-74-0, stock: 3.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁FN₂OS₂.

Lycoramine, CAS: 21133-52-8, stock: 5.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃NO₃.

Lycoramine Hydrobromide, CAS: 89505-76-0, stock: 4.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃NO₃ •  HBr.

Magnoflorine Hydroxide, CAS: 476-63-1, stock: 9.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅NO₅.

Magnoflorine-d3 Iodide, CAS: /, stock: 7.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁D₃INO₄.

Malaoxon, CAS: 1634-78-2, stock: 8.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉O₇PS.

Mepenzolate Bromide, CAS: 76-90-4, stock: 1.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆BrNO₃.

Metanicotine, CAS: 15585-43-0, stock: 8.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂.

Metanicotine-d3, CAS: 220088-40-4, stock: 8.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁D₃N₂.

Methapyrilene-d6 hydrochloride, CAS: /, stock: 5.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃D₆N₃S  • HCl.

Methscopolamine-d3 Iodide, CAS: /, stock: 4.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁D₃INO₄.

Methyl (1R,3S)-3-Hydroxycyclopentanecarboxylate, CAS: 79598-73-5, stock: 9.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂O₃.

Methyl 3,6-Dichloro-5-methylpyridazine-4-carboxylate, CAS: 1363381-53-6, stock: 6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆N₂O₂Cl₂.

Methyl Pyrophosphate, CAS: 56399-35-0, stock: 3.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  CH₆O₇P₂.

Methyl Pyrophosphate Sodium Salt (~90%), CAS: /, stock: 5.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  CH₆O₇P₂ • x(Na).

Methyl Varenicline, CAS: 1333145-89-3, stock: 3.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅N₃.

Methylcarbamoyl Chloride, CAS: 6452-47-7, stock: 7.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₄ClNO.

Methylparaoxon, CAS: 950-35-6, stock: 7.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀NO₆P.

Methylphosphonic Dichloride, CAS: 676-97-1, stock: 8.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  CH₃Cl₂OP.

Milameline Hydrochloride, CAS: 139886-04-7, stock: 4.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄N₂O • (HCl).

Miltefosine, CAS: 58066-85-6, stock: 2.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₄₆NO₄P.

Miltefosine-(d9), CAS: /, stock: 3.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₇D₉NO₄P.

Mizolastine, CAS: 108612-45-9, stock: 1.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅FN₆O.

Mizolastine N-β-D-Glucuronide, CAS: /, stock: 1.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₅FN₆O₇.

Mizolastine O-Sulfate, CAS: /, stock: 2.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₄FN₆NaO₄S.

Mizolastine-13C,d3, CAS: /, stock: 5.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃¹³CH₂₂D₃FN₆O.

Mizolastine-d3, CAS: /, stock: 1.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂D₃FN₆O.

Moncrotophos, CAS: 2157-98-4, stock: 7.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄NO₅P.

Moncrotophos Bis(methoxy-D3), CAS: /, stock: 4.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈D₆NO₅P.

Monoethyl Pyrophosphate, CAS: 20680-57-3, stock: 4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₈O₇P₂.

Morantel Citrate, CAS: 69525-81-1, stock: 6.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂S • C  ₆H₈O₇.

Mouse Ache(Acetylcholinesterase) ELISA Kit (96T), CAS: /, stock: 2.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Bche (Cholinesterase) ELISA Kit (96T), CAS: /, stock: 5.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Cept1 (Choline/ethanolaminephosphotransferase 1) ELISA Kit (96T), CAS: /, stock: 1.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Chat( Choline O-acetyltransferase) ELISA Kit (96T), CAS: /, stock: 4.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Chdh (Choline dehydrogenase, mitochondrial) ELISA Kit (96T), CAS: /, stock: 3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Chka (Choline kinase alpha) ELISA Kit (96T), CAS: /, stock: 4.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Chkb (Choline/ethanolamine kinase) ELISA Kit (96T), CAS: /, stock: 8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Chpt1 (Cholinephosphotransferase 1) ELISA Kit (96T), CAS: /, stock: 2.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Chrm1 (Muscarinic acetylcholine receptor M1) ELISA Kit (96T), CAS: /, stock: 4.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse CHRM2(Cholinergic Receptor, Muscarinic 2) ELISA Kit (96T), CAS: /, stock: 4.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Lpcat1 (Lysophosphatidylcholine acyltransferase 1) ELISA Kit (96T), CAS: /, stock: 1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Pctp (Phosphatidylcholine transfer protein) ELISA Kit (96T), CAS: /, stock: 7.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Mouse Slc18a3 (Vesicular acetylcholine transporter) ELISA Kit (96T), CAS: /, stock: 9.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

MPA-Nonapeptide, CAS: 1447725-68-9, stock: 8.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₂N₉O₁₆P.

Cephapirin, CAS: 21593-23-7, stock: 3.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇N₃O₆S₂.

MR 16728 Hydrochloride, CAS: 207403-36-9, stock: 7.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₆N₂O  • ( HCl).

Myristoylcholine Chloride, CAS: 4277-89-8, stock: 2.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₄₀ClNO₂.

Cephapirin Benzathine, CAS: 97468-37-6, stock: 7.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₄N₆O₁₂S₄•C₁₆H₂₀N₂.

Cephapirin Sodium, CAS: 24356-60-3, stock: 7.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆N₃NaO₆S₂.

N,N,1-Trimethyl-3,3-diphenylpropylamine, CAS: 13957-55-6, stock: 5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃N.

N,N-Diethyl-2-((4-(2-methoxybenzamido)benzoyl)oxy)-N-methylethanaminium Iodide, CAS: 26095-52-3, stock: 3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉IN₂O₄.

Cephapirin-d4, CAS: /, stock: 1.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃D₄N₃O₆S₂.

Desacetyl Cephapirin Sodium Salt, CAS: 104557-24-6, stock: 4.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅N₃NaO₅S₂.

N,N-Dimethyl-1,3,2-dioxaphospholan-2-amine 2-Oxide, CAS: 7114-66-1, stock: 9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀NO₃P.

N,N-Dimethylaminoethanol Phosphate (~70%), CAS: 6909-62-2, stock: 7.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₂NO₄P.

Desacetyl Cephapirin Sodium Salt, CAS: 104557-24-6, stock: 2.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₃NaO₅S₂.

Desacetyl Cephapirin-d6 Sodium Salt (Major), CAS: /, stock: 3.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₈D₆N₃NaO₅S₂.

N,N-Dimethylphosphoramidodichloridate, CAS: 677-43-0, stock: 5.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₆Cl₂NOP.

N,N’-Dithiobis[N-(phenylmethyl)-β-alanine 1,1’-Diethyl Ester, CAS: 95255-57-5, stock: 9.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₂N₂O₄S₂.

N,O-Bis(trimethylsilyl)acetamide, CAS: 10416-59-8, stock: 8.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₂₁NOSi₂.

N-(2-Methylamino-ethyl)-N-(2-methyl-4H-3-thia-4,9-diazabenzo[f]azulen-10yl)-hydroxylamine, CAS: /, stock: 7.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₄OS.

N-(N-BOC-Piperidino)pyrazole-4-carboxaldehyde, CAS: 1076224-00-4, stock: 8.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁N₃O₃.

N-(Pyridin-3-ylmethyl)ethanamine, CAS: 3000-75-7, stock: 3.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂.

N-Boc-2-trimethylammonium-A 85380 Triflate, CAS: 233766-75-1, stock: 4.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈F₃N₃O₆S.

N-Boc-[N-3-O-isopropylidene]-D-erythro-sphingosylphosphorylcholine, CAS: /, stock: 4.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₆₁N₂O₇P.

N-Butyl Nor Scopolamine Hydrochloride, CAS: 22235-98-9, stock: 3.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈ClNO₄.

N-Butylscopolammonium Bromide, CAS: 149-64-4, stock: 7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₀BrNO₄.

N-Butylscopolammonium Bromide-d9, CAS: /, stock: 1.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁D₉BrNO₄.

N-Demethyl-N-formylolanzapine-d8, CAS: /, stock: 3.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₀D₈N₄OS.

N-Desbutyl-N-propylscopolammonium Bromide, CAS: /, stock: 8.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈BrNO₄.

N-Desethyl N-Methyl rac-Rivastigmine, CAS: 25081-93-0, stock: 5.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O₂.

N-Desethyl N-Methyl Rivastigmine, CAS: 1230021-28-9, stock: 9.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O₂.

N-Desethyl N-Methyl-d6 rac-Rivastigmine, CAS: /, stock: 8.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄D₆N₂O₂.

N-Desmethyl Cyproheptadine, CAS: 14051-46-8, stock: 2.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉N.

N-Desmethyl Galanthamine, CAS: 41303-74-6, stock: 5.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉NO₃.

Myristyltrimethylamm​onium Bromide, CAS: 1119-97-7, stock: 1.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₈BrN.

N-Desmethyl Galanthamine-O-methyl-d3, CAS: 1128108-98-4, stock: 6.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆D₃NO₃.

N-Docosahexaenoic Sphingomyelin, CAS: 218608-41-4, stock: 8.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₇₉N₂O₆P.

N-Ethyl (S)-Nornicotine, CAS: 5979-92-0, stock: 6.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂.

N-Ethyl-2-hydroxy-N-(2-hydroxyethyl)-N-methylethanaminium Bromide, CAS: 70711-61-4, stock: 2.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₈BrNO₂.

N-Ethyl-2-hydroxy-N-(2-hydroxyethyl)-N-methylethanaminium-d5 Bromide, CAS: /, stock: 4.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₃D₅BrNO₂.

N-Ethyl-N-methyl-3-vinylphenyl Carbamate, CAS: 1346602-84-3, stock: 1.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₂.

N-Ethylcarbamic Acid 3-[(1S)-1-(Dimethylamino)ethyl]phenyl Ester, CAS: 1070660-34-2, stock: 10g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O₂.

N-Ethylcarbamic Acid 3-[(1S)-1-(Dimethylamino)ethyl]phenyl Ester-d6, CAS: /, stock: 2.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄D₆N₂O₂.

N-Ethylnorhyoscine, CAS: 67009-40-9, stock: 2.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃NO₄.

N-Ethylnorhyoscine Hydrochloride, CAS: 22235-93-4, stock: 1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃NO₄ • (HCl).

N-Hydroxy Varenicline, CAS: /, stock: 1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₃O.

N-Methyl Nicotine, CAS: 367939-42-2, stock: 5.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈N₂.

N-Methyl Rivastigmine Chloride, CAS: /, stock: 2.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₅ClN₂O₂.

N-Methyl Rivastigmine-d9 Chloride, CAS: /, stock: 8.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆D₉ClN₂O₂.

N-Methyl-N-phenylcarbamoyl Chloride, CAS: 4285-42-1, stock: 8.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₈ClNO.

N-Methyl-p-tyramine Hydrochloride, CAS: 13062-76-5, stock: 8.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄ClNO.

N-Methylethanolamine Phosphate, CAS: 6909-61-1, stock: 6.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₁₀NO₄P.

N-Propionyl Phenothiazine, CAS: 6622-75-9, stock: 5.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃NOS.

N-Propyldiethanolamine, CAS: 6735-35-9, stock: 8.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₇NO₂.

N-Propylscopolammonium Bromide, CAS: /, stock: 7.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈BrNO₄.

n-Propyltriphenylphosphonium Bromide, CAS: 6228-47-3, stock: 8.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂BrP.

N-[(2-Bromo-4,5-dimethoxyphenyl)methyl]-N-(2-chloroethyl)morpholine Bromide, CAS: /, stock: 4.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂Br₂ClNO₃.

N1-Norposiphen-d5, CAS: /, stock: 2.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆D₅N₃O₂.

N8-Benzoyl Varenicline, CAS: /, stock: 4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇N₃O.

N8-Benzoyloxy Varenicline, CAS: /, stock: 8.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₇N₃O₂.

Naled, CAS: 300-76-5, stock: 3.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇Br₂Cl₂O₄P.

Naled-d6, CAS: 1216605-57-0, stock: 8.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄HD₆Br₂Cl₂O₄P.

Namino-Desmethyl Rivastigmine, CAS: 923035-05-6, stock: 5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O₂.

NAP 226-90, CAS: 139306-10-8, stock: 9.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅NO.

NAP 226-90-d6, CAS: 1217706-31-4, stock: 3.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉D₆NO.

Nefazodone Hydrochloride, CAS: 82752-99-6, stock: 7.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₃Cl₂N₅O₂.

Nefazodone-d6 Dihydrochloride, CAS: /, stock: 7.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈D₆Cl₃N₅O₂.

Neostigmine Bromide, CAS: 114-80-7, stock: 6.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉BrN₂O₂.

Neostigmine Methyl Sulfate, CAS: 51-60-5, stock: 3.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₂N₂O₆S.

Nα-Boc-Nω-nitro-D-arginine, CAS: 50913-12-7, stock: 1.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁N₅O₆.

Norhyoscyamine, CAS: 537-29-1, stock: 7.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₃.

NS 9283, CAS: 913830-15-6, stock: 6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈N₄O.

O,O-Diethyl Dithiophosphate Ammonium Salt, CAS: 1068-22-0, stock: 4.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₄NO₂PS₂.

O,O-Diethyl Dithiophosphate-13C4 Ammonium Salt, CAS: 1329641-22-6, stock: 6.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₄H₁₄NO₂PS₂.

O,O-Diethyl Dithiophosphate-d10 Ammonium Salt, CAS: /, stock: 3.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄D₁₀NO₂PS₂.

O,O-Diethyl Thiophosphate Ammonium Salt, CAS: 5871-16-9, stock: 2.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₄NO₃PS.

O,O-Diethyl Thiophosphate Sodium Salt, CAS: 5852-63-1, stock: 3.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₀NaO₃PS.

O,O-Diethyl Thiophosphate-13C4 Ammonium Salt, CAS: 1330162-89-4, stock: 5.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₄H₁₄NO₃PS.

O,S-Diethyl Methylphosphonothioate, CAS: 06/10/2511, stock: 2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₃O₂PS.

O-(Methyl-d3) Phosphorodichloridothioic Acid Ester, CAS: 13386-78-2, stock: 8.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  CD₃Cl₂OPS.

O-Acetyl Scopolamine Hydrobromide, CAS: 5027-67-8, stock: 7.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄BrNO₅.

O-Acetyl-β-methylcholine Chloride, CAS: 62-51-1, stock: 2.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈ClNO₂.

O-Acetylgalanthamine, CAS: 25650-83-3, stock: 4.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃NO₄.

O-Desmethyl Galanthamine, CAS: 60755-80-8, stock: 7.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉NO₃.

O-Ethyl Methylphosphonothioate, CAS: 18005-40-8, stock: 5.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₉O₂PS.

O-Methyl O-(3,5,6-Trichloro-2-pyridinyl)phosphorochloridothioic Acid Ester-D3, CAS: /, stock: 4.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HD₃Cl₄NO₂PS.

O-Methylscopolamine, CAS: 51732-64-0, stock: 5.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃NO₄.

o-Nicotine, CAS: 23950-04-1, stock: 5.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂.

Obidoxime Chloride, CAS: 114-90-9, stock: 6.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆Cl₂N₄O₃.

Octadecyl 3-​(3,​5-​Di-​tert-​butyl-​4-​hydroxyphenyl)​propionate, CAS: 2082-79-3, stock: 1.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₆₂O₃.

Olanzapine, CAS: 132539-06-1, stock: 1.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₄S.

Olanzapine ( 1.0 mg/mL in Acetonitrile), CAS: 132539-06-1, stock: 6.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₄S.

Olanzapine-d3, CAS: 786686-79-1, stock: 5.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇D₃N₄S.

Olanzapine-d3 (1.0mg/ml in Acetonitrile), CAS: 786686-79-1, stock: 7.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇D₃N₄S.

Oxitropium Bromide, CAS: 30286-75-0, stock: 6.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₆BrNO₄.

Oxotremorine Sesquifumarate, CAS: 17360-35-9, stock: 9.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  2(C₁₂H₁₈N₂O)•3(C₄H4O₄).

Oxytrimethylline, CAS: 4499-40-5, stock: 6.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₁N₅O₃.

p-Fluorohexahydro-sila-difenidol, CAS: 116679-83-5, stock: 3.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₂FNOSi.

P-[[4-[(1-Oxodecyl)amino]phenyl]methyl]phosphonic Acid Cyclohexylamine Salt, CAS: 1333318-20-9, stock: 3.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₁N₂O₄P.

PAF (C16), CAS: 74389-68-7, stock: 2.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₅₄NO₇P.

Palmitoyl Thio-phosphocholine, CAS: 113881-60-0, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₈₀NO₇PS.

Palmitoylcholine Chloride, CAS: 2932-74-3, stock: 1.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₄₄ClNO₂.

Palmitoyldocosahexaenoyl Phosphatidylcholine, CAS: 59403-54-2, stock: 8.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₈₀NO₈P.

Palmitoyldocosahexaenoyl Phosphatidylcholine-d9, CAS: /, stock: 3.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₆H₇₁D₉NO₈P.

Palmitoyleicosapentaenoyl Phosphatidylcholine, CAS: 99296-77-2, stock: 6.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₇₈NO₈P.

Palmitoyleicosapentaenoyl Phosphatidylcholine-d9, CAS: /, stock: 3.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₆₉D₉NO₈P.

Panaxatriol, CAS: 32791-84-7, stock: 4.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₅₂O₄.

Paraherquamide A, CAS: 77392-58-6, stock: 5.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₅N₃O₅.

Paraoxon, CAS: 311-45-5, stock: 8.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄NO₆P.

PazePC, CAS: 117746-89-1, stock: 8.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₆₄NO₁₀P.

PazePC-D14, CAS: /, stock: 2.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₀D₁₄NO₁₀P.

PazePC-D9, CAS: /, stock: 2.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₅D₉NO₁₀P.

PC aa C34:4, CAS: /, stock: 1.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇₆H₁₃₆NO₈P.

PC aa C34:4-d9, CAS: /, stock: 3.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇₆H₁₂₇D₉NO₈P.

PE 154, CAS: 1192750-33-6, stock: 6.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₅N₅O₄.

Pentafluorobenzene, CAS: 363-72-4, stock: 5.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HF₅.

Pheniramine Aminoxide, CAS: 12656-98-3, stock: 1.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀N₂O.

Pheniramine Ammonium Glucuronide, CAS: 145823-17-2, stock: 6.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉ClN₂O₆.

Pheniramine Maleate, CAS: 132-20-7, stock: 2.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂O₄.

Pheniramine-d6 Maleate, CAS: /, stock: 5.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈D₆N₂O₄.

Phorate Oxon, CAS: 2600-69-3, stock: 2.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₇O₃PS₂.

Phorate Oxon Sulfone, CAS: 09/06/2588, stock: 7.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₇O₅PS₂.

Phorate Oxon Sulfoxide, CAS: 08/05/2588, stock: 5.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₇O₄PS₂.

Phorate Oxon-13C4, CAS: /, stock: 1.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₄H₁₇O₃PS₂.

Phorate Oxon-d10, CAS: /, stock: 4.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇D₁₀O₃PS₂.

Phorate Sulfone, CAS: 07/04/2588, stock: 3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₇O₄PS₃.

Phorate Sulfoxide, CAS: 06/03/2588, stock: 1.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₇O₃PS₃.

Phorate, 85%, CAS: 298-02-2, stock: 8.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₇O₂PS₃.

Phosacetim, CAS: 4104-14-7, stock: 8.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃Cl₂N₂O₂PS.

Phosacetim-d8, CAS: /, stock: 5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₅D₈Cl₂N₂O₂PS.

Phosalone, CAS: 2310-17-0, stock: 2.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅ClNO₄PS₂.

Phosphamidon, CAS: 13171-21-6, stock: 2.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉ClNO₄P.

Phosphamidon-d10, CAS: /, stock: 8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉D₁₀ClNO₄P.

Phosphocholine, CAS: 107-73-3, stock: 7.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₅ClNO₄P.

Phosphocholine Chloride Sodium Salt Hydrate, CAS: 16904-96-4, stock: 2.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₃ClNNa₂O₄P  •  xH₂O.

Phosphoric Acid Diethyl Octyl Ester, CAS: 20195-13-5, stock: 2.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₇O₄P.

Physostigmine, CAS: 57-47-6, stock: 8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁N₃O₂.

Physostigmine Hemisulfate, CAS: 64-47-1, stock: 7.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₄N₆O₈S.

Physostigmine-d3, CAS: 1217704-11-4, stock: 2.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈D₃N₃O₂.

Pimethixene, CAS: 314-03-4, stock: 9.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉NS.

Pimethixene Maleate Salt, CAS: 13187-06-9, stock: 3.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉NS  • ( C₄H₄O₄).

Pimethixene-d3, CAS: /, stock: 4.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆D₃NS.

Pinaverium Bromide, CAS: 53251-94-8, stock: 8.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₁Br₂NO₄.

Pinaverium-d4 Bromide, CAS: /, stock: 9.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₇D₄Br₂NO₄.

Piperidolate Hydrochloride, CAS: 129-77-1, stock: 8.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆ClNO₂.

Potassium Carbonate, CAS: 584-08-7, stock: 4.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  CK₂O₃.

Potassium Diisopropylxanthate, CAS: 3419-34-9, stock: 1.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄KO₂PS₂.

POVPC, CAS: 121324-31-0, stock: 1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₆NO₉P.

POVPC-D9, CAS: /, stock: 7.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₇D₉NO₉P.

Pralidoxime Chloride, CAS: 51-15-0, stock: 2.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉ClN₂O.

Pramiverin Hydrochloride, CAS: 14334-41-9, stock: 9.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈ClN.

Pramiverin-d7 Hydrochloride, CAS: 1346598-71-7, stock: 5.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁D₇ClN.

Pridinol Methanesulfonate Salt, CAS: 6856-31-1, stock: 3.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₉NO₄S.

Prifinium Bromide, CAS: 4630-95-9, stock: 3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈BrN.

Prifinium Bromide-d5, CAS: 4630-95-9, stock: 8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃D₅BrN.

Procyclidine Hydrochloride, CAS: 1508-76-5, stock: 7.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₀ClNO.

Procyclidine-d11 Hydrochloride, CAS: /, stock: 2.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈D₁₁NO (HCl).

Profenofos, CAS: 41198-08-7, stock: 3.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅BrClO₃PS.

Profenofos-d7, CAS: 1346603-72-2, stock: 4.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈D₇BrClO₃PS.

Proglumide, CAS: 6620-60-6, stock: 3.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆N₂O₄.

Promethazine Sulfone, CAS: 13754-56-8, stock: 8.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀N₂O₂S.

Propiverine Hydrochloride, CAS: 54556-98-8, stock: 4.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₀ClNO₃.

Propiverine-d7 Hydrochloride, CAS: /, stock: 5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₃D₇ClNO₃.

Propoxur, CAS: 114-26-1, stock: 8.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₃.

Propoxur-d7, CAS: 2140327-65-5, stock: 1.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈D₇NO₃.

Pyridostigmine Bromide, CAS: 101-26-8, stock: 9.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃BrN₂O₂.

Pyridostigmine-d6 Bromide, CAS: /, stock: 1.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇D₆BrN₂O₂.

Pyromeconic Acid O-Methyl Ether, CAS: 1193-64-2, stock: 6.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆O₃.

Pyromeconic Acid O-Methyl Ether-d3, CAS: /, stock: 6.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃D₃O₃.

Quifenadine, CAS: 10447-39-9, stock: 1.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃NO.

Quifenadine-d10, CAS: /, stock: 1.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₃D₁₀NO.

Quilostigmine, CAS: 139314-01-5, stock: 6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇N₃O₂.

Quinolactacin A1, CAS: 815576-68-2, stock: 2.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₂O₂.

Quinuclidin-3-yl Methanesulfonate, CAS: 127424-06-0, stock: 9.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₃S.

R-(-)-3-Quinuclidinol Hydrochloride, CAS: 42437-96-7, stock: 6.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄ClNO.

rac Galanthamine Hydrobromide, CAS: 193146-85-9, stock: 6.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂BrNO₃.

(25R)-5β-Cholestane-3α,7α,26-triol, CAS: 66807-58-7, stock: 3.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₈O₃.

rac O-Methyl Tolterodine Fumarate, CAS: 1240303-69-8, stock: 8.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇NO₅.

(25S)-5β-Cholestane-3α,7α,26-triol, CAS: 66807-59-8, stock: 2.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₈O₃.

(3α,5β,7α)-7-Hydroxy-3-(sulfooxy)-cholan-24-oic Acid Disodium Salt, CAS: 60237-34-5, stock: 5.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₈Na₂O₇S.

rac Rivastigmine-d6, CAS: 194930-04-6, stock: 1.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆D₆N₂O₂.

rac Rivastigmine-d6 Tartrate Salt, CAS: /, stock: 2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂D₆N₂O₈.

(3α,5β,7α)-7-Hydroxy-3-(sulfooxy)-cholan-24-oic Acid-d5 Disodium Salt, CAS: /, stock: 6.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₃D₅Na₂O₇S.

(3α,5β,7α,24E)-3,7-Dihydroxy-cholest-24-en-26-oic Acid, CAS: 161023-77-4, stock: 1.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄O₄.

rac-12-bis(Heptanoylthio)glycerophosphocholine-D9, CAS: /, stock: 8.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₅D₉NO₆PS₂.

(3α,​5β,​7α)​-3,​7-​Dihydroxy-​12-​oxocholan-​24-​oic Acid Methyl Ester, CAS: 10538-64-4, stock: 9.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₀O₅.

rac-3-Hexadecanamido-2-ethoxypropan-1-ol Phosphocholine Monohydrate, CAS: /, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₅₅O₆N₂P•H₂O.

rac-3-Hexadecanamido-2-methoxypropan-1-ol Phosphocholine Monohydrate, CAS: 163751-35-7, stock: 3.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₅₅N₂O₇P.

2-Ethoxy-1-ethoxycarbonyl-1,2-dihydroquinoline, CAS: 16357-59-8, stock: 1.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇NO₃.

3,12-Diketo-5β-cholanoic Acid, CAS: 06/05/2958, stock: 4.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₆O₄.

rac-3-Octadecanamido-2-ethoxypropan-1-ol Phosphocholine, CAS: 112989-02-3, stock: 3.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₅₉O₆N₂P.

rac-3-Octadecanamido-2-Methoxypropan-1-ol Phosphocholine, CAS: 163702-19-0, stock: 7.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₅₇O₆N₂P•1.5H₂O.

rac-Benzilonium Bromide, CAS: 1050-48-2, stock: 1.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈BrNO₃.

rac-Benzilonium Bromide-d5, CAS: /, stock: 4.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃D₅BrNO₃.

Rat Ach(Acetylcholine) ELISA Kit (96T), CAS: /, stock: 3.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Ache(Acetylcholinesterase) ELISA Kit (96T), CAS: /, stock: 8.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

3-Sulfo-taurochenodeoxycholic Acid Disodium Salt, CAS: 66874-06-4, stock: 1.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₃NNa₂O₉S₂.

3α,6α,7α-Trihydroxy-5β-cholanic Acid, CAS: 547-75-1, stock: 6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₀O₅.

Rat AChRab(Acetylcholine Receptor Antibody) ELISA Kit (96T), CAS: /, stock: 5.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Cept1 (Choline/ethanolaminephosphotransferase 1) ELISA Kit (96T), CAS: /, stock: 8.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

6-Ethylchenodeoxycholic Acid, CAS: 459789-99-2, stock: 4.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₄O₄.

6-Ethylchenodeoxycholic-d5 Acid, CAS: 1992000-80-2, stock: 3.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₉D₅O₄.

Rat Chat(Choline O-acetyltransferase) ELISA Kit (96T), CAS: /, stock: 2.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Chka (Choline kinase alpha) ELISA Kit (96T), CAS: /, stock: 9.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

6β-Ethyl-7-keto-obeticholic Acid, CAS: 915038-25-4, stock: 6.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₂O₄.

7-epi-6β-Ethyl Ursodeoxycholic Acid, CAS: 1708092-13-0, stock: 3.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₄O₄.

Rat Chkb (Choline/ethanolamine kinase) ELISA Kit (96T), CAS: /, stock: 7.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat Chpt1 (Cholinephosphotransferase 1) ELISA Kit (96T), CAS: /, stock: 5.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

7-epi-Obeticholic Acid 3-Obeticholate Ester, CAS: 1908444-28-9, stock: 2.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₂H₈₆O₇.

7-Formyloxy Glycochenodeoxycholic Acid-d5 Ethyl Ester, CAS: /, stock: 4.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₂D₅NO₆.

Rat Chrm1 (Muscarinic acetylcholine receptor M1) ELISA Kit (96T), CAS: /, stock: 5.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat CHRM2(Cholinergic Receptor, Muscarinic 2) ELISA Kit (96T), CAS: /, stock: 8.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Chenodeoxycholic Acid, CAS: 474-25-9, stock: 5.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₀O₄.

Chenodeoxycholic Acid 24-Acyl-β-D-glucuronide, CAS: 208038-27-1, stock: 2.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₈O₁₀.

Rat Lpcat1 (Lysophosphatidylcholine acyltransferase 1) ELISA Kit (96T), CAS: /, stock: 9.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Rat M-ACHR(Muscarinic AcetylcholineReceptor) ELISA Kit (96T), CAS: /, stock: 9.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Chenodeoxycholic Acid 24-Acyl-β-D-glucuronide Allyl Ester, CAS: /, stock: 3.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₅₂O₁₀.

Chenodeoxycholic Acid 24-Acyl-β-D-glucuronide Allyl Ester-D5, CAS: /, stock: 10g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₇D₅O₁₀.

Rat N-ACHR(Nicotinic Acetylcholine Receptor) ELISA Kit (96T), CAS: /, stock: 6.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Chenodeoxycholic acid diacetate methyl ester, CAS: 2616-71-9, stock: 6.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₆O₆.

Chenodeoxycholic Acid Methyl Ester, CAS: 03/04/3057, stock: 3.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₂O₄.

Rat Slc18a3 (Vesicular acetylcholine transporter) ELISA Kit (96T), CAS: /, stock: 7.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Chenodeoxycholic Acid Methyl Ester Triacetyl-β-D-glucuronic Acid Methyl Ester, CAS: /, stock: 8.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₅₈O₁₃.

Chenodeoxycholic Acid Sodium Salt, CAS: 2646-38-0, stock: 1.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₀O₄ • Na.

Rat Slc18a3(Vesicular acetylcholine transporter) ELISA Kit (96T), CAS: /, stock: 2.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Chenodeoxycholic acid-3-β-D-glucuronide, CAS: 58814-71-4, stock: 7.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₈O₁₀.

Chenodeoxycholic Acid-d4, CAS: 99102-69-9, stock: 3.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₆D₄O₄.

Rivastigmine N-Oxide (Technical Grade), CAS: 1369779-37-2, stock: 4.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂N₂O₃.

Rivastigmine Tartrate Salt, CAS: 129101-54-8, stock: 6.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈N₂O₈.

Chenodeoxycholic Acid-d5 (Major), CAS: 52840-12-7, stock: 3.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₅D₅O₄.

Chenodeoxycholic Acid-d5 24-Acyl-β-D-glucuronide Sodium Salt (contains d0 up to 2%), CAS: /, stock: 1.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₂D₅NaO₁₀.

Rivastigmine-d4 Tartrate Salt, CAS: /, stock: 2.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄D₄N₂O₈.

Rivastigmine-d6 N-Oxide, CAS: /, stock: 7.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆D₆N₂O₃.

RTI 70, CAS: 140633-58-5, stock: 6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈ClNO₂.

S 24795, CAS: 304679-75-2, stock: 1.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃BrINO.

Glycochenodeoxycholic Acid 3-Sulfate Disodium Salt, CAS: 66874-09-7, stock: 6.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₁NNa₂O₈S.

S-(-)-Cotinine Methiodide, CAS: 33952-07-7, stock: 6.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅IN₂O.

S-(-)-Nicotine Ditartrate Dihydrate, CAS: 03/06/6019, stock: 1.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂•2(C₄H₆O₆)•2(H₂O).

Glycochenodeoxycholic Acid Sodium Salt (Ultra pure, >97%), CAS: 16564-43-5, stock: 7.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₂NNaO₅.

Glycochenodeoxycholic Acid Sodium Salt, 95%, CAS: 16564-43-5, stock: 9.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₂NNaO₅.

S-(-)-Nicotine-5-carboxaldehyde, CAS: 852238-97-2, stock: 7.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O.

S-(Dimethylcarbamoylmethyl) O,O-Dimethyl Ester Phosphorodithioic Acid, CAS: 60823-19-0, stock: 8.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄NO₃PS₂.

S-(Dimethylcarbamoylmethyl) O,O-Dimethyl Ester Phosphorodithioic Acid-d6, CAS: /, stock: 6.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈D₆NO₃PS₂.

S-Butyrylthiocholine Iodide, CAS: 1866-16-6, stock: 9.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₀NOS  • I.

Glycochenodeoxycholic Acid-3-O-β-glucuronide Disodium Salt, CAS: 75672-22-9, stock: 7.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₉NNa₂O₁₁.

Glycochenodeoxycholic Acid-d5 3-Sulfate Disodium Salt, CAS: /, stock: 8.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₆D₅NNa₂O₈S.

S-Propionylthiocholine Chloride, CAS: 70496-34-3, stock: 8.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₈ClNOS.

Scopolamine, CAS: 51-34-3, stock: 6.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO₄.

Glycochenodeoxycholic Acid-d7 Sodium Salt (Major), CAS: /, stock: 6.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₅D₇NNaO₅.

Glycochenodeoxycholic-d5 Acid-3-O-β-glucuronide Disodium Salt, CAS: /, stock: 4.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₄D₅NNa₂O₁₁.

Scopolamine Hydrobromide Hydrate, CAS: /, stock: 4.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO₄•HBr•x(H₂O).

Scopolamine Methyl Bromide, CAS: 155-41-9, stock: 6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄BrNO₄.

Isochenodeoxycholic Acid, CAS: 566-24-5, stock: 2.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₄₀O₄.

Methyl Isochenodeoxycholic Acid Ester, CAS: 28050-38-6, stock: 4.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₂O₄.

Scopolamine N-Oxide, CAS: 97-75-6, stock: 2.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO₅.

Scopolamine N-Oxide-d3, CAS: /, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈D₃NO₅.

Scopolamine Sulfate, CAS: 866926-81-0, stock: 9.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO₇S.

Scopolamine-13C, d3 Hydrobromide, CAS: /, stock: 2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆¹³CH₁₉D₃BrNO₄.

Nutriacholic Acid, CAS: 4651-67-6, stock: 1.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₈O₄.

Nutriacholic Acid-d5, CAS: /, stock: 4.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₃D₅O₄.

Scopolamine-d3 Hydrobromide, CAS: 1279037-70-5, stock: 6.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉D₃BrNO₄.

Scopolamine-d3 Sulfate, CAS: /, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈D₃NO₇S.

O-Tosyl Chenodeoxycholic Acid Methyl Ester, CAS: /, stock: 2.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₈O₆S.

Obeticholic Acid 3-O-Acyl-β-D-glucuronide, CAS: /, stock: 1.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₂O₁₀.

SEN 12333, CAS: 874450-44-9, stock: 7.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅N₃O₂.

SIB 1508Y, CAS: 192231-16-6, stock: 3.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₂O₄.

Obeticholic Acid Acyl-β-D-glucuronide, CAS: /, stock: 7.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₂O₁₀.

Tauro 6-Ethlchenodeoxycholic Acid-d5 Sodium SaltREPLACES E917463., CAS: /, stock: 4.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₃D₅NNaO₆S.

SIB 1553A Hyrdrochloride, CAS: 191611-89-9, stock: 8.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀ClNOS.

Silatrane, CAS: 283-60-3, stock: 3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₃Si.

Tauro 6-Ethylchenodeoxycholic Acid Sodium SaltREPLACES E917458., CAS: /, stock: 8.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₈NNaO₆S.

Tauro 7α-Hydroxy-3-oxo-chol-4-en-24-oic Acid Sodium Salt, CAS: /, stock: 6.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₀NNaO₆S.

Sinapic-2-(dehydro)-ethyl Chloride, CAS: /, stock: 2.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅ClO₅.

Sinapine Chloride, CAS: 6484-80-6, stock: 1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄ClNO₅.

Tauro 7α-Hydroxy-3-oxo-chol-4-en-24-oic Acid-d4 Sodium Salt, CAS: /, stock: 6.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₆D₄NNaO₆S.

Tauro-(25S)-3α,7α-dihydroxy-5β-cholestan-26-oic Acid Sodium Salt, CAS: /, stock: 1.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₀NNaO₆S.

Sinapine Thiocyanate, CAS: 7431-77-8, stock: 5.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄N₂O₅S.

Tauro-(25S)-3α,7α-dihydroxy-5β-cholestan-26-oic Acid-d4 Sodium Salt, CAS: /, stock: 9.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₆D₄NNaO₆S.

Taurochenodeoxycholic Acid Sodium Salt, CAS: 6009-98-9, stock: 8.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₄NNaO₆S.

sn-Glycero-3-phosphocholine, CAS: 28319-77-9, stock: 7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₂₀NO₆P.

sn-Glycero-3-phosphocholine-d9, CAS: /, stock: 6.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁D₉NO₆P.

Taurochenodeoxycholic Acid-3-O-β-glucuronide Dipotassium Salt, CAS: 75672-23-0, stock: 8.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₉K₂NO₁₂S.

Taurochenodeoxycholic Acid-d5 Sodium Salt, CAS: /, stock: 2.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₉D₅NNaO₆S.

Sodium Dimethylamido-O-(2-cyanoethyl) Phosphate, CAS: 63582-16-1, stock: 2.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀N₂NaO₃P.

Soy PC (95%), CAS: 97281-47-5, stock: 7.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₈₀NO₈P.

[(25R)-3α,7α-Dihydroxy-5β-cholestan-26-oyl]taurine Sodium Salt, CAS: /, stock: 3.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₅₀NNaO₆S.

[(25R)-3α,7α-Dihydroxy-5β-cholestan-26-oyl]taurine-d4 Sodium Salt, CAS: /, stock: 8.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₆D₄NNaO₆S.

Spinosyn A, CAS: 131929-60-7, stock: 5.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₆₅NO₁₀.

SR 16584, CAS: 1150153-86-8, stock: 4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂N₂O.

Stearoyl L-α-Lysolecithin, CAS: 19420-57-6, stock: 1.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₅₄NO₇P.

Stearoyl L-α-Lysolecithin-d9, CAS: /, stock: 8.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₅D₉NO₇P.

Stearoylcholine Chloride, CAS: 25234-57-5, stock: 9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₈ClNO₂.

Strychnine Hydrochloride, CAS: 1421-86-9, stock: 5.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃ClN₂O₂.

Strychnine Hydrochloride (1.0 mg/mL in Methanol), CAS: 1421-86-9, stock: 6.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃ClN₂O₂.

(1R,2S)-m-nitro-erythro-Chloramphenicol, CAS: 1327173-91-0, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂Cl₂N₂O₅.

Suberyl Dicholine Dichloride, CAS: 100930-12-9, stock: 1.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₈Cl₂N₂O₄.

(1S,2R)-2-(2,2-Dichloroacetamido)-1-(4-nitrophenyl)propane-1,3-diyl Bis(4-nitrobenzoate), CAS: /, stock: 8.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₈Cl₂N₄O₁₁.

Succinyl Monocholine Iodide, CAS: 14720-92-4, stock: 3.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₈INO₄.

Succinylcholine Chloride, CAS: 71-27-2, stock: 1.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₃₀Cl₂N₂O₄.

(1S,2S)-2-Amino-1-(3-nitrophenyl)-1,3-propanediol, CAS: 911444-85-4, stock: 1.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₄.

Succinylcholine Chloride Dihydrate, CAS: 6101-15-1, stock: 1.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₃₀N₂O₄ • 2Cl • 2H ₂O.

Succinylcholine Chloride-13C6, CAS: /, stock: 5.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₆H₃₀Cl₂N₂O₄.

(4-Desnitro-2-nitrophenyl)-(R,R)-chloramphenicol, CAS: 22933-62-6, stock: 4.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂Cl₂N₂O₅.

(4-Desnitro-2-nitrophenyl)-(R,S)-chloramphenicol, CAS: /, stock: 7.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂Cl₂N₂O₅.

Sulfotep, CAS: 3689-24-5, stock: 3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₂₀O₅P₂S₂.

(4-Desnitro-2-nitrophenyl)-(S,R)-chloramphenicol, CAS: /, stock: 3.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂Cl₂N₂O₅.

Swertianolin, CAS: 23445-00-3, stock: 2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀O₁₁.

(4-Desnitro-2-nitrophenyl)-(S,S)-chloramphenicol, CAS: 878653-43-1, stock: 3.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂Cl₂N₂O₅.

(4R)-4-[(R)-Hydroxyphenylmethyl]-2,2-dimethyl-3-oxazolidinecarboxylic Acid-d5 1,1-Dimethylethyl Ester, CAS: /, stock: 4.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀D₅NO₄.

Talsaclidine, CAS: 147025-53-4, stock: 9.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅NO.

Talsaclidine Hydrochloride, CAS: /, stock: 9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆ClNO.

(R,S)-Chloramphenicol Bis p-Nitro-benzoate Ester, CAS: /, stock: 6.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₁₈Cl₂N₄O₁₁.

(S,S)-meta-nitro-Chloramphenicol, CAS: 1327173-85-2, stock: 8.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂Cl₂N₂O₅.

Taspine, CAS: 602-07-3, stock: 4.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉NO₆.

TBPB, CAS: 634616-95-8, stock: 8.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂N₄O.

1-Dehydro-2-dedichloroacetyl-chloramphenicol Hydrochloride, CAS: 488797-44-0, stock: 2.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O₄•HCl.

1-Dehydro-chloramphenicol, CAS: 61849-50-1, stock: 5.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀Cl₂N₂O₅.

TC 1698 Dihydrochloride, CAS: 787587-06-8, stock: 2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂ • HCl.

TEPP, CAS: 107-49-3, stock: 5.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₂₀O₇P₂.

1-O-Methylsulfonyl (S,S)-Chloramphenicol, CAS: 400835-38-3, stock: 5.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄Cl₂N₂O₇S.

Terbufoxon Sulfone, CAS: 56070-15-6, stock: 3.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₁O₅PS₂.

Terbufoxon Sulfoxide, CAS: 56165-57-2, stock: 7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₁O₄PS₂.

1-O-Methylsulfonyl 3-O-Trityl-(S,S)-Chloramphenicol, CAS: /, stock: 5.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₈Cl₂N₂O₇S.

2,2-Dichloro-N-((1R,2R)-1-hydroxy-1-(4-nitrophenyl)-3-(trityloxy)propan-2-yl)acetamide, CAS: /, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₆Cl₂N₂O₅.

Terfuboxon, CAS: 56070-14-5, stock: 5.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₁O₃PS₂.

Territrem B, CAS: 70407-20-4, stock: 6.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₄O₉.

Azidamfenicol, CAS: 13838-08-9, stock: 5.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₅O₅.

tert-Butyl (3aR,6aR)-Hexahydropyrrolo[3,4-b]pyrrole-5(1H)-carboxylate, CAS: 370882-39-6, stock: 8.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀N₂O₂.

Bromamphenicol, CAS: 16803-75-1, stock: 3.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂Br₂N₂O₅.

Chloramphenicol, CAS: 56-75-7, stock: 5.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂Cl₂N₂O₅.

tert-Butyl 1,6-Diazaspiro[3.4]octane-1-carboxylate, CAS: 1148044-31-8, stock: 1.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀N₂O₂.

tert-Butyl 6-(O-Phosphorylcholine)hydroxyhexanoate, CAS: 73839-23-3, stock: 8.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₃₂NO₆P.

Chloramphenicol 1-Acetate, CAS: 23214-93-9, stock: 4.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄Cl₂N₂O₆.

Chloramphenicol 1-O-β-D-Glucuronide Triethylammonium Salt, CAS: /, stock: 1.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₅Cl₂N₃O₁₁.

Tetra-n-butylammonium Iodide, CAS: 311-28-4, stock: 9.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₆IN.

Tetradecyl-phosphocholine, CAS: 77733-28-9, stock: 3.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₄₂NO₄P.

Chloramphenicol 3-Acetate, CAS: 10318-16-8, stock: 6.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄Cl₂N₂O₆.

Thenalidine, CAS: 86-12-4, stock: 6.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂N₂S.

Chloramphenicol 3-O-β-D-Glucuronide, CAS: 39751-33-2, stock: 8.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀Cl₂N₂O₁₁.

Chloramphenicol 3-O-β-D-Glucuronide Sodium Salt, CAS: /, stock: 1.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉Cl₂N₂NaO₁₁.

Thenalidine-d5, CAS: /, stock: 2.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇D₅N₂S.

Thieno[2,3-b]pyridine-2-carboxylic Acid, CAS: 59944-76-2, stock: 4.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅NO₂S.

Chloramphenicol 3-O-β-D-Glucuronide-3,2’,3’,4’-tetra-O-acetate Methyl Ester, CAS: /, stock: 5.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₀Cl₂N₂O₁₅.

Thiochrome, CAS: 92-35-3, stock: 8.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₄OS.

Thiometon Sulfoxide, CAS: 2703-37-9, stock: 2.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₅O₃PS₃.

Chloramphenicol Palmitate, CAS: 530-43-8, stock: 4.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₂Cl₂N₂O₆.

Chloramphenicol Succinate, CAS: 3544-94-3, stock: 3.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆Cl₂N₂O₈.

Thiometon-sulfone, CAS: 20301-63-7, stock: 9.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₅O₄PS₃.

Tonibral, CAS: 10549-59-4, stock: 7.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₄.

Chloramphenicol Succinate Sodium, CAS: 982-57-0, stock: 9.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅Cl₂N₂NaO₈.

Chloramphenicol-13C6, CAS: 1217706-02-9, stock: 2.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅¹³C₆H₁₂Cl₂N₂O₅.

TQS, CAS: 353483-92-8, stock: 5.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀N₂O₂S.

trans-9-Octadecenyl Phosphocholine, CAS: 137052-40-5, stock: 7.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₈NO₄P.

Chloramphenicol-3-O-sulfate Sodium Salt, CAS: /, stock: 4.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁Cl₂N₂NaO₈S.

Chloramphenicol-d5, CAS: /, stock: 2.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇D₅Cl₂N₂O₅.

trans-9-Octadecenyl Phosphocholine-D9, CAS: /, stock: 5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₉D₉NO₄P.

trans-Cevimeline Hydrochloride, CAS: 107220-29-1, stock: 5.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈ClNOS.

Chloramphenicol-d5 (100μg/mL in Acetonitrile), CAS: /, stock: 1.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇D₅Cl₂N₂O₅.

Corynecin I, CAS: 4423-58-9, stock: 5.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₂O₅.

Tri-​n-​butyl(1-​ethoxyvinyl)​tin, CAS: 97674-02-7, stock: 9.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₄OSn.

Corynecin II, CAS: 35098-52-3, stock: 9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O₅.

Corynecin III, CAS: 18048-95-8, stock: 5.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₅.

Tri-n-butylallylphosphonium Bromide, CAS: 55894-18-3, stock: 1.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₃₂BrP.

Tri-n-butylallylphosphonium Bromide-d5, CAS: /, stock: 1.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₇D₅BrP.

Corynecin IV, CAS: 40958-11-0, stock: 9.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₂O₆.

Corynecin V, CAS: 40958-12-1, stock: 9.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₂O₆.

Trichlorfon, CAS: 52-68-6, stock: 8.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈Cl₃O₄P.

Tricholine Citrate (ca.65%inWater), CAS: 546-63-4, stock: 5.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅O₇ • 3C ₅H₁₄NO.

D-erythro-Chloramphenicol, CAS: 7387-98-6, stock: 2.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂Cl₂N₂O₅.

D-threo-(-)-2-Amino-1-(4-nitrophenyl)-1,3-propanediol, CAS: 716-61-0, stock: 7.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₄.

Tridihexethyl Chloride, CAS: 4310-35-4, stock: 9.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₆ClNO.

Tridihexethyl Chloride-d5, CAS: /, stock: 6.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁D₅ClNO.

D-threo-1-(4-Aminophenyl)-2-dichloroacetylamino-1,3-propanediol Hydrochloride, CAS: 57704-36-6, stock: 3.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅Cl₃N₂O₃.

D-threo-1-(4-Chlorosulfonylphenyl)-2-dichloroacetylamino-1,3-propanediol, CAS: /, stock: 1.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂Cl₃NO₅S.

Triethanolamine Borate, CAS: 283-56-7, stock: 3.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂BNO₃.

Triisopropyl Phosphite, CAS: 116-17-6, stock: 7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₁O₃P.

D-threo-1-(4-Sulfonylphenyl)-2-dichloroacetylamino-1,3-propanediol Sodium Salt, CAS: 1316849-76-9, stock: 4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂Cl₂NNaO₆S.

DL-Chloramphenicol, CAS: 09/09/2787, stock: 9.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂Cl₂N₂O₅.

Trimesinic Acid, CAS: 554-95-0, stock: 9.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆O₆.

Trimethyl-[10-(trimethylazaniumyl)decyl]azanium Diiodide, CAS: 1420-40-2, stock: 4.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₈I₂N₂.

Ethyl 3-Hydroxy-2-((3-nitrobenzylidene)amino)-3-(3-nitrophenyl)propanoate, CAS: /, stock: 4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇N₃O₇.

β-Hydroxy-3-nitro-phenylalanine Ethyl Ester Hydrochloride (Racemic), CAS: 1219316-71-8, stock: 4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅ClN₂O₅.

Trimethylamine-d9 Hydrochloride, CAS: 18856-86-5, stock: 2.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃HD₉ClN.

Triprolidine Hydrochloride, CAS: 550-70-9, stock: 3.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃ClN₂.

L-(+)-threo-Chloramphenicol, CAS: 134-90-7, stock: 4.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂Cl₂N₂O₅.

L-erythro-Chloramphenicol, CAS: 7384-89-6, stock: 2.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂Cl₂N₂O₅.

Triprolidine-d8 Hydrochloride, CAS: 1795134-06-3, stock: 7.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₅D₈ClN₂.

Tris(N,N-tetramethylene)phosphoric Acid Triamide, CAS: 02/07/6415, stock: 7.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₄N₃OP.

m-nitro-(R,R)-threo-Chloramphenicol, CAS: 7411-65-6, stock: 9.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂Cl₂N₂O₅.

N-Hydroxy-chloramphenicol, CAS: 67058-46-2, stock: 5.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄Cl₂N₂O₄.

Tropic Acid 6-Hydroxy-3-tropanyl Ester, CAS: 17659-49-3, stock: 9.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃NO₄.

N-[(1R,2R)-2-(Acetyloxy)-1-[(acetyloxy)methyl]-2-phenylethyl]acetamide-d5, CAS: /, stock: 1.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄D₅NO₅.

Nitrosochloramphenicol, CAS: 67058-47-3, stock: 2.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂Cl₂N₂O₄.

Trospium Chloride, CAS: 10405-02-4, stock: 7.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₀ClNO₃.

Trospium-d8 Chloride, CAS: /, stock: 6.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₂D₈ClNO₃.

O-Acetoxychloramphenicol 2,3,4,6-Tetra-O-acetyl-β-D-glucuronide Methyl Ester, CAS: /, stock: 1.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₀Cl₂N₂O₁₅.

UB 165 Fumarate, CAS: 200432-86-6, stock: 8.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉ClN₂O₄.

Uridine 5’-​diphosphate choline, CAS: 99492-83-8, stock: 7.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅N₃O₁₂P₂.

rac-2-Amino-1-(3-nitrophenyl)propane-1,3-diol, CAS: /, stock: 5.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₄.

rac-2-Benzamido-3-hydroxy-3-(3-nitrophenyl)propanoic Acid Ethyl Ester, CAS: /, stock: 6.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈N₂O₆.

Uridine Diphosphate Choline Ammonium Salt, CAS: /, stock: 3.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₈N₄O₁₂P₂.

rac-erythro-meta-nitro-Chloramphenicol, CAS: 138125-71-0, stock: 9.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂Cl₂N₂O₅.

rel-m-nitro-threo-Chloramphenicol, CAS: 138125-72-1, stock: 5.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂Cl₂N₂O₅.

Varenicline Carbamoyl β-D-Glucuronide-d4, CAS: /, stock: 5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆D₄N₃O₈.

Varenicline Tartrate, CAS: 375815-87-5, stock: 5.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉N₃O₆.

Thiamphenicol, CAS: 15318-45-3, stock: 4.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅Cl₂NO₅S.

Thiamphenicol-methyl-d3, CAS: /, stock: 9.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂D₃Cl₂NO₅S.

Varenicline-d2,15N2 Dihydrochloride, CAS: /, stock: 1.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃D₂Cl₂N¹⁵N₂.

Varenicline-d4 Dihydrochloride (Major), CAS: /, stock: 9.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉D₄N₃ •2HCl.

[(1S)-2-[[(tert-Butyl)dimethylsilyl]oxy]-1-(hydroxymethyl)ethyl]-carbamic Acid tert-Butyl Ester, CAS: 185692-85-7, stock: 2.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₃₁NO₄Si.

[R-(R*,R*)]-2-Amino-1-(3-nitrophenyl)-1,3-propanediol, CAS: 46423-64-7, stock: 1.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₄.

Vinyl Chloroformate, CAS: 5130-24-5, stock: 9.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₃ClO₂.

VU 0357017 Hydrochloride, CAS: 1135242-13-5, stock: 3.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈ClN₃O₃.

VU 0357017 Hydrochloride, CAS: 1135242-13-5, stock: 9.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇N₃O₃ • HCl.

VU 0467154, CAS: 1451993-15-9, stock: 7.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅F₃N₄O₃S₂.

VU 152100, CAS: 409351-28-6, stock: 9.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉N₃O₂S.

Xenin 25 Acetate Salt, CAS: 144092-28-4, stock: 1.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃₉H₂₂₄N₃₈O₃₂S.

Zanapezil, CAS: 142852-50-4, stock: 5.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂N₂O.

[(Chloromethyl)thio]-ethane, CAS: 1708-73-2, stock: 3.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₇ClS.

[1-(tert-Butoxycarbonyl)azetidin-2-yl]methanol, CAS: 174346-82-8, stock: 1.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇NO₃.

[Hexahydro-5-(4-pyridinyl)pyrrolo[3,4-c]pyrrol-2(1H)-yl][1-(5-isoquinolinylsulfonyl)-3-azetidinyl]-methanone, CAS: 1392443-41-2, stock: 5.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₅N₅O₃S.

(R)-(+)-Celiprolol Hydrochloride, CAS: 125638-91-7, stock: 6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄ClN₃O₄.

(R)-(+)-Celiprolol-d9 Hydrochloride, CAS: 1330045-90-3, stock: 9.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅D₉ClN₃O₄.

(S)-(-)-Celiprolol Hydrochloride, CAS: 102293-39-0, stock: 1.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄ClN₃O₄.

(S)-(-)-Celiprolol-d9 Hydrochloride, CAS: 1330266-42-6, stock: 8.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅D₉ClN₃O₄.

Celiprolol, CAS: 56980-93-9, stock: 7.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₃N₃O₄.

Celiprolol Hydrochloride, CAS: 57470-78-7, stock: 7.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄ClN₃O₄.

Celiprolol-d9 Hydrochloride, CAS: 1215535-20-8, stock: 5.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅D₉ClN₃O₄.

N,N’-Bis[3-acetyl-4-[3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy]phenyl]-urea, CAS: 125579-40-0, stock: 8.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₄₆N₄O₇.

N-Didesethyl, N-tertbutyl Celiprolol, CAS: 57471-01-9, stock: 6.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₃N₃O₄.

N’-[3-Acetyl-4-(3-bromo-2-hydroxypropoxy)phenyl]-N,N-diethyl-urea, CAS: 85045-98-3, stock: 6.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃BrN₂O₄.

10-Deacetyl Cephalomannine, CAS: 76429-85-1, stock: 5.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₅₁NO₁₃.

7-epi-Cephalomannine, CAS: 150547-36-7, stock: 7.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₅₃NO₁₄.

7-O-(Triethylsilyl)-2’-O-tert-butyl(dimethyl)silyl-isocephalomannine, CAS: /, stock: 7.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₇H₈₁NO₁₄Si₂.

Cephalomannine, CAS: 71610-00-9, stock: 3.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₅₃NO₁₄.

Desmethyl Ethyldihydrocephalomannin​e, CAS: 514801-83-3, stock: 4.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₅₃NO₁₄.

Dihydrocephalomannin​e, CAS: 159001-25-9, stock: 1.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₅₅NO₁₄.

Iso Cephalomannine, CAS: 173101-54-7, stock: 4.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₅₃NO₁₄.

Iso Cephalomannine-d3, CAS: /, stock: 6.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₅₀D₃NO₁₄.

5-(3-Hydroxyphenyl)-2-piperidinone, CAS: 1896110-51-2, stock: 8.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₂.

Cenicriviroc, CAS: 497223-25-3, stock: 4.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₅₂N₄O₄S.

Cenicriviroc Sulfone, CAS: 497223-22-0, stock: 9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₅₂N₄O₅S.

Cenicriviroc Sulfone-d9, CAS: /, stock: 5.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₃D₉N₄O₅S.

Cenicriviroc-d9, CAS: /, stock: 2.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₃D₉N₄O₄S.

δ-Valerolactam, CAS: 675-20-7, stock: 5.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₉NO.

δ-Valerolactam-d4, CAS: /, stock: 9.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅D₄NO.

(±)-Cetirizine-d4 Dihydrochloride, CAS: 1219803-84-5, stock: 8.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃D₄Cl₃N₂O₃.

(R)-1-[(4-Chlorophenyl)phenylmethyl]piperazine, CAS: 300543-56-0, stock: 5.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉ClN₂.

(R)-Cetirizine Dihydrochloride, CAS: 130018-87-0, stock: 1.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇Cl₃N₂O₃.

(R)-Cetirizine N-Oxide, CAS: 442863-80-1, stock: 6.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅ClN₂O₄.

(R)-Cetirizine-d4 Dihydrochloride, CAS: 1133210-23-7, stock: 5.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃D₄Cl₃N₂O₃.

(R)-De(carboxymethoxy) Cetirizine Acetic Acid, CAS: 942193-17-1, stock: 4.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁ClN₂O₂.

(R)-De(carboxymethoxy) Cetirizine Acetic Acid Methyl Ester, CAS: /, stock: 8.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃ClN₂O₂.

(R)-De(carboxymethyl) Cetirizine Ethanol Dihydrochloride, CAS: 728948-88-7, stock: 3.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₅Cl₃N₂O.

(S)-1-[(4-Chlorophenyl)phenylmethyl]piperazine, CAS: 439858-21-6, stock: 9.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉ClN₂.

(S)-Cetirizine Dihydrochloride, CAS: 163837-48-7, stock: 4.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇Cl₃N₂O₃.

1-[(4-Chlorophenyl)phenylmethyl]-4-(phenylsulfonyl)piperazine, CAS: 1391052-52-0, stock: 8.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₃ClN₂O₂S.

1-[(4-Chlorophenyl)phenylmethyl]piperazine, CAS: 303-26-4, stock: 7.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉ClN₂.

1-[(4-Chlorophenyl)phenylmethyl]piperazine-d8, CAS: 1189925-23-2, stock: 3.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₁D₈ClN₂.

1-[4-[(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]ethanone Hydrochloride, CAS: 19178-80-4, stock: 6.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁ClN₂O  • HCl.

2-((tert-Butyldimethylsilyl)oxy)propyl 2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetate, CAS: /, stock: 5.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₅ClN₂O₄Si.

2-(2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)ethoxy)acetic Acid tert-Butyl Ester, CAS: /, stock: 8.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇ClN₂O₄.

2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic Acid Sodium Salt, CAS: 130018-91-6, stock: 3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄ClN₂NaO₃.

2-(2-Chloroethoxy)acetonitrile, CAS: 31250-08-5, stock: 9.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆ClNO.

2-(tert-Butyldimethylsilanyloxy)propan-1-ol, CAS: 142072-07-9, stock: 9.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₂₂O₂Si.

2-​[2-​[4-​[(R)​-​(4-​Chlorophenyl)​phenylmethyl]​-​1-​piperazinyl]​ethoxy]​-acetamide, CAS: 909779-33-5, stock: 4.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆ClN₃O₂.

2-Oxopropyl 2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetate, CAS: /, stock: 4.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉ClN₂O₄.

2-[4-[(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]ethanol-d4, CAS: 1794756-21-0, stock: 5.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉D₄ClN₂O.

2-[4-[2-(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]ethanol, CAS: 1391053-56-7, stock: 5.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃ClN₂O.

2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]propanoic Acid Ethyl Ester, CAS: 105198-38-7, stock: 2.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₄O₃Si.

4-(p-Chloro-α-phenylbenzyl)-1-piperazineethanol Dihydrochloride, CAS: 164726-80-1, stock: 4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₅Cl₃N₂O.

4-Chloro-alpha-phenyl-benzenemethanamine, CAS: 28022-43-7, stock: 2.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂ClN.

4-[(R)-(4-Chlorophenyl)phenylmethyl]-1-piperazinecarboxaldehyde, CAS: 1136010-98-4, stock: 8.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉ClN₂O.

Cetirizine (2,2-Dimethyl-1,3-dioxolan-4-yl)methyl ester, CAS: /, stock: 1.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₅ClN₂O₅.

Cetirizine 1-[(4-Chlorophenyl)phenylmethyl]piperazine Amide, CAS: /, stock: 9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₂Cl₂N₄O₂.

Cetirizine 1-[(4-Chlorophenyl)phenylmethyl]piperazine Amide-d8, CAS: /, stock: 4.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₃₄D₈Cl₂N₄O₂.

Cetirizine 2-Chloro Impurity Dihydrochloride, CAS: 83881-59-8, stock: 4.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇Cl₃N₂O₃.

Cetirizine 3-Chloro Impurity Dihydrochloride, CAS: 1232460-29-5, stock: 8.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇Cl₃N₂O₃.

Cetirizine 6,6’-O-Lactose Ester Dihydrochloride(6,6’-Mixture), CAS: /, stock: 8.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₅ClN₂O₁₃ • 2( HCl).

Cetirizine Allyl Ester Dihydrochloride, CAS: /, stock: 8.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₁Cl₃N₂O₃.

Cetirizine Amide, CAS: 83881-37-2, stock: 7.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆ClN₃O₂.

Cetirizine Amide Dihydrochloride, CAS: 200707-85-3, stock: 7.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈Cl₃N₃O₂.

Cetirizine Dihydrochloride, CAS: 83881-52-1, stock: 1.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₇Cl₃N₂O₃.

Cetirizine Ethyl Ester, CAS: 246870-46-2, stock: 2.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉ClN₂O₃.

Cetirizine Glycerol Ester Dihydrochloride (Mixture of Diastereomers), CAS: /, stock: 7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₃Cl₃N₂O₅.

Cetirizine Glycol Ester Dihydrochloride, CAS: /, stock: 9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₁ClN₂O₄.

Cetirizine Lactose Ester Hydrochloride Salt (Technical Grade)(α/β-mixture, mixture of diastereomers), CAS: /, stock: 9.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₅ClN₂O₁₃ .HCl.

Cetirizine Methyl Ester Dihydrochloride, CAS: 83881-48-5, stock: 5.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉Cl₃N₂O₃.

Cetirizine N-(2-Ethoxyacetate), CAS: /, stock: 6.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₁ClN₂O₆.

Cetirizine Polyethylene Glycol (PEG) Ester, CAS: 1509941-93-8, stock: 9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅ClN₂O₃[C₂H₄O]n.

Cetirizine Propanediol Ester Dihydrochloride(Mixture of regioisomers), CAS: /, stock: 10g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₃Cl₃N₂O₄.

Cetirizine-d8 Dihydrochloride, CAS: 2070015-04-0, stock: 5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉D₈Cl₃N₂O₃.

Cetirizine-d8 N-(2-Ethoxyacetate), CAS: /, stock: 1.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₃D₈ClN₂O₆.

D-Glucitol 1-[2-[2-[4-[(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetate], CAS: 1243652-35-8, stock: 7.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇ClN₂O₈.

De(carboxymethoxy) Cetirizine Acetic Acid Dihydrochloride, CAS: 1000690-91-4, stock: 9.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁ClN₂O₂ •2HCl.

Deschloro Cetirizine Dihydrochloride, CAS: 83881-54-3, stock: 5.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈Cl₂N₂O₃.

Deschloro Cetirizine tert-Butyl Ester, CAS: /, stock: 9.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₄N₂O₃.

Heptatrimethylsilyl D-Lactose Acetate, CAS: /, stock: 3.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₈₀O₁₂Si₇.

Heptatrimethylsilyl D-Lactose-6-ol, CAS: /, stock: 4.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₇₈O₁₁Si₇.

Heptatrimethylsilyl D-Lactose-6’-ol, CAS: /, stock: 4.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₇₈O₁₁Si₇.

Hexatrimethylsilyl D-Lactose-6-[1-((4-chlorophenyl)(phenyl)methyl)-4-(2-methoxyethyl)piperazine] Ester, CAS: /, stock: 9.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₁₀₁ClN₂O₁₃Si₇.

Hexatrimethylsilyl D-Lactose-6’-[1-((4-chlorophenyl)(phenyl)methyl)-4-(2-methoxyethyl)piperazine] Ester, CAS: /, stock: 6.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₄H₁₀₁ClN₂O₁₃Si₇.

Hydroxyzine Acetic Acid Dihydrochloride, CAS: 83881-56-5, stock: 2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁Cl₃N₂O₄.

Levocetirizine, CAS: 130018-77-8, stock: 1.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅N₂O₃Cl.

N,N-Bis(2-Chloroethyl)-4-methoxybenzenesulfonamide, CAS: 86357-59-7, stock: 3.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅Cl₂NO₃S.

N,N-Bis(2-chloroethyl)-p-toluenesulfonamide, Technical Grade 90%, CAS: 42137-88-2, stock: 4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅Cl₂NO₂S.

N,N-Bis(2-chloroethyl)benzenesulfonamide, CAS: 58023-19-1, stock: 6.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃Cl₂NO₂S.

N,N-Bis(2-chloroethyl)benzenesulfonamide-d5, CAS: /, stock: 2.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈D₅Cl₂NO₂S.

N,N-Bis(2-hydroxyethyl)benzenesulfonamide, CAS: 13127-79-2, stock: 2.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅NO₄S.

N,N’-Dibenzylglycinamide, CAS: 1089-31-2, stock: 3.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₂O.

N-Benzyl-2-[2-[(2-hydroxyethyl)amino]ethoxy]acetamide, CAS: 1391053-09-0, stock: 5.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₀N₂O₃.

N-Benzyl-N-[2-(benzylamino)-2-oxoethyl]-2-chloroacetamide, CAS: 1391051-79-8, stock: 2.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉ClN₂O₂.

Octatrimethylsilyl D-Lactose, CAS: /, stock: 2.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₈₆O₁₁Si₈.

rac Cetirizine N-Oxide > 90% by HPLC(Mixture of Diastereomers), CAS: 1076199-80-8, stock: 9.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅ClN₂O₄.

rac Cetirizine-d8 N-Oxide, CAS: 1216444-13-1, stock: 8.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₇D₈ClN₂O₄.

tert-Butyl (S)-Cetirizine, CAS: 1276303-81-1, stock: 7.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₃ClN₂O₃.

tert-Butyl Cetirizine, CAS: 335017-46-4, stock: 3.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₃ClN₂O₃.

tert-Butyl Cetirizine-d8, CAS: 1189466-71-4, stock: 2.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₅D₈ClN₂O₃.